[{"entities":{"urls":[{"start":266,"end":289,"url":"https://t.co/zkeIt3UI5u","expanded_url":"https://www.gofundme.com/f/3tcws3-help-little-baby-marina-cure-a-marina?utm_source=customer&utm_medium=copy_link-tip&utm_campaign=p_cp+share-sheet","display_url":"gofundme.com/f/3tcws3-help-…"}],"annotations":[{"start":21,"end":26,"probability":0.9065,"type":"Person","normalized_text":"Talita"},{"start":127,"end":149,"probability":0.6505,"type":"Other","normalized_text":"Spinal Muscular Atrophy"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1153006474546896897","id":"1261844200502558722","in_reply_to_user_id":"116716199","text":"@EMA_News My name is Talita and i’m Marina’s mother. She’s a 1 year n 8 month old baby who was born with a rare disease called Spinal Muscular Atrophy and needs the most expensive medication in the world. Help share the campaign to get her medication! PLEASE HELP🇧🇷 https://t.co/zkeIt3UI5u","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1261307500860669955","created_at":"2020-05-17T02:21:15.000Z","referenced_tweets":[{"type":"replied_to","id":"1261307500860669955"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":25,"end":48,"url":"https://t.co/Q8Vra2rlzX","expanded_url":"https://t.co/Q8Vra2rlzX","display_url":"t.co/Q8Vra2rlzX"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":11,"end":24,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"und","author_id":"717711144761298944","id":"1261825908371001347","in_reply_to_user_id":"116716199","text":"@EMA_News \n#NurownEurope https://t.co/Q8Vra2rlzX","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1261825908371001347","created_at":"2020-05-17T01:08:34.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/FnGWwqPXfz","expanded_url":"https://twitter.com/BrainstormCell/status/1259876011795234816","display_url":"twitter.com/BrainstormCell…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":42,"end":49,"tag":"nurown"},{"start":55,"end":68,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1261795022904623105","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health \nALS community needs #nurown now!\n#NurownEurope https://t.co/FnGWwqPXfz","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1261795022904623105","created_at":"2020-05-16T23:05:51.000Z","referenced_tweets":[{"type":"quoted","id":"1259876011795234816"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":174,"end":183,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":11,"end":24,"tag":"NurownEurope"},{"start":42,"end":46,"tag":"ALS"},{"start":79,"end":86,"tag":"NUROWN"},{"start":141,"end":148,"tag":"NUROWN"},{"start":159,"end":172,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"es","author_id":"717711144761298944","id":"1261787559597875207","in_reply_to_user_id":"116716199","text":"@EMA_News \n#NurownEurope \nCómo enferma de #ALS pido la aprobacion acelerada de #NUROWN, me estoy muriendo, no tengo tiempo para esperar más. #NUROWN YAAAA!!!!\n#NurownEurope \n@EMA_News","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"1261787559597875207","created_at":"2020-05-16T22:36:11.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":201,"end":216,"username":"BrainstormCell","id":"802020620"},{"start":235,"end":249,"username":"SKyriakidesEU","id":"2476130260"},{"start":250,"end":259,"username":"euronews","id":"25067168"}],"hashtags":[{"start":219,"end":232,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1261722974224371712","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health ALS Patients are dying everyday. \nIts inhumane/unethical. \nWould you deny insulin to diabetic, chemo to cancer patient? \nWe need an efficient treatment. Please approve NurOwn from @BrainstormCell  \n#NurownEurope \n @SKyriakidesEU @euronews","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-16T18:19:33.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3903,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"},{"start":252,"end":267,"username":"MaryKayTurner1","id":"3270550555"},{"start":268,"end":275,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":238,"end":251,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1261700570546606085","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. \n\nPatients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":3,"quote_count":0},"conversation_id":"1261700570546606085","created_at":"2020-05-16T16:50:31.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":183,"end":206,"url":"https://t.co/9h8mfqSXKE","expanded_url":"https://www.estrategiasdeinversion.com/actualidad/noticias/otras/la-comision-europea-aprueba-adcetrisr-vedotina-n-448451","display_url":"estrategiasdeinversion.com/actualidad/not…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":28,"end":43,"username":"TakedaOncology","id":"321974233"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"941764790","id":"1261289190211366918","in_reply_to_user_id":"116716199","text":"@EMA_News aprueba ADCETRIS® @TakedaOncology (vedotina brentuximab) para el tratamiento de pacientes adultos con linfoma anaplásico sistémico de células grandes no tratado previamente https://t.co/9h8mfqSXKE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1261289190211366918","created_at":"2020-05-15T13:35:51.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":23,"username":"EUnetHTA","id":"56493220"},{"start":230,"end":239,"username":"EUnetHTA","id":"56493220"}],"hashtags":[{"start":248,"end":257,"tag":"ECRD2020"},{"start":258,"end":275,"tag":"BelieveInSpecial"}]},"possibly_sensitive":false,"lang":"en","author_id":"3066012784","id":"1261284333429690371","in_reply_to_user_id":"116716199","text":"@EMA_News and @EUnetHTA have many ways of involving patients across activities and drug development processes, including IMI projects. More info available on their websites. Requests for patient representatives are regular on the @EUnetHTA website\n#ECRD2020 #BelieveInSpecial","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1261284333429690371","created_at":"2020-05-15T13:16:33.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":273,"end":296,"url":"https://t.co/hd5PdKHTyU","expanded_url":"https://twitter.com/IobaUVa/status/1261201423821348865/photo/1","display_url":"pic.twitter.com/hd5PdKHTyU"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":183,"end":191,"username":"IobaUVa","id":"2525123430"},{"start":263,"end":272,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"2525123430","id":"1261201423821348865","in_reply_to_user_id":"116716199","text":"@EMA_News\n alerta a los pacientes sobre el uso de productos de terapia celular no aprobados. Verifica siempre la aprobación de dichos tratamientos, beneficios y riesgos. Actualmente \n@IobaUVa\n se aplica productos de terapia celular, todos ellos aprobados por la \n@AEMPSGOB https://t.co/hd5PdKHTyU","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1261201423821348865","created_at":"2020-05-15T07:47:06.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1261201398785597440"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":107,"end":109,"probability":0.6238,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"986296752","id":"1260962407733555200","in_reply_to_user_id":"116716199","text":"@EMA_News I have a proposal for revolutionary therapeutic method for COVID-19 which is under the review of FDA.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1260949631074217992","created_at":"2020-05-14T15:57:20.000Z","referenced_tweets":[{"type":"replied_to","id":"1260949631074217992"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":84,"end":107,"url":"https://t.co/9TShjgEbGB","expanded_url":"https://twitter.com/JDallySF/status/1260690012825362433","display_url":"twitter.com/JDallySF/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"Cylebo","id":"1201751724"},{"start":18,"end":34,"username":"FDACommissioner","id":"1113782559194984448"},{"start":35,"end":44,"username":"SteveFDA","id":"2904169317"},{"start":45,"end":57,"username":"jaldanabula","id":"607598099"},{"start":58,"end":70,"username":"INSColombia","id":"151922663"},{"start":71,"end":83,"username":"MinSaludCol","id":"371797057"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"379563962","id":"1260920985789874176","in_reply_to_user_id":"116716199","text":"@EMA_News @Cylebo @FDACommissioner @SteveFDA @jaldanabula @INSColombia @MinSaludCol https://t.co/9TShjgEbGB","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1260920985789874176","created_at":"2020-05-14T13:12:44.000Z","referenced_tweets":[{"type":"quoted","id":"1260690012825362433"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":231,"end":254,"url":"https://t.co/Ny0AYdeeuV","expanded_url":"https://tinyurl.com/yajacb5t","display_url":"tinyurl.com/yajacb5t"}],"annotations":[{"start":10,"end":12,"probability":0.4291,"type":"Organization","normalized_text":"EMA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"459335626","id":"1260876405400842240","in_reply_to_user_id":"116716199","text":"@EMA_News EMA is waiving its fees for on-site inspections of manufacturing sites and blood establishments inspected remotely during COVID-19 pandemic, but where the remote inspection could not confirm compliance with GMP standards https://t.co/Ny0AYdeeuV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1260876405400842240","created_at":"2020-05-14T10:15:35.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":104,"end":127,"url":"https://t.co/wjK2PkaRzn","expanded_url":"https://buff.ly/2zyceLC","display_url":"buff.ly/2zyceLC"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":31,"end":42,"tag":"remdesivir"},{"start":128,"end":140,"tag":"coronavirus"},{"start":141,"end":149,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"1176081054505013249","id":"1260476607606726658","in_reply_to_user_id":"116716199","text":"@EMA_News recommends expanding #remdesivir compassionate use to patients not on mechanical ventilation: https://t.co/wjK2PkaRzn\n#coronavirus #COVID19","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1260476607606726658","created_at":"2020-05-13T07:46:56.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":193,"end":216,"url":"https://t.co/MMuMMjIeDg","expanded_url":"https://biotechnologia.pl/farmacja/ema-rekomenduje-rozszerzenie-procedury-compassionate-use-dla-remdesiviru-aby-szerzej-leczyc-ciezka-postac-covid-19,19740","display_url":"biotechnologia.pl/farmacja/ema-r…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":84,"tag":"Remdesivir"},{"start":150,"end":158,"tag":"COVID19"},{"start":218,"end":229,"tag":"SARS_CoV_2"},{"start":230,"end":242,"tag":"koronawirus"}]},"possibly_sensitive":false,"lang":"pl","author_id":"1029999630640140288","id":"1260460570475671552","in_reply_to_user_id":"116716199","text":"@EMA_News  rekomendowało rozszerzenie procedury „compassionate use” leku #Remdesivir o kolejne grupy pacjentów tak, aby więcej osób z ciężką postacią #COVID19 mogło zostać poddanych terapii. \n\nhttps://t.co/MMuMMjIeDg\n\n#SARS_CoV_2 #koronawirus","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1260460570475671552","created_at":"2020-05-13T06:43:12.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":69,"end":92,"url":"https://t.co/wdVWT2oaSV","expanded_url":"https://twitter.com/stevens_nation/status/1257882734610927617","display_url":"twitter.com/stevens_nation…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"sandrac37082124","id":"1156350328553574400"},{"start":27,"end":42,"username":"invimacolombia","id":"374557401"},{"start":43,"end":55,"username":"INSColombia","id":"151922663"},{"start":56,"end":68,"username":"MinSaludCol","id":"371797057"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"379563962","id":"1260400364085485569","in_reply_to_user_id":"116716199","text":"@EMA_News @sandrac37082124 @invimacolombia @INSColombia @MinSaludCol https://t.co/wdVWT2oaSV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1260400364085485569","created_at":"2020-05-13T02:43:58.000Z","referenced_tweets":[{"type":"quoted","id":"1257882734610927617"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"991843255196225536","id":"1260137008636313600","in_reply_to_user_id":"116716199","text":"@EMA_News Where is the NIAD-ACTT data supporting this move? The numbers have just been put out without any further supporting information so far","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1260112814255079425","created_at":"2020-05-12T09:17:29.000Z","referenced_tweets":[{"type":"replied_to","id":"1260112814255079425"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":24,"tag":"clinicaltrial"}]},"possibly_sensitive":false,"lang":"en","author_id":"134450541","id":"1259869616110698499","in_reply_to_user_id":"116716199","text":"@EMA_News #clinicaltrial regulation 536/2014 I have a question regarding the European portal:where we are? Thanks 🙏🏽 for your answer","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1259869616110698499","created_at":"2020-05-11T15:34:58.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"place_id":"09f6a7707f18e0b1","coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3941,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"},{"start":250,"end":265,"username":"MaryKayTurner1","id":"3270550555"},{"start":266,"end":273,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1218445201691283459","id":"1259160731091689472","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1259160731091689472","created_at":"2020-05-09T16:38:07.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3941,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"},{"start":250,"end":265,"username":"MaryKayTurner1","id":"3270550555"},{"start":266,"end":273,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1259156738697302018","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"1259156738697302018","created_at":"2020-05-09T16:22:15.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":155,"end":170,"username":"MaryKayTurner1","id":"3270550555"},{"start":171,"end":178,"username":"Cylebo","id":"1201751724"},{"start":179,"end":193,"username":"david_setboun","id":"1388111186"},{"start":194,"end":205,"username":"ralph_kern","id":"275748639"},{"start":206,"end":221,"username":"BrainstormCell","id":"802020620"},{"start":222,"end":231,"username":"EMA_News","id":"116716199"},{"start":232,"end":246,"username":"EU_Commission","id":"157981564"},{"start":247,"end":259,"username":"Europarl_EN","id":"36329597"},{"start":260,"end":267,"username":"Groote","id":"16297777"},{"start":268,"end":278,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":26,"end":30,"tag":"ALS"},{"start":140,"end":153,"tag":"nurowneurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1259154586356666369","in_reply_to_user_id":"116716199","text":"@EMA_News  can you assure #ALS sufferers the acceleration of the approval of the nurOwn treatment as soon as Brainstorm present the results\n#nurowneurope \n@MaryKayTurner1 @Cylebo @david_setboun @ralph_kern @BrainstormCell @EMA_News @EU_Commission @Europarl_EN @Groote @EU_Health","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":6,"quote_count":1},"conversation_id":"1259154586356666369","created_at":"2020-05-09T16:13:42.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":65,"end":74,"username":"EMA_News","id":"116716199"},{"start":209,"end":218,"username":"EMA_News","id":"116716199"},{"start":237,"end":251,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":40,"end":44,"tag":"ALS"},{"start":173,"end":180,"tag":"Nurown"},{"start":252,"end":265,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1259151955185803265","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health How many more with #ALS have to die for the @EMA_News to act? YEARS of multiple UNPRECEDENTED results, but 1000s are dying without access to lifesaving #Nurown stuck in over a decade long @EMA_News approval process.\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-09T16:03:14.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":272,"end":286,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":287,"end":300,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1259151420420431874","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Will the Emergency Response for COVID medicine be applied to the available treatments for ALS?As you know, there are promising therapies stuck in Ph 2/ 3 are safe and effective. \nOur lives cannot go back to normal with COVID and we cannot get vaccine\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-09T16:01:07.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":208,"end":222,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":223,"end":236,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1259150939618979840","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Where’s the urgency with ALS treatment? People are still dying from ALS everyday and more being diagnosed. Approve Nurown for ALL ALS patients! Stop placebo trails for terminal patients!\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-09T15:59:12.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":261,"end":275,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":276,"end":289,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1259150601100972034","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health As a nurse, please comment on EMA status of review of Nurown trials for ALS? ALS patients have urgency in finding treatment. In my 21 year career I have never witnessed such horrific symptoms and suffering as in ALS. How can you help them?\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-09T15:57:51.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"},{"start":70,"end":85,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":57,"end":64,"tag":"NurOwn"},{"start":95,"end":99,"tag":"ALS"},{"start":100,"end":104,"tag":"MND"},{"start":105,"end":109,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1259064236103348225","in_reply_to_user_id":"116716199","text":"@EMA_News When @EMA_News is going to say something about #NurOwn from @BrainstormCell to treat #ALS #MND #ELA?","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"1259030346105884672","created_at":"2020-05-09T10:14:40.000Z","referenced_tweets":[{"type":"replied_to","id":"1259030346105884672"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1242837336645304327","id":"1258894468851392512","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide.","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":4,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-08T23:00:05.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"805828968683368456","id":"1258330274024194048","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health We need nurowm now! Please help thousands with ALS.","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-07T09:38:10.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"},{"start":157,"end":172,"tag":"SticklerStrong"},{"start":173,"end":180,"tag":"RiseUp"}]},"possibly_sensitive":false,"lang":"en","author_id":"1226358404865761280","id":"1258236133521199112","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW. #SticklerStrong #RiseUp","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-07T03:24:05.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":35,"end":48,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"pt","author_id":"1254408808576815104","id":"1258176984930287618","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Os doentes de #NurownEurope ALS têm 100 % de mortalidade. Precisamos de tratamento URGENTE. Pedimos a aprovação acelerada do NUROWN em todo o mundo AGORA.","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T23:29:03.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":23,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"798958406677757957","id":"1258162298587357189","in_reply_to_user_id":"116716199","text":"@EMA_News #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1258162298587357189","created_at":"2020-05-06T22:30:42.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":38,"end":43,"probability":0.2933,"type":"Place","normalized_text":"Nurown"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":107,"end":120,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"es","author_id":"717711144761298944","id":"1258108180980260870","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Aprobación ya de Nurown para todo el mundo. Los enfermos de ELA nos estamos muriendo.\n#NurownEurope","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T18:55:39.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":33,"tag":"NurowEurope"}]},"possibly_sensitive":false,"lang":"es","author_id":"717711144761298944","id":"1258107481185816576","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurowEurope ALS tienen un 100 % de mortalidad. Necesitamos tratamiento urgente. Pedimos la aprobación acelerada de NUROWN en todo el mundo.","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T18:52:52.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":12,"end":25,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"2427656108","id":"1258102365527388165","in_reply_to_user_id":"116716199","text":"@EMA_News \n\n#NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1258102365527388165","created_at":"2020-05-06T18:32:33.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"135272416","id":"1258069876889059328","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":13,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T16:23:27.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1257268914343555072","id":"1258064188783636480","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":14,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T16:00:50.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"2897724544","id":"1258054319301107713","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T15:21:37.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"522253004","id":"1258038678653489155","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":16,"reply_count":1,"like_count":7,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T14:19:28.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1220105629274198018","id":"1258038640137117697","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":8,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T14:19:19.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1230841227198844930","id":"1258014532825382913","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":16,"reply_count":0,"like_count":10,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:43:32.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"634162888","id":"1258009740883484672","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:24:29.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"634162888","id":"1258009643831484416","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:24:06.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2275064921","id":"1258008681721073666","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide.","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":10,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:20:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":249,"end":263,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":264,"end":277,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1258008069423935488","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health WHY ARE WE NOT GETTING TREATMENT FOR ALS?  YOU ARE WELL AWARE THAT PEOPLE WITH ALS ARE DIEING WITH A DISEASE THAT IS 100% FATAL!  WHY MUST WE BEG AND BEG FOR TREATMENT!  YOU CAN ABSOLUTELY CAN DO SOMETHING NOW! SO DO IT!  NOW!!\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":8,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:17:51.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":166,"end":180,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":181,"end":194,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1258006194955960320","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health ---------------------------------\nDON'T LET MORE PEOPLE DIE , EXISTING NUROWN IN YOUR HANDS. ALS IS 100% LETAL. COVID IS 5%. WHAT ARE YOU DOING?\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":10,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:10:24.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":272,"end":286,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":287,"end":300,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1258005613092777984","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Will the Emergency Response for COVID medicine be applied to the available treatments for ALS? \n There are several promising therapies stuck in Phase 2/ 3 are safe and effective. Our lives cannot go back to normal with COVID and we cannot get vaccine\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":7,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:08:05.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":107,"end":121,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":65,"end":69,"tag":"ALS"},{"start":122,"end":135,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1235085666230448128","id":"1258005349346443265","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health you are working hard for covid 3% of death, #ALS 100%fatal and cruel but no drug WHY?\n@SKyriakidesEU\n#NurownEurope.","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":8,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:07:02.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":102,"end":116,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":117,"end":130,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1235085666230448128","id":"1258004922995531776","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health als patients have 100% mortality. We want the accelerated approval of NUROWN NOW\n@SKyriakidesEU\n#NurownEurope.","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":9,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:05:20.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1229036256409026560","id":"1258004561534607360","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Why not treating als the same way?","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:03:54.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":201,"end":216,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":57,"end":65,"tag":"COVID19"},{"start":66,"end":70,"tag":"ALS"},{"start":176,"end":180,"tag":"ALS"},{"start":217,"end":230,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1235085666230448128","id":"1258004340985528320","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Please, do for ALS what you did for #COVID19 #ALS is 100% fatal! Ask any family who has experienced ALS if it is contagious. They will say; Yes we all had #ALS Approve NUROWN from @BrainstormCell\n#NurownEurope","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":10,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:03:02.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":138,"end":142,"tag":"ALS"},{"start":287,"end":300,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1258004305132609536","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health I, along with 50K other dying patients, would like to know your plans for offering the same speed and flexibility to #ALS trials and treatments as you have for COVID-19, a substantially less serious condition.We’re talking 100% fatal here. Don’t ignore us to death.\n#NurownEurope","public_metrics":{"retweet_count":23,"reply_count":1,"like_count":11,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:02:53.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":86,"end":101,"username":"BrainstormCell","id":"802020620"},{"start":136,"end":150,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":73,"end":80,"tag":"NurOwn"},{"start":104,"end":108,"tag":"ALS"},{"start":109,"end":113,"tag":"MND"},{"start":151,"end":164,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1235085666230448128","id":"1258003984842981376","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health So its possible accelerate regulatory procedures to #NurOwn from @BrainstormCell?  #ALS #MND needs treatments too.\n@SKyriakidesEU\n#NurownEurope","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":10,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-06T12:01:37.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"555363515","id":"1258003295135817729","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T11:58:52.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":32,"end":40,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"1235085666230448128","id":"1258003212004622336","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Understand #COVID19 is a very serious issue. This deserves attention. What you about the people who will continue to suffer after the pandemic? Will you address ALS, with same urgency? This could be a teachable moment for you, to address all deadly diseases with the same urgency","public_metrics":{"retweet_count":14,"reply_count":0,"like_count":9,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T11:58:32.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":25,"tag":"ALS"},{"start":187,"end":200,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1235085666230448128","id":"1258002553247277056","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #ALS sufferers are going to die, why are we ignored while an efficient treatment exist, you can save thousands of lives, we need nurOwn treatment now we have no time\n#NurownEurope","public_metrics":{"retweet_count":26,"reply_count":1,"like_count":15,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-06T11:55:55.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":21,"end":34,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156350328553574400","id":"1258002487342137345","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health #NurownEurope ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide NOW.","public_metrics":{"retweet_count":23,"reply_count":0,"like_count":12,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T11:55:40.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1156350328553574400","id":"1258001868896296965","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health ALS sufferers have 100% mortality. We need URGENT treatment. We ask for the accelerated approval of NUROWN worldwide.","public_metrics":{"retweet_count":21,"reply_count":0,"like_count":10,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-06T11:53:12.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/75TZcw2hvV","expanded_url":"https://twitter.com/abidrazvi/status/1257793100371521537/photo/1","display_url":"pic.twitter.com/75TZcw2hvV"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"96965620","id":"1257793100371521537","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/75TZcw2hvV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1257793100371521537","created_at":"2020-05-05T22:03:38.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1257793092704321536"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":68,"end":91,"url":"https://t.co/gRi3fFUWXc","expanded_url":"https://www.marketscreener.com/INVENTIVA-34031212/news/Inventiva-2019-Annual-Financial-Report-30533753/","display_url":"marketscreener.com/INVENTIVA-3403…"},{"start":92,"end":115,"url":"https://t.co/DRWUfJJKEr","expanded_url":"https://twitter.com/Primal_Digest/status/1257594132052262913/photo/1","display_url":"pic.twitter.com/DRWUfJJKEr"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"InsightsSalutem","id":"847751958593126401"}],"hashtags":{}},"possibly_sensitive":false,"lang":"it","author_id":"138526255","id":"1257594132052262913","in_reply_to_user_id":"116716199","text":"@EMA_News @InsightsSalutem Inventiva : 2019 Annual Financial Report\nhttps://t.co/gRi3fFUWXc https://t.co/DRWUfJJKEr","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1257334596393410565","created_at":"2020-05-05T08:53:00.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Primal for Twitter","attachments":{"media_keys":["3_1257594131188273152"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2897724544","id":"1257423781108293635","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health NUROWN PLEASE","public_metrics":{"retweet_count":15,"reply_count":0,"like_count":8,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-04T21:36:05.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":203,"end":218,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":57,"end":65,"tag":"COVID19"},{"start":66,"end":70,"tag":"ALS"},{"start":177,"end":181,"tag":"ALS"},{"start":221,"end":234,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1257419188165054464","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health Please, do for ALS what you did for #COVID19 #ALS is 100% fatal!\nAsk any family who has experienced ALS if it is contagious. They will say; Yes we all had  #ALS\n\nApprove NUROWN from @BrainstormCell \n\n#NurownEurope","public_metrics":{"retweet_count":20,"reply_count":0,"like_count":11,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-04T21:17:50.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":86,"end":101,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":73,"end":80,"tag":"NurOwn"},{"start":103,"end":107,"tag":"ALS"},{"start":108,"end":112,"tag":"MND"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1257416698598232064","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health So its possible accelerate regulatory procedures to #NurOwn from @BrainstormCell?\n#ALS #MND needs treatments too.","public_metrics":{"retweet_count":24,"reply_count":0,"like_count":13,"quote_count":1},"conversation_id":"1257334596393410565","created_at":"2020-05-04T21:07:57.000Z","referenced_tweets":[{"type":"replied_to","id":"1257334596393410565"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3941,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"},{"start":250,"end":265,"username":"MaryKayTurner1","id":"3270550555"},{"start":266,"end":273,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1228360145970827266","id":"1257039234592124929","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"1257039234592124929","created_at":"2020-05-03T20:08:02.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":45,"end":47,"probability":0.4039,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":115,"end":130,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":246,"end":259,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1256652291505037312","in_reply_to_user_id":"116716199","text":"@EMA_News  50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait!\n\n Please help us!\n Move to approve!\n #NurownEurope","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"1256652291505037312","created_at":"2020-05-02T18:30:28.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3941,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"},{"start":250,"end":265,"username":"MaryKayTurner1","id":"3270550555"},{"start":266,"end":273,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1256614678962339842","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":5,"quote_count":0},"conversation_id":"1256614678962339842","created_at":"2020-05-02T16:01:00.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":58,"end":63,"probability":0.2547,"type":"Other","normalized_text":"Nurown"},{"start":94,"end":96,"probability":0.9043,"type":"Place","normalized_text":"USA"},{"start":220,"end":222,"probability":0.5672,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1200326935005532160","id":"1256434695526584321","in_reply_to_user_id":"116716199","text":"@EMA_News Hello, Have you enquired or started a review of Nurown, from Brainstorm Cell in the USA. It's a peerless life saving ALS treatment that's nearing the end of Phase 3 trials but may be put forward imminently for FDA review. Thank you.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1256434695526584321","created_at":"2020-05-02T04:05:49.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"place_id":"7d3d8e59b4047344","coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":262,"end":285,"url":"https://t.co/cOYlHA3Am5","expanded_url":"https://www.sciencedirect.com/science/article/pii/S1551741120303910","display_url":"sciencedirect.com/science/articl…"}],"annotations":[{"start":59,"end":63,"probability":0.4109,"type":"Other","normalized_text":"Lupus"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"4341703709","id":"1255834276869922818","in_reply_to_user_id":"116716199","text":"@EMA_News Hydroxychloroquine is in clinical use for RA and Lupus since more than 5 decades. This warning should be clearly stated for concomitant use with other QT prolonging drugs, particularly Azithromycin. Read the below recent study from US-FAERS database👇\n\nhttps://t.co/cOYlHA3Am5","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-30T12:19:58.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":150,"end":173,"url":"https://t.co/GBqlnIsTo6","expanded_url":"https://cornallergyadvocacyresources.blogspot.com/2017/04/corn-allergy-statistics-monthly.html","display_url":"…allergyadvocacyresources.blogspot.com/2017/04/corn-a…","status":200,"title":"Corn Allergy Statistics (Monthly)","description":"Update : In the future, corn allergy statistics will be calculated on a quarterly basis.  EMERGING CORN ALLERGY CRISIS/STATISTICS:      ...","unwound_url":"https://cornallergyadvocacyresources.blogspot.com/2017/04/corn-allergy-statistics-monthly.html"}],"annotations":[{"start":23,"end":55,"probability":0.4803,"type":"Product","normalized_text":"Month-End Corn Allergy Statistics"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"758377092853686272","id":"1255744142870708229","in_reply_to_user_id":"116716199","text":"@EMA_News April, 2020, Month-End Corn Allergy Statistics: 919.3% Increase in 82 Months\n(Corn is ubiquitous and corn allergen warnings are voluntary.)\nhttps://t.co/GBqlnIsTo6","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255744142870708229","created_at":"2020-04-30T06:21:48.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":271,"end":294,"url":"https://t.co/4Th5epSNUt","expanded_url":"https://twitter.com/Gema19522252/status/1255569255808073735/photo/1","display_url":"pic.twitter.com/4Th5epSNUt"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"salvadorilla","id":"233240412"},{"start":24,"end":35,"username":"sanidadgob","id":"232124120"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"1161561387950321664","id":"1255569255808073735","in_reply_to_user_id":"116716199","text":"@EMA_News @salvadorilla @sanidadgob \nTodas las que hemos tenido problemas, han sido muchos años, entre pruebas médicas, y diferentes médicos. Muchos estudios hay, otra cosa es que no queramos ver,  no hay diferencia entre las mujeres, el sistema reproductivo es el mismo https://t.co/4Th5epSNUt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255569255808073735","created_at":"2020-04-29T18:46:52.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1255569245360066562"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/kF4NA4CEuF","expanded_url":"https://www.youtube.com/watch?v=iBHRTf9Q7eA","display_url":"youtube.com/watch?v=iBHRTf…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":51,"end":62,"tag":"Leronlimab"},{"start":75,"end":83,"tag":"Cytodyn"},{"start":161,"end":165,"tag":"FDA"},{"start":214,"end":225,"tag":"Leronlimab"}]},"possibly_sensitive":false,"lang":"en","author_id":"1238900646276820992","id":"1255533259955621889","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/kF4NA4CEuF\nHere's the CURE, #Leronlimab antibody by #Cytodyn helps mild, moderate &amp; severely ill patients RECOVER in 1 to 7 days! Two #FDA approved trials, this IS a RANTES driven virus, #Leronlimab slows/stops the cytokine storm!","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1255420095838502915","created_at":"2020-04-29T16:23:50.000Z","referenced_tweets":[{"type":"replied_to","id":"1255420095838502915"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":36,"end":59,"url":"https://t.co/d3vekuXZTJ","expanded_url":"https://www.empr.com/home/news/essure-implanted-contraceptive-postmarketing-safety-bayer/","display_url":"empr.com/home/news/essu…","status":200,"unwound_url":"https://www.empr.com/home/news/essure-implanted-contraceptive-postmarketing-safety-bayer/"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"salvadorilla","id":"233240412"},{"start":24,"end":35,"username":"sanidadgob","id":"232124120"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1161561387950321664","id":"1255451932703023104","in_reply_to_user_id":"116716199","text":"@EMA_News\n@salvadorilla\n@sanidadgob\nhttps://t.co/d3vekuXZTJ","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255451932703023104","created_at":"2020-04-29T11:00:40.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/ZBTGxKUYXx","expanded_url":"https://twitter.com/EuropaBio/status/1255429431390277632/photo/1","display_url":"pic.twitter.com/ZBTGxKUYXx"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"19642657","id":"1255429431390277632","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/ZBTGxKUYXx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255116778574880774","created_at":"2020-04-29T09:31:15.000Z","referenced_tweets":[{"type":"replied_to","id":"1255116778574880774"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1255429411853209601"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/GhyB1d792o","expanded_url":"https://twitter.com/JerryTobias12/status/1255207724830330884","display_url":"twitter.com/JerryTobias12/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1239582067832360965","id":"1255237724665262085","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/GhyB1d792o","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255237724665262085","created_at":"2020-04-28T20:49:29.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":130,"end":153,"url":"https://t.co/nA2NGkEyaI","expanded_url":"https://twitter.com/BobBrokman/status/1255225739596779521/photo/1","display_url":"pic.twitter.com/nA2NGkEyaI"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"860222703491399680","id":"1255225739596779521","in_reply_to_user_id":"116716199","text":"@EMA_News Here is a summary of what the HCQ situation is today and why it's important that people demand their freedom of choice: https://t.co/nA2NGkEyaI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-28T20:01:51.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1255225481588363265"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":208,"end":231,"url":"https://t.co/V0wW6rczOz","expanded_url":"https://bit.ly/2xXBXNp","display_url":"bit.ly/2xXBXNp"},{"start":232,"end":255,"url":"https://t.co/7SZ9ISSklf","expanded_url":"https://twitter.com/rkessler05/status/1255137741739683849","display_url":"twitter.com/rkessler05/sta…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":184,"end":192,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"965926911212998656","id":"1255139744440176645","in_reply_to_user_id":"116716199","text":"@EMA_News and international regulators call for large, well-designed, controlled clinical trials capable of giving robust evidence of the safety and efficacy of proposed therapies for #COVID19. Details here: https://t.co/V0wW6rczOz https://t.co/7SZ9ISSklf","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255139744440176645","created_at":"2020-04-28T14:20:09.000Z","referenced_tweets":[{"type":"quoted","id":"1255137741739683849"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":170,"end":184,"probability":0.9794,"type":"Person","normalized_text":"Jacob Glanville"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"MedicijnNL","id":"883813550"},{"start":22,"end":32,"username":"EU_Health","id":"606325697"},{"start":33,"end":41,"username":"ECDC_EU","id":"204752573"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"460996127","id":"1255110491174813696","in_reply_to_user_id":"116716199","text":"@EMA_News @MedicijnNL @EU_Health @ECDC_EU So.., basically you TELL us to only believe yóu (old-boys-network) guys! Hmmm, maybe you should check these folks yourselfs..?? Jacob Glanville biotech company Distributed Bio: in sept a vaccin that works &lt; 20 min and this one; Oxfort Uni also ready in sept..!! Where are you?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1252927767080992768","created_at":"2020-04-28T12:23:54.000Z","referenced_tweets":[{"type":"replied_to","id":"1252927767080992768"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":22,"end":45,"url":"https://t.co/WDh0qaCS4w","expanded_url":"https://twitter.com/gwendolynrain/status/1254942170114654210","display_url":"twitter.com/gwendolynrain/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"sanidadgob","id":"232124120"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1161561387950321664","id":"1255084844142546946","in_reply_to_user_id":"116716199","text":"@EMA_News @sanidadgob https://t.co/WDh0qaCS4w","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1255084844142546946","created_at":"2020-04-28T10:41:59.000Z","referenced_tweets":[{"type":"quoted","id":"1254942170114654210"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/xBe4HaZqu8","expanded_url":"https://buff.ly/33UYl5x","display_url":"buff.ly/33UYl5x"},{"start":136,"end":159,"url":"https://t.co/FI7cyudp1Q","expanded_url":"https://twitter.com/CytonBio/status/1255031504096419840/photo/1","display_url":"pic.twitter.com/FI7cyudp1Q"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":65,"tag":"VeterinaryMedicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1255031504096419840","in_reply_to_user_id":"116716199","text":"@EMA_News report - Ten years of MUMS: 22 new #VeterinaryMedicines authorised for minor uses and minor species. \nhttps://t.co/xBe4HaZqu8 https://t.co/FI7cyudp1Q","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1255031504096419840","created_at":"2020-04-28T07:10:02.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1255031502347407365"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"it","author_id":"1240212639554338816","id":"1254884571763675136","in_reply_to_user_id":"116716199","text":"@EMA_News Idrossiclorochina da 70 anni nessun problema! Il vostro business è un problema!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-27T21:26:11.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"lv","author_id":"1240212639554338816","id":"1254879372026228736","in_reply_to_user_id":"116716199","text":"@EMA_News Idioti","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-27T21:05:31.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3425936409","id":"1254677736242786306","in_reply_to_user_id":"116716199","text":"@EMA_News ‘Recommended’? Missed opportunity to add an adverb (strongly, firmly) or use a stronger command verb (directed, warned), or better still a modal verb (should, must).","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-27T07:44:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":37,"end":60,"url":"https://t.co/qS1iXRREG2","expanded_url":"https://www.fda.gov/news-events/press-announcements/fda-provides-updates-adverse-event-reports-and-postmarket-activities-associated-essure","display_url":"fda.gov/news-events/pr…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":24,"username":"salvadorilla","id":"233240412"},{"start":25,"end":36,"username":"sanidadgob","id":"232124120"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1161561387950321664","id":"1254150523701338112","in_reply_to_user_id":"116716199","text":"@EMA_News \n@salvadorilla\n@sanidadgob\nhttps://t.co/qS1iXRREG2","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1254150523701338112","created_at":"2020-04-25T20:49:20.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":23,"end":46,"url":"https://t.co/CujEE3qd3R","expanded_url":"https://twitter.com/FDADeviceInfo/status/1254149440815890433","display_url":"twitter.com/FDADeviceInfo/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":22,"username":"sanidadgob","id":"232124120"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1161561387950321664","id":"1254149722631213056","in_reply_to_user_id":"116716199","text":"@EMA_News \n@sanidadgob https://t.co/CujEE3qd3R","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1254149722631213056","created_at":"2020-04-25T20:46:09.000Z","referenced_tweets":[{"type":"quoted","id":"1254149440815890433"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3941,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"},{"start":250,"end":265,"username":"MaryKayTurner1","id":"3270550555"},{"start":266,"end":273,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1254135345379258369","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":5,"quote_count":0},"conversation_id":"1254135345379258369","created_at":"2020-04-25T19:49:01.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":281,"end":304,"url":"https://t.co/UG1NZgt2tr","expanded_url":"https://twitter.com/MaraEraalta7/status/1254082433047236610/photo/1","display_url":"pic.twitter.com/UG1NZgt2tr"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":120,"end":135,"username":"BrainstormCell","id":"802020620"},{"start":243,"end":258,"username":"MaryKayTurner1","id":"3270550555"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"717711144761298944","id":"1254082433047236610","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 peopledying from ALS. Parientes need acceso total a promising treatment called NurOwn from @BrainstormCell that os stuck un a pase 3 clínicas trial. Patients do not have time to wait! Please help us!\n@NurownEurope\n@MaryKayTurner1 @Cycebo\n@david_setbou https://t.co/UG1NZgt2tr","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1254082433047236610","created_at":"2020-04-25T16:18:46.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1254082422431518720"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":120,"end":135,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":227,"end":240,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1200563024903450624","id":"1254013128632938496","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50,000 European ALS sufferers. pALS need early access to a promising treatment called NurOwn from @BrainstormCell that is in a phase 3 clinical trial.\n\nPatients do not have time to wait. Please act NOW. \n\n#NurownEurope","public_metrics":{"retweet_count":26,"reply_count":1,"like_count":12,"quote_count":0},"conversation_id":"1254013128632938496","created_at":"2020-04-25T11:43:22.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":29,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":50,"end":59,"tag":"prevenar"},{"start":61,"end":71,"tag":"pneumovax"},{"start":72,"end":81,"tag":"pnwumo23"},{"start":94,"end":102,"tag":"covid19"}]},"possibly_sensitive":false,"lang":"en","author_id":"1215029620250152962","id":"1253795110611030016","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health @ECDC_EU Any suggestions for #prevenar  #pneumovax #pnwumo23 vaccine for #covid19 side infections?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1252927767080992768","created_at":"2020-04-24T21:17:03.000Z","referenced_tweets":[{"type":"replied_to","id":"1252927767080992768"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3915,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":97,"end":112,"username":"BrainstormCell","id":"802020620"},{"start":170,"end":185,"username":"MaryKayTurner1","id":"3270550555"},{"start":186,"end":200,"username":"david_setboun","id":"1388111186"},{"start":201,"end":212,"username":"ralph_kern","id":"275748639"},{"start":213,"end":228,"username":"BrainstormCell","id":"802020620"},{"start":229,"end":238,"username":"EMA_News","id":"116716199"},{"start":239,"end":253,"username":"EU_Commission","id":"157981564"},{"start":254,"end":266,"username":"Europarl_EN","id":"36329597"},{"start":267,"end":276,"username":"LuchaEla","id":"1190393189053685761"}],"hashtags":[{"start":156,"end":169,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"555363515","id":"1253708376405692417","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. #NurownEurope\n@MaryKayTurner1 @david_setboun @ralph_kern @BrainstormCell @EMA_News @EU_Commission @Europarl_EN @LuchaEla","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253708376405692417","created_at":"2020-04-24T15:32:24.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1035686784200585222","id":"1253653084082974721","in_reply_to_user_id":"116716199","text":"@EMA_News You cannot get to see or speak to a doctor ... are you for real... ?","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"1253650974155124737","created_at":"2020-04-24T11:52:41.000Z","referenced_tweets":[{"type":"replied_to","id":"1253650974155124737"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":31,"end":54,"url":"https://t.co/CV4TV2v8et","expanded_url":"https://bit.ly/3aA1Jo2","display_url":"bit.ly/3aA1Jo2"},{"start":55,"end":78,"url":"https://t.co/rWaBhekTri","expanded_url":"https://twitter.com/P_Martelletti/status/1253611318071963648/photo/1","display_url":"pic.twitter.com/rWaBhekTri"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1213597848","id":"1253611318071963648","in_reply_to_user_id":"116716199","text":"@EMA_News program for CoViD-19 https://t.co/CV4TV2v8et https://t.co/rWaBhekTri","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253611318071963648","created_at":"2020-04-24T09:06:43.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1253610419362639872"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":200,"end":223,"url":"https://t.co/11AIdBJAuk","expanded_url":"https://twitter.com/nouvelleurope/status/1253557944517562369/photo/1","display_url":"pic.twitter.com/11AIdBJAuk"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"fr","author_id":"807902284365660160","id":"1253557944517562369","in_reply_to_user_id":"116716199","text":"@EMA_News Comme eux disent en le même rapport, l'hydroxychloroquine, peut-être dangereuse,notamment prises à forte dose \nEn plus est dangereuse si se avère efficace pour l’économie des laboratoires ? https://t.co/11AIdBJAuk","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-24T05:34:38.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter for iPad","attachments":{"media_keys":["3_1253557937680908288"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3952,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"94326309","id":"1253447443435397121","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope","public_metrics":{"retweet_count":22,"reply_count":0,"like_count":10,"quote_count":0},"conversation_id":"1253447443435397121","created_at":"2020-04-23T22:15:33.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":155,"end":178,"url":"https://t.co/9OtKXU2WkZ","expanded_url":"https://twitter.com/VirusWar/status/1253094951195459584","display_url":"twitter.com/VirusWar/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":55,"end":74,"tag":"hydroxychloroquine"},{"start":79,"end":92,"tag":"azithromycin"}]},"possibly_sensitive":false,"lang":"en","author_id":"2366128891","id":"1253442218775494660","in_reply_to_user_id":"116716199","text":"@EMA_News A recent study from pharmacologists say that #hydroxychloroquine and #azithromycin taken together are safe if heart rhythm is monitored properly https://t.co/9OtKXU2WkZ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-23T21:54:47.000Z","referenced_tweets":[{"type":"quoted","id":"1253094951195459584"},{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/T9jWy3d5L9","expanded_url":"https://melwy.com/blog/coronavirus-therapeutics-real-world-evidence-with-ai-can-deliver-results-faster","display_url":"melwy.com/blog/coronavir…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"761510396159225856","id":"1253320388743843842","in_reply_to_user_id":"116716199","text":"@EMA_News Coronavirus therapeutics - Real World Evidence with AI can deliver results faster\nhttps://t.co/T9jWy3d5L9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-23T13:50:40.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":16,"username":"strnb","id":"337613918"}],"hashtags":{}},"possibly_sensitive":false,"lang":"fr","author_id":"315795677","id":"1253309857064800259","in_reply_to_user_id":"116716199","text":"@EMA_News @strnb maintenant c'est clair : le médoc ressemble à un calisson. Et le calisson c'est aix, pas marseille.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1253288718351380480","created_at":"2020-04-23T13:08:49.000Z","referenced_tweets":[{"type":"replied_to","id":"1253288718351380480"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":139,"end":141,"probability":0.8399,"type":"Organization","normalized_text":"FDA"},{"start":201,"end":203,"probability":0.8391,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"365004971","id":"1253271936307781632","in_reply_to_user_id":"116716199","text":"@EMA_News That’s great. Where are you on approving the new Cancer drugs  critical to the many, Enhertu / Tucatinib, you are way behind the FDA. The speed of new approvals needs to be much quicker once FDA approved, you are just far too slow to provide marketing authorisation to Pharma.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1253270080366039040","created_at":"2020-04-23T10:38:08.000Z","referenced_tweets":[{"type":"replied_to","id":"1253270080366039040"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":60,"end":65,"probability":0.9996,"type":"Place","normalized_text":"Brazil"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":29,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":96,"end":105,"tag":"COVIDー19"}]},"possibly_sensitive":false,"lang":"en","author_id":"163846201","id":"1253237796631982081","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health @ECDC_EU It has been so tragic here in Brazil. Instead of fighting against #COVIDー19 politicians from Right and Left prefer make politc and Brazilians down. 😢","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1252927767080992768","created_at":"2020-04-23T08:22:29.000Z","referenced_tweets":[{"type":"replied_to","id":"1252927767080992768"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"place_id":"6cb473206b0e7b8e","coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":91,"end":114,"url":"https://t.co/K5S6buruU3","expanded_url":"https://www.lifescienceleader.com/doc/ema-publishes-noteworthy-updates-amidst-avalanche-of-covid-communications-0001","display_url":"lifescienceleader.com/doc/ema-publis…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":65,"end":73,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"19751597","id":"1252590638316621824","in_reply_to_user_id":"116716199","text":"@EMA_News EMA Publishes 3 Noteworthy Updates Amidst Avalanche of #COVID19 Communications   https://t.co/K5S6buruU3","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1252590638316621824","created_at":"2020-04-21T13:30:54.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":177,"end":200,"url":"https://t.co/GHpw8PmLaw","expanded_url":"https://bit.ly/3agTlK0","display_url":"bit.ly/3agTlK0"},{"start":201,"end":224,"url":"https://t.co/pW05laACbd","expanded_url":"https://twitter.com/PrimeVigilance/status/1252238568526774275/photo/1","display_url":"pic.twitter.com/pW05laACbd"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":55,"end":60,"tag":"PRAC"}]},"possibly_sensitive":false,"lang":"en","author_id":"2615562036","id":"1252238568526774275","in_reply_to_user_id":"116716199","text":"@EMA_News &amp;PR: 14-17 April 2020 Meeting highlights #PRAC on all topics discussed by the PRAC and recommendations on risk management of medicines for human available now at: https://t.co/GHpw8PmLaw https://t.co/pW05laACbd","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1252238568526774275","created_at":"2020-04-20T14:11:54.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1252238530107060224"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":111,"end":134,"url":"https://t.co/ph3wB9OQw7","expanded_url":"https://twitter.com/DrHannahBB/status/1252009624410226696","display_url":"twitter.com/DrHannahBB/sta…"}],"annotations":[{"start":60,"end":61,"probability":0.646,"type":"Organization","normalized_text":"EU"},{"start":74,"end":98,"probability":0.4733,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"800075637725622272","id":"1252015862577606657","in_reply_to_user_id":"116716199","text":"@EMA_News said this some time ago. Benefits of belonging to EU is you get European Medicines Agency news first https://t.co/ph3wB9OQw7","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1252015862577606657","created_at":"2020-04-19T23:26:57.000Z","referenced_tweets":[{"type":"quoted","id":"1252009624410226696"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/5OnCGVTYBp","expanded_url":"https://twitter.com/ZeJi07626937/status/1251547062522523648/photo/1","display_url":"pic.twitter.com/5OnCGVTYBp"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"},{"start":38,"end":45,"username":"Groote","id":"16297777"},{"start":46,"end":56,"username":"EU_Health","id":"606325697"},{"start":57,"end":71,"username":"SKyriakidesEU","id":"2476130260"},{"start":72,"end":88,"username":"eupatientsforum","id":"545343465"},{"start":89,"end":94,"username":"epic","id":"1393164308"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"705827606","id":"1251549978532761601","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN @Groote @EU_Health @SKyriakidesEU @eupatientsforum @epic https://t.co/5OnCGVTYBp","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1251549978532761601","created_at":"2020-04-18T16:35:42.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1251547031795126272"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":276,"end":299,"url":"https://t.co/QCXfavuGGk","expanded_url":"https://twitter.com/Ana99788279/status/1251549401409093633/photo/1","display_url":"pic.twitter.com/QCXfavuGGk"}],"annotations":[{"start":56,"end":58,"probability":0.3855,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":127,"end":142,"username":"BrainstormCell","id":"802020620"},{"start":252,"end":267,"username":"MaryKayTurner1","id":"3270550555"},{"start":268,"end":275,"username":"Cylebo","id":"1201751724"}],"hashtags":[{"start":238,"end":251,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1239582067832360965","id":"1251549401409093633","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from \n@BrainstormCell\n that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope\n@MaryKayTurner1 @Cylebo https://t.co/QCXfavuGGk","public_metrics":{"retweet_count":11,"reply_count":1,"like_count":6,"quote_count":0},"conversation_id":"1251549401409093633","created_at":"2020-04-18T16:33:24.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1251549376369045504"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/VPzHCHqMqN","expanded_url":"https://twitter.com/ZeJi07626937/status/1251547062522523648/photo/1","display_url":"pic.twitter.com/VPzHCHqMqN"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"},{"start":38,"end":45,"username":"Groote","id":"16297777"},{"start":46,"end":56,"username":"EU_Health","id":"606325697"},{"start":57,"end":71,"username":"SKyriakidesEU","id":"2476130260"},{"start":72,"end":88,"username":"eupatientsforum","id":"545343465"},{"start":89,"end":94,"username":"epic","id":"1393164308"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1235085666230448128","id":"1251547062522523648","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN @Groote @EU_Health @SKyriakidesEU @eupatientsforum @epic https://t.co/VPzHCHqMqN","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1251547062522523648","created_at":"2020-04-18T16:24:06.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1251547031795126272"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3952,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"705827606","id":"1251544408937205760","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":8,"quote_count":0},"conversation_id":"1251544408937205760","created_at":"2020-04-18T16:13:34.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":95,"end":118,"url":"https://t.co/6cDh3kYTiL","expanded_url":"https://twitter.com/ZeJi07626937/status/1251544107505389570/photo/1","display_url":"pic.twitter.com/6cDh3kYTiL"},{"start":95,"end":118,"url":"https://t.co/6cDh3kYTiL","expanded_url":"https://twitter.com/ZeJi07626937/status/1251544107505389570/photo/1","display_url":"pic.twitter.com/6cDh3kYTiL"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"},{"start":38,"end":45,"username":"Groote","id":"16297777"},{"start":46,"end":56,"username":"EU_Health","id":"606325697"},{"start":57,"end":71,"username":"SKyriakidesEU","id":"2476130260"},{"start":72,"end":88,"username":"eupatientsforum","id":"545343465"},{"start":89,"end":94,"username":"epic","id":"1393164308"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1235085666230448128","id":"1251544107505389570","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN @Groote @EU_Health @SKyriakidesEU @eupatientsforum @epic https://t.co/6cDh3kYTiL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1251544107505389570","created_at":"2020-04-18T16:12:22.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1251544085896269824","3_1251544100676997126"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":124,"end":147,"url":"https://t.co/DivrjrsXrY","expanded_url":"https://twitter.com/ZeJi07626937/status/1251543551625830401/photo/1","display_url":"pic.twitter.com/DivrjrsXrY"},{"start":124,"end":147,"url":"https://t.co/DivrjrsXrY","expanded_url":"https://twitter.com/ZeJi07626937/status/1251543551625830401/photo/1","display_url":"pic.twitter.com/DivrjrsXrY"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"},{"start":38,"end":45,"username":"Groote","id":"16297777"},{"start":46,"end":56,"username":"EU_Health","id":"606325697"},{"start":57,"end":71,"username":"SKyriakidesEU","id":"2476130260"},{"start":72,"end":88,"username":"eupatientsforum","id":"545343465"},{"start":89,"end":97,"username":"EPHA_EU","id":"184756856"},{"start":98,"end":105,"username":"EUpALS","id":"802796089711673344"},{"start":106,"end":113,"username":"ENCALS","id":"223581319"},{"start":114,"end":123,"username":"LuchaEla","id":"1190393189053685761"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1235085666230448128","id":"1251543551625830401","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN @Groote @EU_Health @SKyriakidesEU @eupatientsforum @EPHA_EU @EUpALS @ENCALS @LuchaEla https://t.co/DivrjrsXrY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1251543551625830401","created_at":"2020-04-18T16:10:09.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1251543489453740034","3_1251543520311234561"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3952,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":236,"end":249,"tag":"NurownEurope"}]},"possibly_sensitive":false,"lang":"en","author_id":"1237339698936328200","id":"1251542709640323080","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us! #NurownEurope","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":10,"quote_count":0},"conversation_id":"1251542709640323080","created_at":"2020-04-18T16:06:49.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":124,"end":147,"url":"https://t.co/jhsUippyDL","expanded_url":"https://twitter.com/ZeJi07626937/status/1251541269219811328/photo/1","display_url":"pic.twitter.com/jhsUippyDL"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"},{"start":38,"end":45,"username":"Groote","id":"16297777"},{"start":46,"end":56,"username":"EU_Health","id":"606325697"},{"start":57,"end":71,"username":"SKyriakidesEU","id":"2476130260"},{"start":72,"end":88,"username":"eupatientsforum","id":"545343465"},{"start":89,"end":97,"username":"EPHA_EU","id":"184756856"},{"start":98,"end":105,"username":"EUpALS","id":"802796089711673344"},{"start":106,"end":113,"username":"ENCALS","id":"223581319"},{"start":114,"end":123,"username":"LuchaEla","id":"1190393189053685761"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1235085666230448128","id":"1251541269219811328","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN @Groote @EU_Health @SKyriakidesEU @eupatientsforum @EPHA_EU @EUpALS @ENCALS @LuchaEla https://t.co/jhsUippyDL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1251541269219811328","created_at":"2020-04-18T16:01:05.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1251541266480926721"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":96,"end":119,"url":"https://t.co/JAhXiqg7kI","expanded_url":"https://twitter.com/BestForBritain/status/1250693853440552962","display_url":"twitter.com/BestForBritain…"}],"annotations":[{"start":93,"end":94,"probability":0.8786,"type":"Place","normalized_text":"UK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"800075637725622272","id":"1251097109916418048","in_reply_to_user_id":"116716199","text":"@EMA_News works for everybody’s safety. We need its regulations and expertise to protect the UK https://t.co/JAhXiqg7kI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1251097109916418048","created_at":"2020-04-17T10:36:09.000Z","referenced_tweets":[{"type":"quoted","id":"1250693853440552962"}],"source":"Twitter for iPad","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":245,"end":268,"url":"https://t.co/NHl9jFmvlt","expanded_url":"https://twitter.com/EMA_News/status/1250800566860763139","display_url":"twitter.com/EMA_News/statu…"}],"annotations":[{"start":30,"end":47,"probability":0.2641,"type":"Organization","normalized_text":"Interferon Beta 1a"},{"start":89,"end":94,"probability":0.9905,"type":"Place","normalized_text":"Europe"},{"start":97,"end":98,"probability":0.9693,"type":"Place","normalized_text":"UK"},{"start":101,"end":106,"probability":0.9969,"type":"Place","normalized_text":"Russia"},{"start":109,"end":113,"probability":0.9963,"type":"Place","normalized_text":"China"},{"start":116,"end":119,"probability":0.9893,"type":"Place","normalized_text":"Cuba"},{"start":221,"end":222,"probability":0.9807,"type":"Place","normalized_text":"UK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":186,"end":199,"username":"Synairgenplc","id":"2994280721"}],"hashtags":[{"start":226,"end":235,"tag":"Covid_19"},{"start":236,"end":244,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"775657289831317504","id":"1251096251602526209","in_reply_to_user_id":"116716199","text":"@EMA_News is seems crazy that Interferon Beta 1a trials are not being accelerated across Europe. UK, Russia, China, Cuba and other countries are all seeing positive results. SNG001 from @Synairgenplc now on trials across UK ! #Covid_19 #COVID19 https://t.co/NHl9jFmvlt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1251096251602526209","created_at":"2020-04-17T10:32:45.000Z","referenced_tweets":[{"type":"quoted","id":"1250800566860763139"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":215,"end":238,"url":"https://t.co/YdTTybdzVg","expanded_url":"https://www.ema.europa.eu/en/news/guidance-regulatory-requirements-context-covid-19-pandemic","display_url":"ema.europa.eu/en/news/guidan…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":240,"end":255,"tag":"pharmaceutical"},{"start":256,"end":266,"tag":"medicines"},{"start":267,"end":275,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"631043895","id":"1251069884894756864","in_reply_to_user_id":"116716199","text":"@EMA_News have released this Q&amp;A document to provide some guidance on regulatory adaptations arising from the current pandemic, including measures to address constraints MAA holders may currently be faced with.\nhttps://t.co/YdTTybdzVg  #pharmaceutical #medicines #COVID19","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1251069884894756864","created_at":"2020-04-17T08:47:58.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":201,"end":216,"username":"BrainstormCell","id":"802020620"},{"start":219,"end":234,"username":"MaryKayTurner1","id":"3270550555"},{"start":235,"end":242,"username":"Cylebo","id":"1201751724"},{"start":243,"end":257,"username":"david_setboun","id":"1388111186"},{"start":258,"end":269,"username":"ralph_kern","id":"275748639"}],"hashtags":[{"start":187,"end":194,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1250519703128281088","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health ALS Patients are dying everyday. Its inhumane/unethical. Would you deny insulin to diabetic, chemo to cancer patient? We need an efficient treatment. Please  approve #NurOwn  from @BrainstormCell \n\n@MaryKayTurner1 @Cylebo @david_setboun @ralph_kern","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"1248199941115252736","created_at":"2020-04-15T20:21:45.000Z","referenced_tweets":[{"type":"replied_to","id":"1248199941115252736"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":177,"end":200,"url":"https://t.co/VWomXWFCd8","expanded_url":"https://bit.ly/2yc9fIc","display_url":"bit.ly/2yc9fIc"},{"start":201,"end":224,"url":"https://t.co/aTZkwdyFVM","expanded_url":"https://twitter.com/CRO_Forum/status/1250424019599294464/photo/1","display_url":"pic.twitter.com/aTZkwdyFVM"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":18,"tag":"COVID19"},{"start":152,"end":164,"tag":"coronavirus"}]},"possibly_sensitive":false,"lang":"en","author_id":"3940681335","id":"1250424019599294464","in_reply_to_user_id":"116716199","text":"@EMA_News #COVID19 response team has been in contact with developers of around 40 therapeutic medicines, allowing for better understanding of potential #coronavirus treatments. https://t.co/VWomXWFCd8 https://t.co/aTZkwdyFVM","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1250424019599294464","created_at":"2020-04-15T14:01:32.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1250424015694360580"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2756183928","id":"1250248596018077696","in_reply_to_user_id":"116716199","text":"@EMA_News Please what is exactly the « zero day » mutual recognition procedure (Covid-19 situation) ?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1250248596018077696","created_at":"2020-04-15T02:24:28.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":93,"end":98,"probability":0.9931,"type":"Place","normalized_text":"Canada"},{"start":103,"end":108,"probability":0.9853,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":20,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"507853471","id":"1247937352305184772","in_reply_to_user_id":"116716199","text":"@EMA_News \n@EMA_News \nHi, I want the lable of approved &amp; submission of \"Secnidazole drug\" in Canada or Europe. Thanks","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247937352305184772","created_at":"2020-04-08T17:20:25.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":56,"end":79,"url":"https://t.co/6hxtnF1QzS","expanded_url":"https://www.google.com/url?sa=t&source=web&cd=10&ved=2ahUKEwjal5-S2dfoAhVkk-AKHdm7DcMQFjAJegQIBRAB&url=https%3A%2F%2Fm.economictimes.com%2Fnews%2Fscience%2Fsalt-can-make-surgical-masks-into-a-virus-killer%2Famp_articleshow%2F56402336.cms&usg=AOvVaw3O-fJgp-MkSO0fRrF9LTmu","display_url":"google.com/url?sa=t&sourc…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"},{"start":15,"end":29,"username":"EU_Commission","id":"157981564"},{"start":30,"end":43,"username":"GovCanHealth","id":"36375825"},{"start":44,"end":55,"username":"WHO_Europe","id":"125403342"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1169566238793764865","id":"1247701708454735873","in_reply_to_user_id":"116716199","text":"@EMA_News @WHO @EU_Commission @GovCanHealth @WHO_Europe https://t.co/6hxtnF1QzS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1247508382480769024","created_at":"2020-04-08T01:44:03.000Z","referenced_tweets":[{"type":"replied_to","id":"1247508382480769024"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"},{"start":15,"end":29,"username":"EU_Commission","id":"157981564"},{"start":30,"end":43,"username":"GovCanHealth","id":"36375825"},{"start":44,"end":55,"username":"WHO_Europe","id":"125403342"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1169566238793764865","id":"1247699435620118528","in_reply_to_user_id":"116716199","text":"@EMA_News @WHO @EU_Commission @GovCanHealth @WHO_Europe Did you guys tested salt with water to rinse reinfected persons trout and nose in early stages","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247508382480769024","created_at":"2020-04-08T01:35:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1247508382480769024"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":33,"end":56,"probability":0.7031,"type":"Organization","normalized_text":"University of Pittsburgh"},{"start":86,"end":87,"probability":0.7491,"type":"Place","normalized_text":"US"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"34223944","id":"1247601486164627459","in_reply_to_user_id":"116716199","text":"@EMA_News Why not speak with the University of Pittsburgh's School of Medicine in the US? They're onto something.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247601486164627459","created_at":"2020-04-07T19:05:48.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":144,"end":167,"url":"https://t.co/VK5JAV4PrA","expanded_url":"https://buff.ly/2Rip2vG","display_url":"buff.ly/2Rip2vG"},{"start":168,"end":191,"url":"https://t.co/kLJxhG8ft6","expanded_url":"https://twitter.com/WMidsMedsInfo/status/1247438217655312385/photo/1","display_url":"pic.twitter.com/kLJxhG8ft6"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":70,"tag":"remdesivir"},{"start":75,"end":83,"tag":"COVID19"},{"start":84,"end":96,"tag":"coronavirus"}]},"possibly_sensitive":false,"lang":"en","author_id":"1176081054505013249","id":"1247438217655312385","in_reply_to_user_id":"116716199","text":"@EMA_News provides recommendations on compassionate use of #remdesivir for #COVID19 #coronavirus, including dosage regimen, reconstitution etc: https://t.co/VK5JAV4PrA https://t.co/kLJxhG8ft6","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1247438217655312385","created_at":"2020-04-07T08:17:02.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1247438216321515520"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":137,"end":160,"url":"https://t.co/8qIb3gWHzj","expanded_url":"https://buff.ly/3dWeV9C","display_url":"buff.ly/3dWeV9C"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":106,"end":114,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1247421351834660865","in_reply_to_user_id":"116716199","text":"@EMA_News organises second workshop of international regulators to discuss available knowledge supporting #COVID19 medicine development \nhttps://t.co/8qIb3gWHzj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247421351834660865","created_at":"2020-04-07T07:10:00.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/4TIYrF0XF7","expanded_url":"https://www.europeanpharmaceuticalreview.com/news/116057/ema-warns-consumers-about-falsified-covid-19-drugs-from-online-pharmacies/","display_url":"europeanpharmaceuticalreview.com/news/116057/em…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":104,"end":112,"tag":"covid19"},{"start":113,"end":120,"tag":"corona"},{"start":121,"end":136,"tag":"counterfeiting"},{"start":137,"end":149,"tag":"substandard"},{"start":150,"end":159,"tag":"spurious"},{"start":160,"end":170,"tag":"medicines"},{"start":171,"end":186,"tag":"Pharmaceutical"}]},"possibly_sensitive":false,"lang":"en","author_id":"46639767","id":"1247380137017888769","in_reply_to_user_id":"116716199","text":"@EMA_News warns consumers about falsified COVID-19 drugs from online pharmacies https://t.co/4TIYrF0XF7 #covid19 #corona #counterfeiting #substandard #spurious #medicines #Pharmaceutical","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247380137017888769","created_at":"2020-04-07T04:26:14.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":21,"end":44,"url":"https://t.co/g8WqWG8lVL","expanded_url":"https://twitter.com/JodyPressman/status/1247254298217664512","display_url":"twitter.com/JodyPressman/s…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":20,"username":"SteveFDA","id":"2904169317"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1239582067832360965","id":"1247256575540170762","in_reply_to_user_id":"116716199","text":"@EMA_News  @SteveFDA https://t.co/g8WqWG8lVL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247256575540170762","created_at":"2020-04-06T20:15:15.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":175,"end":198,"url":"https://t.co/Zb0DlF4xH9","expanded_url":"http://ow.ly/O8Cz50z6xnI","display_url":"ow.ly/O8Cz50z6xnI"},{"start":242,"end":265,"url":"https://t.co/Yx7il2kLun","expanded_url":"http://ow.ly/IzCU50z6xnL","display_url":"ow.ly/IzCU50z6xnL"},{"start":266,"end":289,"url":"https://t.co/gQgriDGZeg","expanded_url":"https://twitter.com/EuropaBio/status/1247179475290333185/photo/1","display_url":"pic.twitter.com/gQgriDGZeg"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":76,"end":86,"tag":"medicines"},{"start":141,"end":149,"tag":"COVID19"},{"start":211,"end":219,"tag":"biotech"},{"start":228,"end":240,"tag":"CoronaVirus"}]},"possibly_sensitive":false,"lang":"en","author_id":"19642657","id":"1247179475290333185","in_reply_to_user_id":"116716199","text":"@EMA_News will act as “central coordinator” to tackle shortages of critical #medicines in intensive care units during the high demand due to #COVID19\nRead the full statement: https://t.co/Zb0DlF4xH9\n\nFollow the #biotech news on #CoronaVirus: https://t.co/Yx7il2kLun https://t.co/gQgriDGZeg","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247179475290333185","created_at":"2020-04-06T15:08:53.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1247179472866086913"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/rfNyPeJCq8","expanded_url":"https://www.firstwordpharma.com/node/1713025","display_url":"firstwordpharma.com/node/1713025"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":32,"end":43,"tag":"remdesivir"}]},"possibly_sensitive":false,"lang":"en","author_id":"1200425216486326272","id":"1247073944743575554","in_reply_to_user_id":"116716199","text":"@EMA_News CHMP backs the use of #remdesivir for compassionate use. Compassionate use, not a blanket approval.\nhttps://t.co/rfNyPeJCq8","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1247073944743575554","created_at":"2020-04-06T08:09:32.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":152,"end":175,"url":"https://t.co/y0Tp085w2M","expanded_url":"https://clinicaltrials.gov/ct2/results?cond=COVID&age_v=&gndr=&type=Intr&rslt=&Search=Apply","display_url":"clinicaltrials.gov/ct2/results?co…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"PMDA_JPN","id":"1174144057473241088"},{"start":20,"end":24,"username":"WHO","id":"14499829"},{"start":25,"end":39,"username":"EU_Commission","id":"157981564"},{"start":40,"end":50,"username":"EU_Health","id":"606325697"},{"start":51,"end":62,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":129,"end":137,"tag":"COVID19"},{"start":138,"end":147,"tag":"SARSCoV2"}]},"possibly_sensitive":false,"lang":"en","author_id":"3872654956","id":"1247073125910577154","in_reply_to_user_id":"116716199","text":"@EMA_News @PMDA_JPN @WHO @EU_Commission @EU_Health @WHO_Europe There are more than 200 interventional clinical trials listed for #COVID19 #SARSCoV2  at https://t.co/y0Tp085w2M","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1246039667759349760","created_at":"2020-04-06T08:06:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1246039667759349760"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/5fYLJAICTy","expanded_url":"https://twitter.com/Richard52950257/status/1246849054400798720","display_url":"twitter.com/Richard5295025…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"INFARMED_IP","id":"1392501529"},{"start":23,"end":38,"username":"BrainstormCell","id":"802020620"},{"start":39,"end":46,"username":"Cylebo","id":"1201751724"},{"start":47,"end":62,"username":"MaryKayTurner1","id":"3270550555"}],"hashtags":[{"start":63,"end":70,"tag":"nurown"},{"start":71,"end":75,"tag":"ALS"},{"start":76,"end":80,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"und","author_id":"1097624872925188097","id":"1246939338086273029","in_reply_to_user_id":"116716199","text":"@EMA_News @INFARMED_IP @BrainstormCell @Cylebo @MaryKayTurner1 #nurown #ALS #ELA https://t.co/5fYLJAICTy","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1246939338086273029","created_at":"2020-04-05T23:14:39.000Z","referenced_tweets":[{"type":"quoted","id":"1246849054400798720"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/IIgJNmx8lJ","expanded_url":"https://www.change.org/p/u-s-department-of-health-and-human-services-medical-biologic-products-with-dextrose-must-be-contraindicated-for-corn-allergic-patients","display_url":"change.org/p/u-s-departme…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"758377092853686272","id":"1246905629542887429","in_reply_to_user_id":"116716199","text":"@EMA_News PETITION:  MEDICAL/BIOLOGIC PRODUCTS WITH DEXTROSE MUST BE CONTRAINDICATED FOR CORN-ALLERGIC PATIENTS\nhttps://t.co/IIgJNmx8lJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1246905629542887429","created_at":"2020-04-05T21:00:43.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":29,"end":52,"url":"https://t.co/PZ124c2puH","expanded_url":"https://www.termedia.pl/Experimental-immunology-The-effect-of-Uncaria-tomentosa-bark-water-extract-on-chemokinetic-activity-of-spleen-lymphocytes-in-mice,10,13967,0,1.html","display_url":"termedia.pl/Experimental-i…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"324495269","id":"1246450600134541315","in_reply_to_user_id":"116716199","text":"@EMA_News Uncaria Tomentosa  https://t.co/PZ124c2puH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245350551874940928","created_at":"2020-04-04T14:52:35.000Z","referenced_tweets":[{"type":"replied_to","id":"1245350551874940928"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":63,"end":86,"url":"https://t.co/PZ124c2puH","expanded_url":"https://www.termedia.pl/Experimental-immunology-The-effect-of-Uncaria-tomentosa-bark-water-extract-on-chemokinetic-activity-of-spleen-lymphocytes-in-mice,10,13967,0,1.html","display_url":"termedia.pl/Experimental-i…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"PMDA_JPN","id":"1174144057473241088"},{"start":20,"end":24,"username":"WHO","id":"14499829"},{"start":25,"end":39,"username":"EU_Commission","id":"157981564"},{"start":40,"end":50,"username":"EU_Health","id":"606325697"},{"start":51,"end":62,"username":"WHO_Europe","id":"125403342"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"324495269","id":"1246450108469784576","in_reply_to_user_id":"116716199","text":"@EMA_News @PMDA_JPN @WHO @EU_Commission @EU_Health @WHO_Europe https://t.co/PZ124c2puH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1246039667759349760","created_at":"2020-04-04T14:50:38.000Z","referenced_tweets":[{"type":"replied_to","id":"1246039667759349760"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":19,"end":42,"url":"https://t.co/PZ124c2puH","expanded_url":"https://www.termedia.pl/Experimental-immunology-The-effect-of-Uncaria-tomentosa-bark-water-extract-on-chemokinetic-activity-of-spleen-lymphocytes-in-mice,10,13967,0,1.html","display_url":"termedia.pl/Experimental-i…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"GCessak","id":"556859372"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"324495269","id":"1246449931570884610","in_reply_to_user_id":"116716199","text":"@EMA_News @GCessak https://t.co/PZ124c2puH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245005612867620864","created_at":"2020-04-04T14:49:56.000Z","referenced_tweets":[{"type":"replied_to","id":"1245005612867620864"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":93,"end":116,"url":"https://t.co/wf8unh9Xyu","expanded_url":"https://twitter.com/EMA_News/status/1246056503498420224","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":92,"username":"IPPOSI","id":"945982350"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3320529515","id":"1246424906243457026","in_reply_to_user_id":"116716199","text":"@EMA_News publishes opinion on compassionate use of remdesivir in COVID-19 patients. @IPPOSI https://t.co/wf8unh9Xyu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1246424906243457026","created_at":"2020-04-04T13:10:29.000Z","referenced_tweets":[{"type":"quoted","id":"1246056503498420224"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":37,"end":54,"tag":"PeaceAndSecurity"},{"start":56,"end":68,"tag":"Coronavirus"},{"start":268,"end":284,"tag":"GlobalCeasefire"}]},"possibly_sensitive":false,"lang":"en","author_id":"1198690532861497344","id":"1246297866332585987","in_reply_to_user_id":"116716199","text":"@EMA_News It's time to pursue global #PeaceAndSecurity\n\n#Coronavirus is not a local, regional, or national issue.  It's a GLOBAL problem that we need to face head on.  So are the world's wars and conflicts! They affect us ALL.\n\nNOW is the time for the world to pursue #GlobalCeasefire 🌏 🕊","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1246056503498420224","created_at":"2020-04-04T04:45:41.000Z","referenced_tweets":[{"type":"replied_to","id":"1246056503498420224"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1331773748","id":"1246220441800376327","in_reply_to_user_id":"116716199","text":"@EMA_News Thank you for a sensible approach to evidence based medicine","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-04-03T23:38:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1067766300443852802","id":"1246096125679075328","in_reply_to_user_id":"116716199","text":"@EMA_News This in an accelerated time🙏","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1246056503498420224","created_at":"2020-04-03T15:24:02.000Z","referenced_tweets":[{"type":"replied_to","id":"1246056503498420224"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":238,"end":261,"url":"https://t.co/5mc4J0NsP7","expanded_url":"https://thegoodlobby.eu/campaigns/covid19-europe-can-fight-it/","display_url":"thegoodlobby.eu/campaigns/covi…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":196,"end":212,"tag":"COVID19Pandemic"}]},"possibly_sensitive":false,"lang":"en","author_id":"3108011055","id":"1246051754933878784","in_reply_to_user_id":"116716199","text":"@EMA_News This is great news - but we think more can be done. That is why we are asking you to join us in our call to the 27 European Union Member States to coordinate a strategic response to the #COVID19Pandemic. Sign the petition here: https://t.co/5mc4J0NsP7","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245291192876703744","created_at":"2020-04-03T12:27:43.000Z","referenced_tweets":[{"type":"replied_to","id":"1245291192876703744"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":238,"end":261,"url":"https://t.co/FuViEPvE30","expanded_url":"https://www.ema.europa.eu/en/news/ema-issue-electronic-certificates-medicines","display_url":"ema.europa.eu/en/news/ema-is…"},{"start":262,"end":285,"url":"https://t.co/pKBm8cCnNR","expanded_url":"https://twitter.com/seQureLS/status/1246049646503505920/photo/1","display_url":"pic.twitter.com/pKBm8cCnNR"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":170,"end":178,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1246049646503505920","in_reply_to_user_id":"116716199","text":"@EMA_News has implemented a new system to issue electronic certificates for human and veterinary medicines to maintain it’s ability to provide these documents during the #COVID19 pandemic. More details on the certificates available here: https://t.co/FuViEPvE30 https://t.co/pKBm8cCnNR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1246049646503505920","created_at":"2020-04-03T12:19:20.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1246049635392577540"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":75,"end":79,"tag":"dtv"}]},"possibly_sensitive":false,"lang":"ca","author_id":"432862662","id":"1245973689239306243","in_reply_to_user_id":"116716199","text":"@EMA_News, kan Cat's claw (Uncaria tomentosa) iets betekenen tegen corona? #dtv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245973689239306243","created_at":"2020-04-03T07:17:31.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":63,"end":67,"tag":"dtv"}]},"possibly_sensitive":false,"lang":"nl","author_id":"432862662","id":"1245973030234402817","in_reply_to_user_id":"116716199","text":"@EMA_News\nKan H. CORDATA (kruid)  de longen helpen te genezen? #dtv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245973030234402817","created_at":"2020-04-03T07:14:54.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":108,"end":112,"tag":"dtv"}]},"possibly_sensitive":false,"lang":"nl","author_id":"432862662","id":"1245839081189359616","in_reply_to_user_id":"116716199","text":"@EMA_News, even een vraag van een leek. Kan het aminozuur LYSINE uit spirulina ingezet worden tegen corona? #dtv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245839081189359616","created_at":"2020-04-02T22:22:38.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":61,"end":84,"url":"https://t.co/hNiCJI5Xys","expanded_url":"https://www.youtube.com/watch?v=qyFUlLX_JuE&t=54s","display_url":"youtube.com/watch?v=qyFUlL…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"754666096188329984","id":"1245822757725708288","in_reply_to_user_id":"116716199","text":"@EMA_News People need to watch this all of the way through:\n\nhttps://t.co/hNiCJI5Xys","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245350551874940928","created_at":"2020-04-02T21:17:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1245350551874940928"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":23,"end":46,"url":"https://t.co/c5t1o4MLe5","expanded_url":"https://twitter.com/fmarcanojr/status/1244886637030649856","display_url":"twitter.com/fmarcanojr/sta…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"MinHealthCY","id":"2789455430"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1118119981441536001","id":"1245800121545220097","in_reply_to_user_id":"116716199","text":"@EMA_News @MinHealthCY https://t.co/c5t1o4MLe5","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245800121545220097","created_at":"2020-04-02T19:47:49.000Z","referenced_tweets":[{"type":"quoted","id":"1244886637030649856"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/8kZUJJpmIS","expanded_url":"https://twitter.com/CurlyJungleJake/status/1245221326358327296","display_url":"twitter.com/CurlyJungleJak…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1118119981441536001","id":"1245799524003647489","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/8kZUJJpmIS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245799524003647489","created_at":"2020-04-02T19:45:27.000Z","referenced_tweets":[{"type":"quoted","id":"1245221326358327296"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1234177674005839874","id":"1245793276659187714","in_reply_to_user_id":"116716199","text":"@EMA_News Check and double check care guidelines and treatment protocols.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245350551874940928","created_at":"2020-04-02T19:20:37.000Z","referenced_tweets":[{"type":"replied_to","id":"1245350551874940928"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":159,"end":182,"url":"https://t.co/PpYAPRcfMO","expanded_url":"https://twitter.com/EMA_News/status/1245019692491776000","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"296135205","id":"1245720709780901889","in_reply_to_user_id":"116716199","text":"@EMA_News Regulatory Science to 2025 strategy has been finalized after 3 years of co-design with stakeholders. A model to follow for other strategies to come. https://t.co/PpYAPRcfMO","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245720709780901889","created_at":"2020-04-02T14:32:16.000Z","referenced_tweets":[{"type":"quoted","id":"1245019692491776000"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":35,"username":"EU_Commission","id":"157981564"},{"start":36,"end":48,"username":"Europarl_EN","id":"36329597"},{"start":49,"end":57,"username":"EU_ECHA","id":"331604970"},{"start":58,"end":66,"username":"EFSA_EU","id":"84582815"},{"start":67,"end":77,"username":"EUCouncil","id":"206717989"},{"start":78,"end":92,"username":"SKyriakidesEU","id":"2476130260"},{"start":93,"end":109,"username":"Eurosurveillanc","id":"455839750"},{"start":110,"end":118,"username":"EU_EESC","id":"257415817"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1030685163024510976","id":"1245624918034673665","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health @EU_Commission @Europarl_EN @EU_ECHA @EFSA_EU @EUCouncil @SKyriakidesEU @Eurosurveillanc @EU_EESC 😯😲😥😯😫😩😨👽👹👽😹🤖👹👹👹👺","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245624918034673665","created_at":"2020-04-02T08:11:37.000Z","referenced_tweets":{},"source":"Twitter for iPad","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":44,"end":67,"url":"https://t.co/ey7RelKXDH","expanded_url":"https://www.bjpharm.org.uk/article/id/745/","display_url":"bjpharm.org.uk/article/id/745/"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"117772147","id":"1245431388146368512","in_reply_to_user_id":"116716199","text":"@EMA_News Our critical review supports this https://t.co/ey7RelKXDH","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1245350551874940928","created_at":"2020-04-01T19:22:36.000Z","referenced_tweets":[{"type":"replied_to","id":"1245350551874940928"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2878063612","id":"1245351599406485504","in_reply_to_user_id":"116716199","text":"@EMA_News When will we have the trials results? 2023?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245350551874940928","created_at":"2020-04-01T14:05:33.000Z","referenced_tweets":[{"type":"replied_to","id":"1245350551874940928"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":170,"end":193,"url":"https://t.co/0z9R0iE9Pl","expanded_url":"https://www.preprints.org/manuscript/202003.0235/v2","display_url":"preprints.org/manuscript/202…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1446791905","id":"1245323756198866952","in_reply_to_user_id":"116716199","text":"@EMA_News I report the link to a recent study for prevention: \"Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths\" https://t.co/0z9R0iE9Pl","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245005612867620864","created_at":"2020-04-01T12:14:55.000Z","referenced_tweets":[{"type":"replied_to","id":"1245005612867620864"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"Vivivovi","id":"960965864"},{"start":20,"end":31,"username":"rkessler05","id":"965926911212998656"},{"start":32,"end":39,"username":"HAITim","id":"37710059"}],"hashtags":{}},"possibly_sensitive":false,"lang":"pl","author_id":"837335683215798272","id":"1245286594707406848","in_reply_to_user_id":"116716199","text":"@EMA_News @Vivivovi @rkessler05 @HAITim ICYMI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1245019692491776000","created_at":"2020-04-01T09:47:15.000Z","referenced_tweets":[{"type":"replied_to","id":"1245019692491776000"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":167,"end":190,"url":"https://t.co/hy9aGuEWUA","expanded_url":"https://twitter.com/EMA_News/status/1245005612867620864","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":74,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"860264214","id":"1245007076167991298","in_reply_to_user_id":"116716199","text":"@EMA_News has been in contact with producers of a dozen potential #COVID19 vaccines, estimates will take more than a year for one to reach approval and widespread use https://t.co/hy9aGuEWUA","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1245007076167991298","created_at":"2020-03-31T15:16:32.000Z","referenced_tweets":[{"type":"quoted","id":"1245005612867620864"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/T0WzwpJFYj","expanded_url":"https://www.transparimed.org/single-post/2020/03/27/COVID-19-clinical-trials-information-sources","display_url":"transparimed.org/single-post/20…","status":200,"unwound_url":"https://www.transparimed.org/single-post/2020/03/27/COVID-19-clinical-trials-information-sources"},{"start":81,"end":104,"url":"https://t.co/AGsUTaaZPt","expanded_url":"https://twitter.com/TranspariMED/status/1245005955819098113/photo/1","display_url":"pic.twitter.com/AGsUTaaZPt"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"837335683215798272","id":"1245005955819098113","in_reply_to_user_id":"116716199","text":"@EMA_News FYI - All COVID-19 clinical trials at a glance\nhttps://t.co/T0WzwpJFYj https://t.co/AGsUTaaZPt","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1245005612867620864","created_at":"2020-03-31T15:12:05.000Z","referenced_tweets":[{"type":"replied_to","id":"1245005612867620864"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1245005942476943362"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EuropaBio","id":"19642657"},{"start":21,"end":35,"username":"EU_Commission","id":"157981564"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"938978799655436289","id":"1244613626272645120","in_reply_to_user_id":"116716199","text":"@EMA_News @EuropaBio @EU_Commission very useful!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1244564880008642560","created_at":"2020-03-30T13:13:06.000Z","referenced_tweets":[{"type":"replied_to","id":"1244564880008642560"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1244610179485913089","id":"1244611880880087042","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission The updated guidance for either 27-MAR or today is not available the link goes to version 1 20-MAR version.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1244564880008642560","created_at":"2020-03-30T13:06:10.000Z","referenced_tweets":[{"type":"replied_to","id":"1244564880008642560"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":264,"end":287,"url":"https://t.co/JfEfMA6fEJ","expanded_url":"https://bit.ly/2WTgCi3","display_url":"bit.ly/2WTgCi3"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":58,"end":73,"tag":"clinicaltrials"},{"start":90,"end":98,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"3229894975","id":"1244605873324019712","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission &amp; Medicines Agencies updated #clinicaltrials Guidance during #COVID19 for safety reporting, distribution of in vitro diagnostics &amp; auditing incorporating communicating w authorities, consent, investigational medicines distribution https://t.co/JfEfMA6fEJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1244605873324019712","created_at":"2020-03-30T12:42:18.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":175,"end":198,"url":"https://t.co/iYnzlvmXi9","expanded_url":"https://twitter.com/Claryss27642648/status/1244585327966257153/photo/1","display_url":"pic.twitter.com/iYnzlvmXi9"},{"start":175,"end":198,"url":"https://t.co/iYnzlvmXi9","expanded_url":"https://twitter.com/Claryss27642648/status/1244585327966257153/photo/1","display_url":"pic.twitter.com/iYnzlvmXi9"},{"start":175,"end":198,"url":"https://t.co/iYnzlvmXi9","expanded_url":"https://twitter.com/Claryss27642648/status/1244585327966257153/photo/1","display_url":"pic.twitter.com/iYnzlvmXi9"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1124721231004164097","id":"1244585327966257153","in_reply_to_user_id":"116716199","text":"@EMA_News Hello, please, I would like you to help me indicating if the doctor that I am attaching in photos works in your company, it is urgent to find him. Thanks. (Xelevia) https://t.co/iYnzlvmXi9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1244585327966257153","created_at":"2020-03-30T11:20:40.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1244585112026730496","3_1244585171543867392","3_1244585197884133376"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":210,"end":233,"url":"https://t.co/d3IC9UsfWy","expanded_url":"https://www.ema.europa.eu/en/news/guidance-sponsors-how-manage-clinical-trials-during-covid-19-pandemic","display_url":"ema.europa.eu/en/news/guidan…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":80,"end":88,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"pl","author_id":"64006062","id":"1244334079862091777","in_reply_to_user_id":"116716199","text":"@EMA_News wydała rekomendacje dotyczące prowadzenia badań klinicznych w trakcie #COVID19! Najważniejsze! Ograniczenie wizyt pacjentów w ośrodkach! Jeśli tylko to możliwe, należy wydawać lek pacjentowi do domu!\nhttps://t.co/d3IC9UsfWy","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1244334079862091777","created_at":"2020-03-29T18:42:17.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":12,"end":35,"url":"https://t.co/RMPjGC0N4g","expanded_url":"https://twitter.com/bart_professor/status/1244203115122917376","display_url":"twitter.com/bart_professor…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"937043107811659778","id":"1244204893054918656","in_reply_to_user_id":"116716199","text":"@EMA_News 😊 https://t.co/RMPjGC0N4g","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1244204893054918656","created_at":"2020-03-29T10:08:57.000Z","referenced_tweets":[{"type":"quoted","id":"1244203115122917376"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":154,"end":177,"url":"https://t.co/8K910cMTOi","expanded_url":"https://www.fda.gov/medical-devices/3d-printing-medical-devices/faqs-3d-printing-medical-devices-accessories-components-and-parts-during-covid-19-pandemic","display_url":"fda.gov/medical-device…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"281944445","id":"1244007368972738560","in_reply_to_user_id":"116716199","text":"@EMA_News @AEMPSGOB Take the initiative for one!!\nFAQs on 3D Printing of Medical Devices, Accessories, Components, and Parts During the COVID-19 Pandemic https://t.co/8K910cMTOi","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1244007368972738560","created_at":"2020-03-28T21:04:03.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"place_id":"8c86b8b4cb716103","coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"330030881","id":"1243911338600136709","in_reply_to_user_id":"116716199","text":"@EMA_News @ECDC_EU Any alternatives for example Cozaar?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1243576636043333632","created_at":"2020-03-28T14:42:28.000Z","referenced_tweets":[{"type":"replied_to","id":"1243576636043333632"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":20,"end":32,"username":"VeristatCRO","id":"2885790880"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2854680832","id":"1243631959030599690","in_reply_to_user_id":"116716199","text":"@EMA_News Thank you @VeristatCRO","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1243465919839551490","created_at":"2020-03-27T20:12:19.000Z","referenced_tweets":[{"type":"replied_to","id":"1243465919839551490"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":228,"end":251,"url":"https://t.co/69hX3Egzvj","expanded_url":"https://twitter.com/EMA_News/status/1243576636043333632","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":221,"end":227,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":44,"end":50,"tag":"COVID"},{"start":216,"end":219,"tag":"EU"}]},"possibly_sensitive":false,"lang":"en","author_id":"2876403948","id":"1243579170485161987","in_reply_to_user_id":"116716199","text":"@EMA_News truly stepping up in the times of #COVID-19 pandemic; to provide the science-based and verified and trustworthy information which is their every day work - now so valuable! Great to have a strong Agengy in #EU  @EFPIA https://t.co/69hX3Egzvj","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1243579170485161987","created_at":"2020-03-27T16:42:33.000Z","referenced_tweets":[{"type":"quoted","id":"1243576636043333632"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":169,"end":192,"url":"https://t.co/HxG7LVyLAP","expanded_url":"https://www.xenleta.com/?gclid=Cj0KCQjwyPbzBRDsARIsAFh15JbjrkRMQ2pNCJoNUhQAViACkU_qa3gKPt_Vqeih4JZ4DkFb2KSQCwMaAv1oEALw_wcB","display_url":"xenleta.com/?gclid=Cj0KCQj…"}],"annotations":[{"start":44,"end":52,"probability":0.3806,"type":"Organization","normalized_text":"Lefamulin"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"161661769","id":"1243565587554418688","in_reply_to_user_id":"116716199","text":"@EMA_News please fast track the approval of Lefamulin (FDA approved) a much need drug in treat secondary bacterial infections (Fast acting on Pneumonia) from COVID-19 \n\nhttps://t.co/HxG7LVyLAP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1243565587554418688","created_at":"2020-03-27T15:48:35.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"117459814","id":"1243537220889427970","in_reply_to_user_id":"116716199","text":"@EMA_News Gilead has given back the orphan drug status granted for remdesivir","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1242860112248791041","created_at":"2020-03-27T13:55:51.000Z","referenced_tweets":[{"type":"replied_to","id":"1242860112248791041"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/T2DP9sziha","expanded_url":"http://tiny.cc/emawarn","display_url":"tiny.cc/emawarn"},{"start":131,"end":154,"url":"https://t.co/qIPKhktg8c","expanded_url":"http://tiny.cc/wecovid19","display_url":"tiny.cc/wecovid19"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":111,"end":119,"tag":"covid19"}]},"possibly_sensitive":false,"lang":"en","author_id":"708589971079307266","id":"1243139897793314819","in_reply_to_user_id":"116716199","text":"@EMA_News Warns: Beware of falsified (COVID-19) medicines from unregistered websites https://t.co/T2DP9sziha | #covid19 Resources: https://t.co/qIPKhktg8c","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1243139897793314819","created_at":"2020-03-26T11:37:02.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":132,"end":155,"url":"https://t.co/xb0ewwNAii","expanded_url":"https://www.google.nl/amp/s/mobile.reuters.com/article/amp/idUSL1N2BI1PA","display_url":"google.nl/amp/s/mobile.r…"}],"annotations":[{"start":59,"end":61,"probability":0.5922,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":98,"end":109,"tag":"regulatory"},{"start":110,"end":120,"tag":"medicines"},{"start":121,"end":131,"tag":"COVID2019"}]},"possibly_sensitive":false,"lang":"en","author_id":"1223324206026366978","id":"1242882866297679874","in_reply_to_user_id":"116716199","text":"@EMA_News It appears there is now a request to retract the FDA orphan designation for remdesivir. #regulatory #medicines #COVID2019 https://t.co/xb0ewwNAii","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1242860112248791041","created_at":"2020-03-25T18:35:41.000Z","referenced_tweets":[{"type":"replied_to","id":"1242860112248791041"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"DeutschJill","id":"559989747"},{"start":23,"end":34,"username":"eturnermd1","id":"4282193834"},{"start":35,"end":46,"username":"ellenthoen","id":"28312814"},{"start":47,"end":58,"username":"jamie_love","id":"15211869"},{"start":59,"end":67,"username":"YNatsis","id":"741404372"},{"start":68,"end":76,"username":"RAPSorg","id":"111425542"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"837335683215798272","id":"1242865111242506240","in_reply_to_user_id":"116716199","text":"@EMA_News @DeutschJill @eturnermd1 @ellenthoen @jamie_love @YNatsis @RAPSorg \nFYI:\n\nEMA says no to orpham status for COVID drugs","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1242860112248791041","created_at":"2020-03-25T17:25:08.000Z","referenced_tweets":[{"type":"replied_to","id":"1242860112248791041"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":142,"end":165,"url":"https://t.co/DKTQWHzrhI","expanded_url":"https://bit.ly/2WHTzqs","display_url":"bit.ly/2WHTzqs"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":201,"end":216,"username":"Forbrukerradet","id":"112666537"},{"start":217,"end":231,"username":"AyshaConsumes","id":"1235575480520249347"},{"start":232,"end":248,"username":"ParorendeAllian","id":"4048152814"},{"start":249,"end":264,"username":"Nf_folkehelsen","id":"1148709864"}],"hashtags":{}},"possibly_sensitive":false,"lang":"no","author_id":"4023822982","id":"1242818148648333313","in_reply_to_user_id":"116716199","text":"@EMA_News advarer mot salg av forfalskede medisiner. Alle registrerte nettapotek har en felles logo for å bekrefte at nettstedet er godkjent, https://t.co/DKTQWHzrhI Slik unngår du å kjøpe uekte vare. @Forbrukerradet @AyshaConsumes @ParorendeAllian @Nf_folkehelsen","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":1},"conversation_id":"1242818148648333313","created_at":"2020-03-25T14:18:31.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/qcvYy5AKgD","expanded_url":"https://buff.ly/33quZf5","display_url":"buff.ly/33quZf5"},{"start":112,"end":135,"url":"https://t.co/OemxjTJe8o","expanded_url":"https://twitter.com/WMidsMedsInfo/status/1242398314844360704/photo/1","display_url":"pic.twitter.com/OemxjTJe8o"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":78,"end":86,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"en","author_id":"1176081054505013249","id":"1242398314844360704","in_reply_to_user_id":"116716199","text":"@EMA_News advice on the use of non-steroidal anti-inflammatories (NSAIDs) for #COVID19: https://t.co/qcvYy5AKgD https://t.co/OemxjTJe8o","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1242398314844360704","created_at":"2020-03-24T10:30:15.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1242398313061781504"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1088528703498407936","id":"1242026401089425410","in_reply_to_user_id":"116716199","text":"@EMA_News How much time is needed to start a clinical trial in order to solve covid in this situation? It's so sad","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240956394783813632","created_at":"2020-03-23T09:52:24.000Z","referenced_tweets":[{"type":"replied_to","id":"1240956394783813632"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":36,"end":59,"url":"https://t.co/i2HMZxxx2K","expanded_url":"https://twitter.com/hahahaha11100/status/1241770667374149635/photo/1","display_url":"pic.twitter.com/i2HMZxxx2K"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":true,"lang":"en","author_id":"607694139","id":"1241770667374149635","in_reply_to_user_id":"116716199","text":"@EMA_News How can i buy this item ? https://t.co/i2HMZxxx2K","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240956394783813632","created_at":"2020-03-22T16:56:12.000Z","referenced_tweets":[{"type":"replied_to","id":"1240956394783813632"}],"source":"Twitter for iPhone","attachments":{"media_keys":["3_1241770617961136128"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":165,"end":188,"url":"https://t.co/UYkUkqLAku","expanded_url":"https://www.worldduchenne.org/news/live-covid-19-coronavirus-and-duchenne-becker-muscular-dystrophy/","display_url":"worldduchenne.org/news/live-covi…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"890860865985105920","id":"1241293110631694337","in_reply_to_user_id":"116716199","text":"@EMA_News published new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic. \nhttps://t.co/UYkUkqLAku","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1241293110631694337","created_at":"2020-03-21T09:18:34.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":164,"end":187,"url":"https://t.co/UYkUkqLAku","expanded_url":"https://www.worldduchenne.org/news/live-covid-19-coronavirus-and-duchenne-becker-muscular-dystrophy/","display_url":"worldduchenne.org/news/live-covi…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":85,"end":100,"tag":"clinicaltrials"}]},"possibly_sensitive":false,"lang":"en","author_id":"890860865985105920","id":"1241284312567291904","in_reply_to_user_id":"116716199","text":"@EMA_News published new recommendations for sponsors on how to manage the conduct of #clinicaltrials in the context of the coronavirus disease (COVID-19) pandemic. https://t.co/UYkUkqLAku","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1241284312567291904","created_at":"2020-03-21T08:43:36.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":41,"end":55,"probability":0.4969,"type":"Person","normalized_text":"Hossein Haghgoo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1241239407987998720","id":"1241273987168186368","in_reply_to_user_id":"116716199","text":"@EMA_News @ECDC_EU Dear Sir/ Madam\n\nI am Hossein Haghgoo , if you are realated to  treatment of coronaviruse , please try to check RIVANOL Solvent 0.001 percent used by Aerator for breathing of critical patients . You will find good results.\n\nRegards","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-21T08:02:34.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":38,"end":61,"url":"https://t.co/TbJZThmb93","expanded_url":"https://scholar.google.pl/scholar?q=Uncaria+tomentosa+Yezhou+Shenga&hl=pl&as_sdt=0&as_vis=1&oi=scholart","display_url":"scholar.google.pl/scholar?q=Unca…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"},{"start":15,"end":29,"username":"EU_Commission","id":"157981564"},{"start":30,"end":37,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"324495269","id":"1240759945282359296","in_reply_to_user_id":"116716199","text":"@EMA_News @WHO @EU_Commission @US_FDA https://t.co/TbJZThmb93","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240635932895830018","created_at":"2020-03-19T21:59:57.000Z","referenced_tweets":[{"type":"replied_to","id":"1240635932895830018"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":199,"end":222,"url":"https://t.co/Qp3MYyMhZt","expanded_url":"https://twitter.com/medicinesforEU/status/1240260730659766278","display_url":"twitter.com/medicinesforEU…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"},{"start":15,"end":30,"username":"medicinesforEU","id":"2315763655"}],"hashtags":[{"start":145,"end":155,"tag":"ibuprofen"},{"start":156,"end":163,"tag":"NSAIDs"},{"start":168,"end":177,"tag":"Covid_19"}]},"possibly_sensitive":false,"lang":"en","author_id":"2609933191","id":"1240712797014519810","in_reply_to_user_id":"116716199","text":"@EMA_News @WHO @medicinesforEU thanks for providing clarification in response to the diverse information we read in media and social media about #ibuprofen #NSAIDs and #Covid_19 during the last days https://t.co/Qp3MYyMhZt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1240712797014519810","created_at":"2020-03-19T18:52:36.000Z","referenced_tweets":[{"type":"quoted","id":"1240260730659766278"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"place_id":"fa342e611b0662c7","coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":17,"end":26,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":149,"end":159,"tag":"Ibuprofen"},{"start":161,"end":168,"tag":"NSAIDs"},{"start":187,"end":196,"tag":"Covid_19"}]},"possibly_sensitive":false,"lang":"en","author_id":"2609933191","id":"1240711132936994817","in_reply_to_user_id":"116716199","text":"@EMA_News Thanks @EMA_News for giving us this important clarification in response to the diverse information we read in media and social media about #Ibuprofen, #NSAIDs and patients with #Covid_19 during the last days.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-19T18:46:00.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"place_id":"fa342e611b0662c7","coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":133,"end":156,"url":"https://t.co/cVN2eqT7Z9","expanded_url":"https://www.sermescro.com/la-ema-y-la-fda-copresiden-el-primer-taller-regulatorio-sobre-covid-19-para-el-desarrollo-de-vacunas/","display_url":"sermescro.com/la-ema-y-la-fd…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":103,"end":115,"username":"psnresearch","id":"2512986313"},{"start":116,"end":132,"username":"FundacionSermes","id":"2159498684"}],"hashtags":[{"start":64,"end":72,"tag":"COVID19"}]},"possibly_sensitive":false,"lang":"es","author_id":"1488143666","id":"1240616072031731713","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA copresiden el primer taller regulatorio sobre #COVID19 para el desarrollo de vacunas @psnresearch @FundacionSermes https://t.co/cVN2eqT7Z9","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240616072031731713","created_at":"2020-03-19T12:28:15.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"29654415","id":"1240532598306361344","in_reply_to_user_id":"116716199","text":"@EMA_News @ECDC_EU (European Society of Cardiology) Researchers suggest ACEis and ARBs medications may be protective against COVID-19 and are potential treatments of the infection. Randomized controlled trials are currently in development that will provide more information about the impact.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-19T06:56:34.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":282,"end":305,"url":"https://t.co/2XjaAPDby8","expanded_url":"https://www.crueltyfreeinternational.org/why-we-do-it/alternatives-animal-testing","display_url":"crueltyfreeinternational.org/why-we-do-it/a…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"VaccinesEurope","id":"1262320285"}],"hashtags":[{"start":26,"end":38,"tag":"coronavirus"}]},"possibly_sensitive":false,"lang":"en","author_id":"4217373916","id":"1240445176541306880","in_reply_to_user_id":"116716199","text":"@EMA_News @VaccinesEurope #coronavirus\n😭\nFORBID ANIMAL TESTING IMMEDIATELY\n\nDO NOT ANIMAL TESTING IMMEDIATELY\nUse alternative methods without animals\nGod sees everything\nDo not torture animals\ndo not kill animals\nDO NOT EAT ANIMALS\nEating animals make sick: corona virus, cancer..\n\nhttps://t.co/2XjaAPDby8","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1238497037185953797","created_at":"2020-03-19T01:09:11.000Z","referenced_tweets":[{"type":"replied_to","id":"1238497037185953797"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":255,"end":278,"url":"https://t.co/FF0Scen56I","expanded_url":"https://aesgp.eu/articles/statement-on-the-use-of-non-steroidal-anti-inflammatories-and-covid-19","display_url":"aesgp.eu/articles/state…"}],"annotations":[{"start":10,"end":34,"probability":0.5364,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":100,"end":107,"tag":"NSAIDS"},{"start":149,"end":159,"tag":"ibuprofen"},{"start":182,"end":190,"tag":"COVID19"},{"start":243,"end":254,"tag":"pharmacist"}]},"possibly_sensitive":false,"lang":"en","author_id":"293991390","id":"1240264385836310531","in_reply_to_user_id":"116716199","text":"@EMA_News European Medicines Agency says:\n✅NO SCIENTIFIC EVIDENCE establishes a link between taking #NSAIDS (non-steroid inflammatory drugs, such as #ibuprofen) and the worsening of #COVID19\n📜Read information leaflet\n⚕️ In doubt, contact your #pharmacist\nhttps://t.co/FF0Scen56I","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1240264385836310531","created_at":"2020-03-18T13:10:47.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"juancpedreira","id":"374256165"},{"start":25,"end":40,"username":"mrjohelpadilla","id":"135239971"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"904740870817120256","id":"1240264335315939329","in_reply_to_user_id":"116716199","text":"@EMA_News @juancpedreira @mrjohelpadilla","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-18T13:10:35.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":37,"end":50,"probability":0.2717,"type":"Other","normalized_text":"ACE inhibitors"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3335258632","id":"1240260137639710720","in_reply_to_user_id":"116716199","text":"@EMA_News Do you also have advice on ACE inhibitors, as mentioned in the same Lancet article?","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-18T12:53:54.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"TweetDeck","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"},{"start":36,"end":50,"username":"NaomiOhReally","id":"155203891"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"22614847","id":"1240251449789091840","in_reply_to_user_id":"116716199","text":"@EMA_News @ECDC_EU .@susmitchellSBP @NaomiOhReally","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-18T12:19:23.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"place_id":"b2aba3537cb3f974","coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1088528703498407936","id":"1240248255142903810","in_reply_to_user_id":"116716199","text":"@EMA_News Why are not trying aplidin with humans yet?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1240238307872657416","created_at":"2020-03-18T12:06:41.000Z","referenced_tweets":[{"type":"replied_to","id":"1240238307872657416"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":269,"end":292,"url":"https://t.co/2XjaAPDby8","expanded_url":"https://www.crueltyfreeinternational.org/why-we-do-it/alternatives-animal-testing","display_url":"crueltyfreeinternational.org/why-we-do-it/a…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"VaccinesEurope","id":"1262320285"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"4217373916","id":"1240088189831909378","in_reply_to_user_id":"116716199","text":"@EMA_News @VaccinesEurope 😭\nFORBID ANIMAL TESTING IMMEDIATELY\n\nDO NOT ANIMAL TESTING IMMEDIATELY\nUse alternative methods without animals\nGod sees everything\nDo not torture animals\ndo not kill animals\nDO NOT EAT ANIMALS\nEating animals make sick: corona virus, cancer..\n\nhttps://t.co/2XjaAPDby8","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1238497037185953797","created_at":"2020-03-18T01:30:38.000Z","referenced_tweets":[{"type":"replied_to","id":"1238497037185953797"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":273,"end":296,"url":"https://t.co/ZU8j1uxXaT","expanded_url":"https://twitter.com/LorenitaCofre/status/1239998719497560065/photo/1","display_url":"pic.twitter.com/ZU8j1uxXaT"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":114,"end":127,"tag":"covid19chile"},{"start":256,"end":272,"tag":"YoMeQuedoEnCasa"}]},"possibly_sensitive":false,"lang":"es","author_id":"191279165","id":"1239998719497560065","in_reply_to_user_id":"116716199","text":"@EMA_News informa q no existe evidencia suficiente para descartar el analgésico ibuprofeno en tratar síntomas por #covid19chile.   Todos los analgésicos antiinflamatorios le pueden ayudar a minimizar síntomas. Debe tomarlos por períodos cortos. No exceder #YoMeQuedoEnCasa https://t.co/ZU8j1uxXaT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239998719497560065","created_at":"2020-03-17T19:35:07.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1239998712522440704"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":209,"end":232,"url":"https://t.co/OacoLvvScw","expanded_url":"http://bit.ly/2Wf93Sj","display_url":"bit.ly/2Wf93Sj"},{"start":262,"end":285,"url":"https://t.co/LQPAmLFUoL","expanded_url":"https://twitter.com/FecavaVets/status/1239869980587560961/photo/1","display_url":"pic.twitter.com/LQPAmLFUoL"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":233,"end":261,"tag":"responsibleUseOfAntibiotics"}]},"possibly_sensitive":false,"lang":"en","author_id":"2857173381","id":"1239869980587560961","in_reply_to_user_id":"116716199","text":"@EMA_News  - European Medicines Agency prepared informative infographics on Categorisation of antibiotics for use in animals as well as Veterinary medicines highlights 2019 \nYou can find the documents here  👉 https://t.co/OacoLvvScw\n#responsibleUseOfAntibiotics https://t.co/LQPAmLFUoL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239869980587560961","created_at":"2020-03-17T11:03:33.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":["3_1239869650516824065"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":175,"end":198,"url":"https://t.co/dMSqzLlrnv","expanded_url":"https://bit.ly/3aXaeKs","display_url":"bit.ly/3aXaeKs"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":59,"tag":"PRAC"}]},"possibly_sensitive":false,"lang":"en","author_id":"2615562036","id":"1239586208604401667","in_reply_to_user_id":"116716199","text":"@EMA_News &amp;PR: 9-12 March 2020 Meeting highlights #PRAC on all topics discussed by the PRAC and recommendations on risk management of medicines for human available now at https://t.co/dMSqzLlrnv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239586208604401667","created_at":"2020-03-16T16:15:57.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":223,"end":246,"url":"https://t.co/zvc4BYg82D","expanded_url":"http://bit.ly/2QkXhSP","display_url":"bit.ly/2QkXhSP"},{"start":247,"end":270,"url":"https://t.co/FpLWoprKjD","expanded_url":"https://twitter.com/PharmaReview/status/1239567125578121220/photo/1","display_url":"pic.twitter.com/FpLWoprKjD"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":63,"tag":"pharmacovigilance"},{"start":107,"end":117,"tag":"medicines"},{"start":129,"end":140,"tag":"ifosfamide"},{"start":175,"end":186,"tag":"drugsafety"},{"start":187,"end":194,"tag":"pharma"},{"start":195,"end":211,"tag":"pharmaceuticals"}]},"possibly_sensitive":false,"lang":"en","author_id":"132897310","id":"1239567125578121220","in_reply_to_user_id":"116716199","text":"@EMA_News announced the results of its March #pharmacovigilance meeting, saying it has started a review of #medicines containing #ifosfamide due to a risk of encephalopathy. \n#drugsafety #pharma #pharmaceuticals\nRead more: https://t.co/zvc4BYg82D https://t.co/FpLWoprKjD","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1239567125578121220","created_at":"2020-03-16T15:00:07.000Z","referenced_tweets":{},"source":"WP to Twitter EPR","attachments":{"media_keys":["3_1239567122872840192"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":231,"end":254,"url":"https://t.co/b6PTmLpXH6","expanded_url":"http://bit.ly/39UYU1d","display_url":"bit.ly/39UYU1d"},{"start":255,"end":278,"url":"https://t.co/98IvfXrJJo","expanded_url":"https://twitter.com/PharmaReview/status/1239536930263613440/photo/1","display_url":"pic.twitter.com/98IvfXrJJo"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":68,"end":76,"tag":"COVID19"},{"start":77,"end":90,"tag":"therapeutics"},{"start":95,"end":104,"tag":"vaccines"},{"start":159,"end":171,"tag":"coronavirus"},{"start":172,"end":183,"tag":"healthnews"},{"start":184,"end":200,"tag":"pharmaceuticals"},{"start":201,"end":203,"tag":"R"}]},"possibly_sensitive":false,"lang":"en","author_id":"132897310","id":"1239536930263613440","in_reply_to_user_id":"116716199","text":"@EMA_News announced it will provide free advice to those working on #COVID19 #therapeutics and #vaccines in the hopes of accelerating approval of a treatment.\n#coronavirus #healthnews #pharmaceuticals #R&amp;D\nRead the story here: https://t.co/b6PTmLpXH6 https://t.co/98IvfXrJJo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239536930263613440","created_at":"2020-03-16T13:00:08.000Z","referenced_tweets":{},"source":"WP to Twitter EPR","attachments":{"media_keys":["3_1239536927424090113"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":120,"end":124,"probability":0.9591,"type":"Place","normalized_text":"Egypt"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"369874033","id":"1239533117993615360","in_reply_to_user_id":"116716199","text":"@EMA_News hi , I want to get. , a drug called.  (  atriance )as it is for non Hodgkin lymphoma, for my daughter, jam in Egypt, plz help me","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239533117993615360","created_at":"2020-03-16T12:44:59.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":167,"end":179,"username":"Janssen_Ned","id":"3147810000"},{"start":180,"end":190,"username":"HematonNL","id":"1011249745"},{"start":191,"end":205,"username":"MyelomaEurope","id":"1277121884"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"161378850","id":"1239517415471538182","in_reply_to_user_id":"116716199","text":"@EMA_News Please approve the subcutaneous administration of Daratumumab a.s.a.p. It will give less burden on hospitals, nurses and doctors in this busy COVID-19 time. @Janssen_Ned @HematonNL @MyelomaEurope","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1239517415471538182","created_at":"2020-03-16T11:42:35.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":31,"end":34,"probability":0.4793,"type":"Organization","normalized_text":"CHMP"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"118819404","id":"1239503611266314241","in_reply_to_user_id":"116716199","text":"@EMA_News hello! do you expect CHMP meetings to take place according to the previous schedule? i.e. next week's meeting will take place?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239503611266314241","created_at":"2020-03-16T10:47:44.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":109,"end":132,"url":"https://t.co/5koEVLE030","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-developers-medicines-vaccines-benefit-free-scientific-advice","display_url":"ema.europa.eu/en/news/covid-…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":96,"end":108,"tag":"coronavirus"}]},"possibly_sensitive":false,"lang":"en","author_id":"533334476","id":"1239493972843810817","in_reply_to_user_id":"116716199","text":"@EMA_News EMA to provide free scientific advice for developers of medicines or vaccines against #coronavirus https://t.co/5koEVLE030","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1239493972843810817","created_at":"2020-03-16T10:09:26.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"in","author_id":"324495269","id":"1239445811924275200","in_reply_to_user_id":"116716199","text":"@EMA_News Koronawirus  Uncaria Tomentosa","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1235217574725586944","created_at":"2020-03-16T06:58:04.000Z","referenced_tweets":[{"type":"replied_to","id":"1235217574725586944"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":110,"end":133,"url":"https://t.co/pnfxhVoOOw","expanded_url":"https://www.ema.europa.eu/en/news/covid-19-developers-medicines-vaccines-benefit-free-scientific-advice","display_url":"ema.europa.eu/en/news/covid-…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"Emma4facs","id":"277466861"},{"start":21,"end":35,"username":"MHRAmedicines","id":"960436586"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"250163834","id":"1238843997927473152","in_reply_to_user_id":"116716199","text":"@EMA_News @Emma4facs @MHRAmedicines this certainly needs to move fast in order to save lives young &amp; old. https://t.co/pnfxhVoOOw","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1238843997927473152","created_at":"2020-03-14T15:06:40.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"337859576","id":"1237844382922858502","in_reply_to_user_id":"116716199","text":"@EMA_News Maaan ....","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T20:54:33.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1871495437","id":"1237829182375198720","in_reply_to_user_id":"116716199","text":"@EMA_News Gutted to see you leave.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T19:54:09.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"430670860","id":"1237811325042032642","in_reply_to_user_id":"116716199","text":"@EMA_News So sad to see you go","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T18:43:11.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2362654501","id":"1237698398226132992","in_reply_to_user_id":"116716199","text":"@EMA_News Sorry to see you go!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T11:14:28.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":83,"end":106,"url":"https://t.co/bOtuBVFXRQ","expanded_url":"https://twitter.com/VirusNederland/status/1237656842173546496","display_url":"twitter.com/VirusNederland…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1235592354297413634","id":"1237682248062730241","in_reply_to_user_id":"116716199","text":"@EMA_News They are doing too little? \nWe should act NOW to prevent further spread.\nhttps://t.co/bOtuBVFXRQ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1237310361113690113","created_at":"2020-03-11T10:10:17.000Z","referenced_tweets":[{"type":"quoted","id":"1237656842173546496"},{"type":"replied_to","id":"1237310361113690113"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":213,"end":236,"url":"https://t.co/a96j9j22BE","expanded_url":"https://www.benzifoundation.org/ema-supports-the-fight-against-coronavirus/","display_url":"benzifoundation.org/ema-supports-t…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":55,"end":67,"tag":"development"},{"start":72,"end":81,"tag":"approval"},{"start":85,"end":94,"tag":"vaccines"},{"start":99,"end":117,"tag":"medicinalproducts"},{"start":126,"end":136,"tag":"treatment"},{"start":141,"end":152,"tag":"prevention"},{"start":164,"end":176,"tag":"Coronavirus"}]},"possibly_sensitive":false,"lang":"en","author_id":"557019066","id":"1237677341846970373","in_reply_to_user_id":"116716199","text":"@EMA_News is taking concrete actions to accelerate the #development and #approval of #vaccines and #medicinalproducts for the #treatment and #prevention of the new #Coronavirus. Discover more on our website! ⬇️💪\n\nhttps://t.co/a96j9j22BE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1237677341846970373","created_at":"2020-03-11T09:50:47.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":36,"end":40,"probability":0.9612,"type":"Place","normalized_text":"China"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1035734480","id":"1237676181115322368","in_reply_to_user_id":"116716199","text":"@EMA_News Is it not possible to sue China for neglectance or something","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"1237310361113690113","created_at":"2020-03-11T09:46:11.000Z","referenced_tweets":[{"type":"replied_to","id":"1237310361113690113"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"294607130","id":"1237663999761801217","in_reply_to_user_id":"116716199","text":"@EMA_News Such a shame","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T08:57:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"926161031524732929","id":"1237661740520873986","in_reply_to_user_id":"116716199","text":"@EMA_News Sad to see you leave good luck for the future .","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T08:48:48.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1225183455694204929","id":"1237648999324233729","in_reply_to_user_id":"116716199","text":"@EMA_News I apologise for us being so dumb.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T07:58:10.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"353199464","id":"1237639930051989505","in_reply_to_user_id":"116716199","text":"@EMA_News 😞😞😞","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T07:22:08.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":240,"end":263,"url":"https://t.co/Uzt1PW1Jcs","expanded_url":"https://twitter.com/EuropeLiver/status/1237638621735378950/photo/1","display_url":"pic.twitter.com/Uzt1PW1Jcs"},{"start":240,"end":263,"url":"https://t.co/Uzt1PW1Jcs","expanded_url":"https://twitter.com/EuropeLiver/status/1237638621735378950/photo/1","display_url":"pic.twitter.com/Uzt1PW1Jcs"},{"start":240,"end":263,"url":"https://t.co/Uzt1PW1Jcs","expanded_url":"https://twitter.com/EuropeLiver/status/1237638621735378950/photo/1","display_url":"pic.twitter.com/Uzt1PW1Jcs"}],"annotations":[{"start":158,"end":173,"probability":0.9959,"type":"Person","normalized_text":"Teresa Casanovas"},{"start":204,"end":226,"probability":0.4458,"type":"Other","normalized_text":"European Liver Patients"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"333363576","id":"1237638621735378950","in_reply_to_user_id":"116716199","text":"@EMA_News, organized  joint meeting held annually between the organizations of patients, consumers and health professionals 👉 saintific committee president, Teresa Casanovas was part of the meeting from European Liver Patients' Association https://t.co/Uzt1PW1Jcs","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":7,"quote_count":0},"conversation_id":"1237638621735378950","created_at":"2020-03-11T07:16:56.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1237638610469498880","3_1237638613963354113","3_1237638617650073600"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"14226944","id":"1237627978021912576","in_reply_to_user_id":"116716199","text":"@EMA_News Impeccable timing. But with no need to be here you can concentrate your efforts on our lost friends","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-11T06:34:38.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"351557555","id":"1237519085761482752","in_reply_to_user_id":"116716199","text":"@EMA_News This is terribly sad.","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-10T23:21:56.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"2345630206","id":"1237518524974850050","in_reply_to_user_id":"116716199","text":"@EMA_News 😔😔😔❤","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1101490431681019909","created_at":"2020-03-10T23:19:42.000Z","referenced_tweets":[{"type":"replied_to","id":"1101490431681019909"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":91,"end":93,"probability":0.5955,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"265315087","id":"1237441277475590154","in_reply_to_user_id":"116716199","text":"@EMA_News Please do somthing about NUROWN  from brainstorm. To speed up the aproval of the FDA","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":10,"quote_count":0},"conversation_id":"1237310361113690113","created_at":"2020-03-10T18:12:45.000Z","referenced_tweets":[{"type":"replied_to","id":"1237310361113690113"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":261,"end":284,"url":"https://t.co/WHiYRF6PC4","expanded_url":"https://www.ema.europa.eu/en/news/addressing-potential-impact-novel-coronavirus-disease-covid-19-medicines-supply-eu","display_url":"ema.europa.eu/en/news/addres…"}],"annotations":[{"start":82,"end":93,"probability":0.505,"type":"Organization","normalized_text":"EU Executive"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":27,"end":56,"tag":"NationalCompetentAuthorities"},{"start":99,"end":113,"tag":"SteeringGroup"},{"start":117,"end":127,"tag":"shortages"},{"start":131,"end":141,"tag":"medicines"},{"start":211,"end":217,"tag":"COVID"},{"start":221,"end":230,"tag":"outbreak"},{"start":238,"end":245,"tag":"supply"},{"start":249,"end":259,"tag":"medicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"2794475589","id":"1237319952216055808","in_reply_to_user_id":"116716199","text":"@EMA_News,@EU_Health &amp; #NationalCompetentAuthorities organised 1st meeting of the EU Executive #SteeringGroup on #shortages of #medicines caused by major events, to discuss measures addressing the impact of #COVID-19 #outbreak on the #supply of #medicines. https://t.co/WHiYRF6PC4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1237319952216055808","created_at":"2020-03-10T10:10:39.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":104,"end":119,"username":"BrainstormCell","id":"802020620"},{"start":120,"end":127,"username":"Cylebo","id":"1201751724"},{"start":128,"end":140,"username":"INFARMED_IP","id":"1392501529"},{"start":141,"end":156,"username":"MaryKayTurner1","id":"3270550555"}],"hashtags":[{"start":26,"end":33,"tag":"NurOwn"},{"start":47,"end":51,"tag":"ALS"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1237096995048902656","in_reply_to_user_id":"116716199","text":"@EMA_News Please, we need #NurOwn approval for #ALS patients. \nThis treatment is real hope in decades! \n@BrainstormCell\n@Cylebo @INFARMED_IP @MaryKayTurner1","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1237096995048902656","created_at":"2020-03-09T19:24:42.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":193,"end":216,"url":"https://t.co/TRXSEhQeVU","expanded_url":"https://www.ema.europa.eu/en/news/emafda-analysis-shows-high-degree-alignment-marketing-application-decisions-between-eu-us","display_url":"ema.europa.eu/en/news/emafda…"}],"annotations":[{"start":18,"end":48,"probability":0.4815,"type":"Organization","normalized_text":"US Food and Drug Administration"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":51,"end":58,"username":"US_FDA","id":"208120290"},{"start":153,"end":168,"username":"BrainstormCell","id":"802020620"},{"start":169,"end":176,"username":"Cylebo","id":"1201751724"},{"start":177,"end":192,"username":"MaryKayTurner1","id":"3270550555"}],"hashtags":[{"start":145,"end":152,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1236794050335866881","in_reply_to_user_id":"116716199","text":"@EMA_News and the US Food and Drug Administration (@US_FDA) are aligned in more than 90% of marketing authorisation decisions for new medicines.\n#NurOwn @BrainstormCell @Cylebo @MaryKayTurner1\nhttps://t.co/TRXSEhQeVU","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"1236794050335866881","created_at":"2020-03-08T23:20:54.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2544141678","id":"1235231476100280321","in_reply_to_user_id":"116716199","text":"@EMA_News Congrats","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1235217574725586944","created_at":"2020-03-04T15:51:48.000Z","referenced_tweets":[{"type":"replied_to","id":"1235217574725586944"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":106,"end":111,"probability":0.9954,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":113,"end":120,"username":"BMA_GP","id":"3964961067"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"800075637725622272","id":"1235203431658328067","in_reply_to_user_id":"116716199","text":"@EMA_News   Two day meeting in the new headquarters. @UEMOPresidency contributing to Medicines debates in Europe @BMA_GP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1235203431658328067","created_at":"2020-03-04T14:00:21.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/MYJ74juqtH","expanded_url":"https://twitter.com/Gema19522252/status/1234809974506827776/photo/1","display_url":"pic.twitter.com/MYJ74juqtH"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":12,"end":21,"username":"AEMPSGOB","id":"326845755"},{"start":46,"end":53,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"1161561387950321664","id":"1234809974506827776","in_reply_to_user_id":"116716199","text":"@EMA_News , @AEMPSGOB  esto es de parte de la @US_FDA https://t.co/MYJ74juqtH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1234809974506827776","created_at":"2020-03-03T11:56:54.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1234809960657281027"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":66,"end":81,"username":"BrainstormCell","id":"802020620"},{"start":214,"end":223,"username":"SteveFDA","id":"2904169317"},{"start":228,"end":237,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":50,"tag":"NurOwn"},{"start":127,"end":131,"tag":"ALS"},{"start":132,"end":136,"tag":"MND"},{"start":165,"end":172,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1097624872925188097","id":"1234281272161206272","in_reply_to_user_id":"116716199","text":"@EMA_News I believe you already know about #NurOwn treatment from @BrainstormCell. This treatment needs to be approved to help #ALS #MND patients around the world! \n#NurOwn needs to be approved at the same time by @SteveFDA and @EMA_News.","public_metrics":{"retweet_count":15,"reply_count":1,"like_count":11,"quote_count":0},"conversation_id":"1233770148164599808","created_at":"2020-03-02T00:56:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1233770148164599808"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":66,"end":81,"username":"BrainstormCell","id":"802020620"},{"start":214,"end":223,"username":"SteveFDA","id":"2904169317"},{"start":228,"end":237,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":50,"tag":"NurOwn"},{"start":127,"end":131,"tag":"ALS"},{"start":132,"end":136,"tag":"MND"},{"start":165,"end":172,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1097624872925188097","id":"1234281058155343875","in_reply_to_user_id":"116716199","text":"@EMA_News I believe you already know about #NurOwn treatment from @BrainstormCell. This treatment needs to be approved to help #ALS #MND patients around the world! \n#NurOwn needs to be approved at the same time by @SteveFDA and @EMA_News.","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"1233354911758180354","created_at":"2020-03-02T00:55:10.000Z","referenced_tweets":[{"type":"replied_to","id":"1233354911758180354"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":66,"end":81,"username":"BrainstormCell","id":"802020620"},{"start":214,"end":223,"username":"SteveFDA","id":"2904169317"},{"start":228,"end":237,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":50,"tag":"NurOwn"},{"start":127,"end":131,"tag":"ALS"},{"start":132,"end":136,"tag":"MND"},{"start":165,"end":172,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1097624872925188097","id":"1234280872548950023","in_reply_to_user_id":"116716199","text":"@EMA_News I believe you already know about #NurOwn treatment from @BrainstormCell. This treatment needs to be approved to help #ALS #MND patients around the world! \n#NurOwn needs to be approved at the same time by @SteveFDA and @EMA_News.","public_metrics":{"retweet_count":19,"reply_count":0,"like_count":11,"quote_count":0},"conversation_id":"1233678292382703616","created_at":"2020-03-02T00:54:26.000Z","referenced_tweets":[{"type":"replied_to","id":"1233678292382703616"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":164,"end":166,"probability":0.6213,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":82,"end":97,"username":"BrainstormCell","id":"802020620"},{"start":138,"end":147,"username":"EMA_News","id":"116716199"},{"start":184,"end":193,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":23,"end":27,"tag":"ALS"},{"start":28,"end":32,"tag":"MND"},{"start":59,"end":66,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1234279061553373192","in_reply_to_user_id":"116716199","text":"@EMA_News Please, help #ALS #MND patients then and look at #NurOwn treatment from @BrainstormCell. This treatment needs to be approved by @EMA_News. Don't wait for FDA approval first. @EMA_News needs to approve at the same time.","public_metrics":{"retweet_count":16,"reply_count":1,"like_count":8,"quote_count":0},"conversation_id":"1233678292382703616","created_at":"2020-03-02T00:47:14.000Z","referenced_tweets":[{"type":"replied_to","id":"1233678292382703616"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":92,"end":97,"probability":0.4253,"type":"Place","normalized_text":"Phase3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":198,"end":205,"username":"Cylebo","id":"1201751724"},{"start":206,"end":221,"username":"BrainstormCell","id":"802020620"},{"start":222,"end":234,"username":"Europarl_EN","id":"36329597"},{"start":235,"end":250,"username":"MaryKayTurner1","id":"3270550555"},{"start":251,"end":265,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":10,"end":17,"tag":"Nurown"},{"start":60,"end":64,"tag":"ALS"},{"start":67,"end":71,"tag":"MND"},{"start":193,"end":197,"tag":"Als"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1234222939081465859","in_reply_to_user_id":"116716199","text":"@EMA_News #Nurown is proving safe and effective in treating #ALS / #MND today, currently in Phase3 trial and groundbreaking results. \nApprove Now! 150 years without any efficient treatment for #Als\n@Cylebo @BrainstormCell @Europarl_EN @MaryKayTurner1 @SKyriakidesEU","public_metrics":{"retweet_count":29,"reply_count":3,"like_count":13,"quote_count":0},"conversation_id":"1233770148164599808","created_at":"2020-03-01T21:04:14.000Z","referenced_tweets":[{"type":"replied_to","id":"1233770148164599808"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":92,"end":97,"probability":0.4253,"type":"Place","normalized_text":"Phase3"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":198,"end":205,"username":"Cylebo","id":"1201751724"},{"start":206,"end":221,"username":"BrainstormCell","id":"802020620"},{"start":222,"end":234,"username":"Europarl_EN","id":"36329597"},{"start":235,"end":250,"username":"MaryKayTurner1","id":"3270550555"},{"start":251,"end":265,"username":"SKyriakidesEU","id":"2476130260"}],"hashtags":[{"start":10,"end":17,"tag":"Nurown"},{"start":60,"end":64,"tag":"ALS"},{"start":67,"end":71,"tag":"MND"},{"start":193,"end":197,"tag":"Als"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1234222751508049921","in_reply_to_user_id":"116716199","text":"@EMA_News #Nurown is proving safe and effective in treating #ALS / #MND today, currently in Phase3 trial and groundbreaking results. \nApprove Now! 150 years without any efficient treatment for #Als\n@Cylebo @BrainstormCell @Europarl_EN @MaryKayTurner1 @SKyriakidesEU","public_metrics":{"retweet_count":28,"reply_count":2,"like_count":15,"quote_count":0},"conversation_id":"1233678292382703616","created_at":"2020-03-01T21:03:29.000Z","referenced_tweets":[{"type":"replied_to","id":"1233678292382703616"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":169,"end":192,"url":"https://t.co/d5gylYT839","expanded_url":"https://www.youtube.com/watch?v=PQUH36KvpRc","display_url":"youtube.com/watch?v=PQUH36…"},{"start":193,"end":216,"url":"https://t.co/uFxwjp5yvT","expanded_url":"https://twitter.com/cosmicfairy444/status/1233695807653720065/photo/1","display_url":"pic.twitter.com/uFxwjp5yvT"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":60,"tag":"SclerodermaFreeWorld"},{"start":61,"end":79,"tag":"RaynaudsFreeWorld"},{"start":80,"end":89,"tag":"Research"},{"start":90,"end":102,"tag":"RareDisease"},{"start":103,"end":114,"tag":"autoimmune"},{"start":115,"end":128,"tag":"LifeChanging"},{"start":129,"end":144,"tag":"RareDiseaseDay"},{"start":145,"end":157,"tag":"Scleroderma"},{"start":158,"end":167,"tag":"Raynauds"}]},"possibly_sensitive":false,"lang":"en","author_id":"805083884","id":"1233695807653720065","in_reply_to_user_id":"116716199","text":"@EMA_News Thanks for all that you do 😍\n#SclerodermaFreeWorld #RaynaudsFreeWorld #Research #RareDisease #autoimmune #LifeChanging #RareDiseaseDay #Scleroderma #Raynauds \nhttps://t.co/d5gylYT839 https://t.co/uFxwjp5yvT","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1233678292382703616","created_at":"2020-02-29T10:09:36.000Z","referenced_tweets":[{"type":"replied_to","id":"1233678292382703616"}],"source":"Twitter for Android","attachments":{"media_keys":["3_1233695704289292288"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/4U0ZkLXMRT","expanded_url":"http://bit.ly/39afvhb","display_url":"bit.ly/39afvhb"},{"start":117,"end":140,"url":"https://t.co/xrM0uEF6L2","expanded_url":"https://twitter.com/RegProRecruit/status/1233397441476558848/photo/1","display_url":"pic.twitter.com/xrM0uEF6L2"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"},{"start":56,"end":65,"username":"Novartis","id":"17226612"}],"hashtags":[{"start":105,"end":116,"tag":"regulatory"}]},"possibly_sensitive":false,"lang":"en","author_id":"1706741204","id":"1233397441476558848","in_reply_to_user_id":"116716199","text":"@EMA_News and @US_FDA both accept application filing of @Novartis’ RMS treatment https://t.co/4U0ZkLXMRT #regulatory https://t.co/xrM0uEF6L2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1233397441476558848","created_at":"2020-02-28T14:24:00.000Z","referenced_tweets":{},"source":"Semrush Social Media Tool","attachments":{"media_keys":["3_1233394046598623235"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":159,"end":164,"probability":0.9936,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1041675265703739392","id":"1233063027735441410","in_reply_to_user_id":"116716199","text":"@EMA_News are there any initiatives taking place to protect international patients against negligence and malpractice? International patients are traveling to Europe for treatment and surgery but currently there is no protection for them.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1233063027735441410","created_at":"2020-02-27T16:15:09.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"384321513","id":"1232335965135310848","in_reply_to_user_id":"116716199","text":"@EMA_News Hello I am doing some research using on adverse reaction of drugs, I currently dont see any API or way to download the data, let me know how can i do that","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1232335965135310848","created_at":"2020-02-25T16:06:04.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"955542322703290368","id":"1232259653939159040","in_reply_to_user_id":"116716199","text":"@EMA_News The link doesn’t work 🤕","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1232236542380400642","created_at":"2020-02-25T11:02:50.000Z","referenced_tweets":[{"type":"replied_to","id":"1232236542380400642"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/bKeugifjob","expanded_url":"https://twitter.com/MarirosiFernan2/status/1231619408927301635/photo/1","display_url":"pic.twitter.com/bKeugifjob"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1228656397388304384","id":"1231619408927301635","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/bKeugifjob","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1231619408927301635","created_at":"2020-02-23T16:38:44.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1231619402040270848"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":48,"end":50,"probability":0.4018,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":106,"end":113,"tag":"NurOwn"},{"start":207,"end":214,"tag":"axeALS"}]},"possibly_sensitive":false,"lang":"en","author_id":"705827606","id":"1231552272754147328","in_reply_to_user_id":"116716199","text":"@EMA_News Please help all the people dying from ALS. Patients need access to a promising treatment called #NurOwn that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us #axeALS!","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1231552272754147328","created_at":"2020-02-23T12:11:57.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":51,"end":57,"probability":0.995,"type":"Place","normalized_text":"Germany"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1041675265703739392","id":"1231396124713537536","in_reply_to_user_id":"116716199","text":"@EMA_News Many international patients are going to Germany for surgery. What protection do we have against negligence and malpractice? My spine conduction was misdiagnosed and now I need a revision surgery. Surgeon is avoiding responsibility.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1231396124713537536","created_at":"2020-02-23T01:51:29.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":210,"end":233,"url":"https://t.co/BO5iidC2nX","expanded_url":"http://www.adrreports.eu/vet/en/index.html","display_url":"adrreports.eu/vet/en/index.h…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":186,"end":197,"tag":"veterinary"},{"start":198,"end":207,"tag":"medicine"}]},"possibly_sensitive":false,"lang":"en","author_id":"1131648964791537666","id":"1231355088729407489","in_reply_to_user_id":"116716199","text":"@EMA_News allowing public access to suspected side effects from centrally authorised veterinary medicinal products - good for transparency and highlighting the benefit:risk of medicines #veterinary #medicine \n\nhttps://t.co/BO5iidC2nX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1231355088729407489","created_at":"2020-02-22T23:08:25.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":216,"end":232,"username":"realDonaldTrump","id":"25073877"}],"hashtags":[{"start":31,"end":36,"tag":"pals"},{"start":106,"end":113,"tag":"NurOwn"},{"start":207,"end":214,"tag":"axeALS"}]},"possibly_sensitive":false,"lang":"en","author_id":"705827606","id":"1229505994801270791","in_reply_to_user_id":"116716199","text":"@EMA_News  Please help all the #pals dying from ALS. Patients need access to a promising treatment called #NurOwn that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us #axeALS! @realdonaldtrump","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1229505994801270791","created_at":"2020-02-17T20:40:46.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":184,"end":207,"url":"https://t.co/8lhJUSn5Gb","expanded_url":"https://twitter.com/EMA_News/status/1227590353173303296","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":50,"end":68,"tag":"Pharmacovigilance"},{"start":78,"end":98,"tag":"VeterinaryMedicines"},{"start":160,"end":173,"tag":"AnimalHealth"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1229415962014822401","in_reply_to_user_id":"116716199","text":"@EMA_News has now gone live with public access to #Pharmacovigilance data for #VeterinaryMedicines. This will undoubtedly introduce some new challenges for the #AnimalHealth industry. https://t.co/8lhJUSn5Gb","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1229415962014822401","created_at":"2020-02-17T14:43:01.000Z","referenced_tweets":[{"type":"quoted","id":"1227590353173303296"}],"source":"Buffer","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/Vx2T1ZF3FB","expanded_url":"https://twitter.com/MarirosiFernan2/status/1229097798097920000","display_url":"twitter.com/MarirosiFernan…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":35,"end":42,"tag":"nurown"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1229134443815866371","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission \nWe need  #nurown Now!\n50.000 European Patients are suffering. https://t.co/Vx2T1ZF3FB","public_metrics":{"retweet_count":8,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"1229134443815866371","created_at":"2020-02-16T20:04:22.000Z","referenced_tweets":[{"type":"quoted","id":"1229097798097920000"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":56,"end":58,"probability":0.3928,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":127,"end":142,"username":"BrainstormCell","id":"802020620"},{"start":238,"end":245,"username":"Cylebo","id":"1201751724"},{"start":246,"end":260,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":114,"end":121,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1228816678097694720","in_reply_to_user_id":"116716199","text":"@EMA_News Please help 50.000 European people dying from ALS. Patients need access to a promising treatment called #NurOwn from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us!\n\n@Cylebo @EU_Commission","public_metrics":{"retweet_count":12,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"1228816678097694720","created_at":"2020-02-15T23:01:41.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":55,"end":57,"probability":0.4222,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":223,"end":239,"username":"realDonaldTrump","id":"25073877"}],"hashtags":[{"start":113,"end":120,"tag":"NurOwn"},{"start":214,"end":221,"tag":"axeALS"}]},"possibly_sensitive":false,"lang":"en","author_id":"1218573082786439171","id":"1228371720375062528","in_reply_to_user_id":"116716199","text":"@EMA_News Please help the 30,000+ Americans dying from ALS. Patients need access to a promising treatment called #NurOwn that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us #axeALS! @realdonaldtrump","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1228371720375062528","created_at":"2020-02-14T17:33:34.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":37,"end":44,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"705827606","id":"1228326283349839873","in_reply_to_user_id":"116716199","text":"@EMA_News Please help us and approve #NurOwn. People are dying. They can't wait!","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1228280749729746945","created_at":"2020-02-14T14:33:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1228280749729746945"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":108,"end":131,"url":"https://t.co/b7QokauW78","expanded_url":"https://www.apmnews.com:443/story.php?objet=347340","display_url":"apmnews.com/story.php?obje…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"fr","author_id":"366466573","id":"1228321875018776577","in_reply_to_user_id":"116716199","text":"@EMA_News Le PRAC recommande de limiter l'utilisation de la cyprotérone en raison d'un risque de méningiome https://t.co/b7QokauW78","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1228321875018776577","created_at":"2020-02-14T14:15:30.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":39,"end":54,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":26,"end":33,"tag":"NurOwn"},{"start":64,"end":68,"tag":"ALS"},{"start":69,"end":73,"tag":"MND"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1228305332184780802","in_reply_to_user_id":"116716199","text":"@EMA_News Please, approve #NurOwn from @BrainstormCell to treat #ALS #MND","public_metrics":{"retweet_count":7,"reply_count":0,"like_count":7,"quote_count":0},"conversation_id":"1228280749729746945","created_at":"2020-02-14T13:09:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1228280749729746945"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":253,"end":276,"url":"https://t.co/qBpLc9ZC5e","expanded_url":"https://lnkd.in/gtZknxJ","display_url":"lnkd.in/gtZknxJ"},{"start":277,"end":300,"url":"https://t.co/0ul3DC0K9G","expanded_url":"https://twitter.com/Asphalion/status/1228224262567124994/photo/1","display_url":"pic.twitter.com/0ul3DC0K9G"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":234,"end":244,"username":"Asphalion","id":"717962540"}],"hashtags":[{"start":43,"end":51,"tag":"ISOIDMP"},{"start":97,"end":101,"tag":"EMA"},{"start":172,"end":180,"tag":"ISOIDMP"}]},"possibly_sensitive":false,"lang":"en","author_id":"717962540","id":"1228224262567124994","in_reply_to_user_id":"116716199","text":"@EMA_News has released version 1 of the EU #ISOIDMP Implementation Guideline. With this release, #EMA is providing information about the implementation requirements of the #ISOIDMP standards and terminologies in the EU. Stay tuned to @Asphalion’s news! https://t.co/qBpLc9ZC5e https://t.co/0ul3DC0K9G","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1228224262567124994","created_at":"2020-02-14T07:47:38.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1228224246310064131"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":53,"end":55,"probability":0.431,"type":"Place","normalized_text":"ALS"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":125,"end":140,"username":"BrainstormCell","id":"802020620"},{"start":235,"end":244,"username":"LuchaEla","id":"1190393189053685761"}],"hashtags":[{"start":111,"end":118,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1228112252227682305","in_reply_to_user_id":"116716199","text":"@EMA_News Please help the 50,000 European dying from ALS. Patients need access to a promising treatment called #NurOwn  from @BrainstormCell that is stuck in a phase 3 clinical trial. Patients do not have time to wait! Please help us  @LuchaEla","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"1228112252227682305","created_at":"2020-02-14T00:22:32.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/o6epPyzHm5","expanded_url":"https://twitter.com/freund_paula/status/1227828092854505472","display_url":"twitter.com/freund_paula/s…"}],"annotations":[{"start":78,"end":83,"probability":0.9934,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"}],"hashtags":[{"start":58,"end":65,"tag":"nurown"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1227919397043474432","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN\n\nALS Community need #nurown approved in Europe. Please see below the impact: https://t.co/o6epPyzHm5","public_metrics":{"retweet_count":25,"reply_count":0,"like_count":10,"quote_count":0},"conversation_id":"1227919397043474432","created_at":"2020-02-13T11:36:12.000Z","referenced_tweets":[{"type":"quoted","id":"1227828092854505472"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":228,"end":251,"url":"https://t.co/pplcEQw3Mx","expanded_url":"https://bit.ly/39x4oij","display_url":"bit.ly/39x4oij"},{"start":255,"end":278,"url":"https://t.co/rzK7rMXMEU","expanded_url":"http://www.adrreports.eu/vet/en/index.html","display_url":"adrreports.eu/vet/en/index.h…"},{"start":279,"end":302,"url":"https://t.co/u1h59YtiPX","expanded_url":"https://twitter.com/FVEurope/status/1227586246802837504/photo/1","display_url":"pic.twitter.com/u1h59YtiPX"},{"start":279,"end":302,"url":"https://t.co/u1h59YtiPX","expanded_url":"https://twitter.com/FVEurope/status/1227586246802837504/photo/1","display_url":"pic.twitter.com/u1h59YtiPX"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1549866445","id":"1227586246802837504","in_reply_to_user_id":"116716199","text":"@EMA_News launches public access to suspected adverse events reports vet medicines. This is an important step to increase transparency around adverse events, much needed as shown of the FVE/EMA publication on pharmacovigilance (https://t.co/pplcEQw3Mx)-  https://t.co/rzK7rMXMEU https://t.co/u1h59YtiPX","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":5,"quote_count":0},"conversation_id":"1227586246802837504","created_at":"2020-02-12T13:32:23.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1227586241656426496","3_1227586241652281350"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":99,"end":122,"url":"https://t.co/q3UGm9dNR4","expanded_url":"https://www.ema.europa.eu/documents/leaflet/responsible-use-antibiotics-protects-animals-people-2011-2017-sales-antibiotics-veterinary-use-are_en.pdf","display_url":"ema.europa.eu/documents/leaf…"},{"start":123,"end":146,"url":"https://t.co/5NNrM54n50","expanded_url":"https://twitter.com/FVEurope/status/1227177371238793217/photo/1","display_url":"pic.twitter.com/5NNrM54n50"}],"annotations":[{"start":87,"end":92,"probability":0.9968,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1549866445","id":"1227177371238793217","in_reply_to_user_id":"116716199","text":"@EMA_News made a nice visual guide on the monitoring of antibiotic sales in animals in Europe. See https://t.co/q3UGm9dNR4 https://t.co/5NNrM54n50","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1227177371238793217","created_at":"2020-02-11T10:27:39.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1227177365769523209"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":53,"end":76,"url":"https://t.co/bbrkxTvkjx","expanded_url":"https://twitter.com/eliasova_zuzana/status/1226626744926580736","display_url":"twitter.com/eliasova_zuzan…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"FDACommissioner","id":"1113782559194984448"},{"start":27,"end":36,"username":"SteveFDA","id":"2904169317"},{"start":37,"end":52,"username":"BrainstormCell","id":"802020620"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1183819761030971393","id":"1226633155630813185","in_reply_to_user_id":"116716199","text":"@EMA_News @FDACommissioner @SteveFDA @BrainstormCell https://t.co/bbrkxTvkjx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1226633155630813185","created_at":"2020-02-09T22:25:08.000Z","referenced_tweets":[{"type":"quoted","id":"1226626744926580736"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":203,"end":226,"url":"https://t.co/zm4IlYANVn","expanded_url":"https://twitter.com/stevens_nation/status/1226398583542308864","display_url":"twitter.com/stevens_nation…"}],"annotations":[{"start":76,"end":83,"probability":0.985,"type":"Place","normalized_text":"Portugal"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":18,"end":30,"username":"SICNoticias","id":"17163446"},{"start":31,"end":40,"username":"cmjornal","id":"124139163"},{"start":41,"end":53,"username":"RTPNoticias","id":"16451028"},{"start":63,"end":67,"username":"tvi","id":"498086098"},{"start":168,"end":183,"username":"stevens_nation","id":"1182121512389632000"},{"start":184,"end":192,"username":"als_now","id":"1123069018682925057"},{"start":193,"end":202,"username":"LuchaEla","id":"1190393189053685761"}],"hashtags":[{"start":99,"end":106,"tag":"nurown"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1226564431380959233","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA @SICNoticias @cmjornal @RTPNoticias @tvi24pt @tvi \n \nFrom Portugal, We also need #nurown a promising treatment for ALS approved wordwide now, please!\n@stevens_nation @als_now @LuchaEla https://t.co/zm4IlYANVn","public_metrics":{"retweet_count":10,"reply_count":4,"like_count":13,"quote_count":0},"conversation_id":"1226564431380959233","created_at":"2020-02-09T17:52:03.000Z","referenced_tweets":[{"type":"quoted","id":"1226398583542308864"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":101,"end":106,"probability":0.9612,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"BSNJSL","id":"131941557"},{"start":18,"end":30,"username":"green4girls","id":"186190338"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3023988238","id":"1226203820251680768","in_reply_to_user_id":"116716199","text":"@EMA_News @BSNJSL @green4girls girls4green!  girls4stem! girls4betterworld! Thank you EMA, thank you Europe! girls4europe!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1226144373437583366","created_at":"2020-02-08T17:59:07.000Z","referenced_tweets":[{"type":"replied_to","id":"1226144373437583366"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":54,"end":77,"url":"https://t.co/VBUxLR8dcI","expanded_url":"https://twitter.com/green4girls/status/1226074830598017025","display_url":"twitter.com/green4girls/st…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":41,"end":53,"username":"green4girls","id":"186190338"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"820745424772415490","id":"1226122057273966592","in_reply_to_user_id":"116716199","text":"@EMA_News medicines life cycle in action @green4girls https://t.co/VBUxLR8dcI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1226122057273966592","created_at":"2020-02-08T12:34:13.000Z","referenced_tweets":[{"type":"quoted","id":"1226074830598017025"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":35,"end":58,"url":"https://t.co/ppzeI3FW8i","expanded_url":"https://twitter.com/DrEScottSills/status/797124194123161600","display_url":"twitter.com/DrEScottSills/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":34,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1161561387950321664","id":"1225915171035590656","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @AEMPSGOB https://t.co/ppzeI3FW8i","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1225915171035590656","created_at":"2020-02-07T22:52:07.000Z","referenced_tweets":[{"type":"quoted","id":"797124194123161600"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/HFZZi6tHZb","expanded_url":"https://twitter.com/ElaAmigos/status/1224948646443126784","display_url":"twitter.com/ElaAmigos/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"Cylebo","id":"1201751724"},{"start":18,"end":33,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":53,"end":60,"tag":"nurown"}]},"possibly_sensitive":false,"lang":"en","author_id":"1183819761030971393","id":"1225063487455535105","in_reply_to_user_id":"116716199","text":"@EMA_News @Cylebo @BrainstormCell \n\nWe need this for #nurown wordwide! https://t.co/HFZZi6tHZb","public_metrics":{"retweet_count":9,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"1225063487455535105","created_at":"2020-02-05T14:27:50.000Z","referenced_tweets":[{"type":"quoted","id":"1224948646443126784"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":179,"end":202,"url":"https://t.co/4F4f2Sjnxk","expanded_url":"https://www.ema.europa.eu/en/news/ema-support-development-vaccines-treatments-novel-coronavirus","display_url":"ema.europa.eu/en/news/ema-su…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":114,"end":121,"username":"LMSTdk","id":"3575073857"},{"start":167,"end":176,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"da","author_id":"875273882298724352","id":"1225016818865254400","in_reply_to_user_id":"116716199","text":"@EMA_News fortæller om regulatoriske tiltag for at fremme udvikling af behandling og vaccine mod 2019-nCoV . Vi i @LMSTdk arbejder naturligvis tæt med vore kolleger i @EMA_News . https://t.co/4F4f2Sjnxk","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1225016818865254400","created_at":"2020-02-05T11:22:23.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/WrNgOCDqMI","expanded_url":"https://twitter.com/EMA_News/status/1224372307856183296","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"4234230077","id":"1224714293930795008","in_reply_to_user_id":"116716199","text":"@EMA_News Congrats 😁👏! New Office and 25th anniversary celebration! 🥳👍 https://t.co/WrNgOCDqMI","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1224714293930795008","created_at":"2020-02-04T15:20:16.000Z","referenced_tweets":[{"type":"quoted","id":"1224372307856183296"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":37,"end":47,"probability":0.9598,"type":"Place","normalized_text":"Netherlands"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"Iamsterdam","id":"43562201"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"18958504","id":"1224684896230264832","in_reply_to_user_id":"116716199","text":"@EMA_News @Iamsterdam Welcome to the Netherlands 🇳🇱","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1224372307856183296","created_at":"2020-02-04T13:23:27.000Z","referenced_tweets":[{"type":"replied_to","id":"1224372307856183296"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"298730063","id":"1224657925064613890","in_reply_to_user_id":"116716199","text":"@EMA_News Patente?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1224656345380442112","created_at":"2020-02-04T11:36:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1224656345380442112"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":24,"end":47,"url":"https://t.co/rqd1CI62Ny","expanded_url":"https://twitter.com/groeestate/status/1224637704308174848/photo/1","display_url":"pic.twitter.com/rqd1CI62Ny"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"relocatemaEN","id":"1005070894602039296"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"3342472756","id":"1224637704308174848","in_reply_to_user_id":"116716199","text":"@EMA_News @relocatemaEN https://t.co/rqd1CI62Ny","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1224372307856183296","created_at":"2020-02-04T10:15:56.000Z","referenced_tweets":[{"type":"replied_to","id":"1224372307856183296"}],"source":"Twitter for iPhone","attachments":{"media_keys":["16_1224637692740284419"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":85,"end":92,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1200563024903450624","id":"1224376104875646977","in_reply_to_user_id":"116716199","text":"@EMA_News Now you can get down to business when will you look into early approval of #NurOwn for treatment of MND?","public_metrics":{"retweet_count":6,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1224372307856183296","created_at":"2020-02-03T16:56:25.000Z","referenced_tweets":[{"type":"replied_to","id":"1224372307856183296"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":161,"end":184,"url":"https://t.co/6BUqtyYdIN","expanded_url":"https://www.ruminantia.it/lema-incoraggia-i-veterinari-a-considerare-le-raccomandazioni-aggiornate-sulla-categorizzazione-degli-antibiotici-a-tutela-di-salute-pubblica-ed-animale/","display_url":"ruminantia.it/lema-incoraggi…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":23,"end":34,"tag":"veterinari"},{"start":108,"end":120,"tag":"antibiotici"},{"start":133,"end":140,"tag":"salute"}]},"possibly_sensitive":false,"lang":"it","author_id":"1235372959","id":"1224293412440104962","in_reply_to_user_id":"116716199","text":"@EMA_News incoraggia i #veterinari a considerare le raccomandazioni aggiornate sulla categorizzazione degli #antibiotici a tutela di #salute pubblica ed animale https://t.co/6BUqtyYdIN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1224293412440104962","created_at":"2020-02-03T11:27:50.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":146,"end":169,"url":"https://t.co/Q3AJz8vdmv","expanded_url":"https://www.ema.europa.eu/en/news/uk-withdrawal-eu-31-january-2020","display_url":"ema.europa.eu/en/news/uk-wit…"},{"start":250,"end":273,"url":"https://t.co/WKkiI64xuT","expanded_url":"https://twitter.com/EMA_News/status/1223237843469963264","display_url":"twitter.com/EMA_News/statu…"}],"annotations":[{"start":72,"end":82,"probability":0.9505,"type":"Place","normalized_text":"Reino Unido"},{"start":138,"end":143,"probability":0.4654,"type":"Organization","normalized_text":"Brexit"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":210,"end":230,"tag":"farmacovigilanciaMX"},{"start":231,"end":249,"tag":"pharmacovigilance"}]},"possibly_sensitive":false,"lang":"es","author_id":"1163290630853808129","id":"1223757944174415872","in_reply_to_user_id":"116716199","text":"@EMA_News indica que las empresas farmacéuticas seguirán operando en el Reino Unido hasta el final de año conforme dure la transición del Brexit. https://t.co/Q3AJz8vdmv. La información oportuna es importante. #farmacovigilanciaMX #pharmacovigilance https://t.co/WKkiI64xuT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1223757944174415872","created_at":"2020-02-02T00:00:04.000Z","referenced_tweets":[{"type":"quoted","id":"1223237843469963264"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":158,"end":181,"url":"https://t.co/obMGKyIW5w","expanded_url":"https://twitter.com/emg0038/status/1223734465790447616/photo/1","display_url":"pic.twitter.com/obMGKyIW5w"},{"start":134,"end":157,"url":"https://t.co/c4mx2KTwjI","expanded_url":"https://twitter.com/sandrac37082124/status/1223664726837809154/photo/1","display_url":"pic.twitter.com/c4mx2KTwjI"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"ComisionEuropea","id":"39727960"},{"start":27,"end":43,"username":"FDACommissioner","id":"1113782559194984448"},{"start":44,"end":56,"username":"Europarl_ES","id":"36626651"},{"start":57,"end":72,"username":"BrainstormCell","id":"802020620"},{"start":73,"end":83,"username":"iamalsorg","id":"1064599477342875649"},{"start":84,"end":92,"username":"bsw5020","id":"941445693331427330"},{"start":93,"end":100,"username":"Cylebo","id":"1201751724"},{"start":101,"end":116,"username":"MaryKayTurner1","id":"3270550555"},{"start":117,"end":126,"username":"LuchaEla","id":"1190393189053685761"},{"start":127,"end":133,"username":"POTUS","id":"1349149096909668363"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1412635454","id":"1223734465790447616","in_reply_to_user_id":"116716199","text":"@EMA_News @ComisionEuropea @FDACommissioner @Europarl_ES @BrainstormCell @iamalsorg @bsw5020 @Cylebo @MaryKayTurner1 @LuchaEla @POTUS https://t.co/c4mx2KTwjI https://t.co/obMGKyIW5w","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1223734465790447616","created_at":"2020-02-01T22:26:47.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1223734457896767489","3_1223664719002816513"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":134,"end":157,"url":"https://t.co/h3DoAtfKrV","expanded_url":"https://twitter.com/sandrac37082124/status/1223664726837809154/photo/1","display_url":"pic.twitter.com/h3DoAtfKrV"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"ComisionEuropea","id":"39727960"},{"start":27,"end":43,"username":"FDACommissioner","id":"1113782559194984448"},{"start":44,"end":56,"username":"Europarl_ES","id":"36626651"},{"start":57,"end":72,"username":"BrainstormCell","id":"802020620"},{"start":73,"end":83,"username":"iamalsorg","id":"1064599477342875649"},{"start":84,"end":92,"username":"bsw5020","id":"941445693331427330"},{"start":93,"end":100,"username":"Cylebo","id":"1201751724"},{"start":101,"end":116,"username":"MaryKayTurner1","id":"3270550555"},{"start":117,"end":126,"username":"LuchaEla","id":"1190393189053685761"},{"start":127,"end":133,"username":"POTUS","id":"1349149096909668363"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1156350328553574400","id":"1223664726837809154","in_reply_to_user_id":"116716199","text":"@EMA_News @ComisionEuropea @FDACommissioner @Europarl_ES @BrainstormCell @iamalsorg @bsw5020 @Cylebo @MaryKayTurner1 @LuchaEla @POTUS https://t.co/h3DoAtfKrV","public_metrics":{"retweet_count":26,"reply_count":2,"like_count":22,"quote_count":2},"conversation_id":"1223664726837809154","created_at":"2020-02-01T17:49:40.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1223664719002816513"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":149,"end":172,"url":"https://t.co/41996Wvnmd","expanded_url":"https://e.lilly/3aYnvDp","display_url":"e.lilly/3aYnvDp"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":38,"end":43,"tag":"CHMP"},{"start":126,"end":135,"tag":"diabetes"}]},"possibly_sensitive":false,"lang":"en","author_id":"1138093171","id":"1223259691662430213","in_reply_to_user_id":"116716199","text":"@EMA_News’ human medicines committee (#CHMP) recommends approval of our new fast-acting mealtime insulin for the treatment of #diabetes. Learn more: https://t.co/41996Wvnmd","public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1223259691662430213","created_at":"2020-01-31T15:00:12.000Z","referenced_tweets":{},"source":"Khoros Publishing","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/2fzi6Z9zig","expanded_url":"https://www.ema.europa.eu/en/news/uk-withdrawal-eu-31-january-2020","display_url":"ema.europa.eu/en/news/uk-wit…"}],"annotations":[{"start":96,"end":97,"probability":0.894,"type":"Place","normalized_text":"UK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"380491613","id":"1223232663181459456","in_reply_to_user_id":"116716199","text":"@EMA_News Sad day for patients, research, (orphan)drugdevelopment. Loosing our experts from the UK at EMA. https://t.co/2fzi6Z9zig","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1223232663181459456","created_at":"2020-01-31T13:12:48.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":184,"end":207,"url":"https://t.co/OAGEgaThpC","expanded_url":"https://www.fve.org/cms/wp-content/uploads/categorisation-antibiotics-use-animals-prudent-responsible-use_en.pdf","display_url":"fve.org/cms/wp-content…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":28,"end":40,"tag":"antibiotics"}]},"possibly_sensitive":false,"lang":"en","author_id":"344140731","id":"1222997880606203905","in_reply_to_user_id":"116716199","text":"@EMA_News Categorization of #antibiotics for use in animals. Drugs grouped by avoid, restrict, caution and prudence. Veterinarians should choose those in the prudence category first.  https://t.co/OAGEgaThpC","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1222997880606203905","created_at":"2020-01-30T21:39:51.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":190,"end":213,"url":"https://t.co/PMcPtAxLcG","expanded_url":"https://www.benzifoundation.org/ten-recommendations-from-ema/","display_url":"benzifoundation.org/ten-recommenda…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":53,"tag":"bigdata"},{"start":65,"end":76,"tag":"innovation"},{"start":81,"end":94,"tag":"publichealth"},{"start":160,"end":176,"tag":"FondazioneBenzi"}]},"possibly_sensitive":false,"lang":"en","author_id":"557019066","id":"1222851958475649028","in_reply_to_user_id":"116716199","text":"@EMA_News published 10 reccomendations about #bigdata to support #innovation and #publichealth.\nBig data can improve the knowledge on a medicine! \nRead more on #FondazioneBenzi website!🧐🧬🖥️\nhttps://t.co/PMcPtAxLcG","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1222851958475649028","created_at":"2020-01-30T12:00:01.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":280,"end":303,"url":"https://t.co/QhSeYidScH","expanded_url":"https://twitter.com/Bijouette83/status/1222835628464857088/photo/1","display_url":"pic.twitter.com/QhSeYidScH"},{"start":280,"end":303,"url":"https://t.co/QhSeYidScH","expanded_url":"https://twitter.com/Bijouette83/status/1222835628464857088/photo/1","display_url":"pic.twitter.com/QhSeYidScH"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":266,"end":279,"tag":"nitrozoaminy"}]},"possibly_sensitive":false,"lang":"pl","author_id":"411441607","id":"1222835628464857088","in_reply_to_user_id":"116716199","text":"@EMA_News rekomenduje kontynuację stosowania metforminy wg dotychczasowych schematów ponieważ ryzyko konsekwencji przerwania terapii jest większe niż skutki zawartości nitrozoamin NDMA w lekach. Do marca trwa szczegółowy przegląd wszystkich leków zlecony przez EMA. #nitrozoaminy https://t.co/QhSeYidScH","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1222835628464857088","created_at":"2020-01-30T10:55:07.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1222835594386202624","3_1222835594386198528"]},"geo":{"place_id":"07d9f33d35083001","coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":247,"end":270,"url":"https://t.co/rnFurkIFUW","expanded_url":"https://bit.ly/38S6uch","display_url":"bit.ly/38S6uch"},{"start":271,"end":294,"url":"https://t.co/FTA3gRU4vx","expanded_url":"https://twitter.com/FVEurope/status/1222197310932836354/photo/1","display_url":"pic.twitter.com/FTA3gRU4vx"},{"start":271,"end":294,"url":"https://t.co/FTA3gRU4vx","expanded_url":"https://twitter.com/FVEurope/status/1222197310932836354/photo/1","display_url":"pic.twitter.com/FTA3gRU4vx"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1549866445","id":"1222197310932836354","in_reply_to_user_id":"116716199","text":"@EMA_News published revised categorisation of antibiotics for animal use. The list antibiotics as 'A: Avoid', 'B: Restrict, 'C: Caution' and 'D: prudence'. An informative infograph shows it all - to hang on the wall in every veterinary practice!! https://t.co/rnFurkIFUW https://t.co/FTA3gRU4vx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":1},"conversation_id":"1222197310932836354","created_at":"2020-01-28T16:38:40.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1222197300753305600","3_1222197300740743169"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":35,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"460516020","id":"1222083038290612227","in_reply_to_user_id":"116716199","text":"@EMA_News Congratulations @EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1221826164349657093","created_at":"2020-01-28T09:04:36.000Z","referenced_tweets":[{"type":"replied_to","id":"1221826164349657093"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":267,"end":286,"probability":0.3938,"type":"Organization","normalized_text":"EMA Management Board"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1549866445","id":"1222067353321713664","in_reply_to_user_id":"116716199","text":"@EMA_News While most of EMA's work is on human medicines, EMA is also doing great work on the authorisation and safety of veterinary medicines, promoting new innovative treatment methods and at 'One Health' aspects such as AMR.  FVE is proud to be represented in the EMA Management Board.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1221826164349657093","created_at":"2020-01-28T08:02:16.000Z","referenced_tweets":[{"type":"replied_to","id":"1221826164349657093"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":35,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1219692835429134342","id":"1221952781411422210","in_reply_to_user_id":"116716199","text":"@EMA_News Congratulations @EMA_News !","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1221826164349657093","created_at":"2020-01-28T00:27:00.000Z","referenced_tweets":[{"type":"replied_to","id":"1221826164349657093"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":224,"end":247,"url":"https://t.co/qqXhtZRnZl","expanded_url":"https://www.ema.europa.eu/en/news/launch-international-pilot-programme-inspection-manufacturers-sterile-medicines","display_url":"ema.europa.eu/en/news/launch…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":248,"end":251,"tag":"QA"},{"start":252,"end":260,"tag":"quality"},{"start":261,"end":265,"tag":"gmp"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1221494277903130626","in_reply_to_user_id":"116716199","text":"@EMA_News and its European and international partners are launching a pilot programme to increase their cooperation in the inspection of manufacturers of sterile medicines for human use. More about this new initiative here: https://t.co/qqXhtZRnZl\n#QA #quality #gmp","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1221494277903130626","created_at":"2020-01-26T18:05:04.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":216,"end":239,"url":"https://t.co/hjUipYgT16","expanded_url":"https://bit.ly/38yiwHq","display_url":"bit.ly/38yiwHq"}],"annotations":[{"start":43,"end":50,"probability":0.5272,"type":"Organization","normalized_text":"Big Data"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":206,"end":214,"tag":"BigData"}]},"possibly_sensitive":false,"lang":"es","author_id":"618202337","id":"1220768324864413700","in_reply_to_user_id":"116716199","text":"@EMA_News propone crear una red europea de Big Data sanitario internacional de la que los países europeos se puedan nutrir y mejorar su toma de decisiones sobre medicamentos. Y formar un foro europeo sobre #BigData. https://t.co/hjUipYgT16  vía diario medico","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1220768324864413700","created_at":"2020-01-24T18:00:24.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"954403456038686720","id":"1220656621862510592","in_reply_to_user_id":"116716199","text":"@EMA_News the EMA portal seems to be down. Can't contact Sercice Desk, can't access Eudrlink packages.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1220656621862510592","created_at":"2020-01-24T10:36:32.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":283,"end":306,"url":"https://t.co/Dsfr2tXhtz","expanded_url":"https://twitter.com/SJaglin/status/1220626674208952320/photo/1","display_url":"pic.twitter.com/Dsfr2tXhtz"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":264,"end":272,"username":"bhwords","id":"753567488"},{"start":273,"end":282,"username":"UKCPAHAT","id":"3414925888"}],"hashtags":[{"start":16,"end":21,"tag":"PRAC"},{"start":154,"end":158,"tag":"VTE"},{"start":171,"end":178,"tag":"stroke"},{"start":191,"end":198,"tag":"cancer"}]},"possibly_sensitive":false,"lang":"en","author_id":"3171214681","id":"1220626674208952320","in_reply_to_user_id":"116716199","text":"@EMA_News -&gt; #PRAC PRAC confirms 4 week limit for use of high-strength estradiol creams (100mcg/g -&gt; 80g tube) due to theoretical increased risk of #VTE (estrogens) #stroke and various #cancer -&gt; although I thought the higher strength was 0.1% (Ovestin©) @bhwords @UKCPAHAT https://t.co/Dsfr2tXhtz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1220626674208952320","created_at":"2020-01-24T08:37:31.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1220626669351948288"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/NN7GM2ntSN","expanded_url":"http://miguelangelblanes.com/2016/10/25/mea","display_url":"miguelangelblanes.com/2016/10/25/mea"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"EUCourtPress","id":"1343714233"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"516897567","id":"1220470042472652813","in_reply_to_user_id":"116716199","text":"@EMA_News @EUCourtPress In case it is useful: measures to increase transparency, accountability and integrity in the EU https://t.co/NN7GM2ntSN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1220034620458250242","created_at":"2020-01-23T22:15:08.000Z","referenced_tweets":[{"type":"replied_to","id":"1220034620458250242"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":123,"end":131,"probability":0.9979,"type":"Place","normalized_text":"Amsterdam"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1090532756491325440","id":"1220321216000643073","in_reply_to_user_id":"116716199","text":"@EMA_News do you have any information about when the EMA traineeship programme for recent graduates will be re-launched in Amsterdam?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1220321216000643073","created_at":"2020-01-23T12:23:45.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"place_id":"4e696bef7e24d378","coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"EUCourtPress","id":"1343714233"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"4652634088","id":"1220075356813742083","in_reply_to_user_id":"116716199","text":"@EMA_News @EUCourtPress Excellent news!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1220034620458250242","created_at":"2020-01-22T20:06:47.000Z","referenced_tweets":[{"type":"replied_to","id":"1220034620458250242"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":73,"end":96,"url":"https://t.co/YX37ybMJLT","expanded_url":"https://www.transparimed.org/single-post/2020/01/22/Court-of-Justice-Clinical-Study-Reports","display_url":"transparimed.org/single-post/20…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":106,"username":"iqwig","id":"302095574"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"837335683215798272","id":"1220006776998940679","in_reply_to_user_id":"116716199","text":"@EMA_News Additional quotes welcoming today's ruling on CSRs added here:\nhttps://t.co/YX37ybMJLT\ncc @iqwig","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1220006776998940679","created_at":"2020-01-22T15:34:16.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":276,"end":299,"url":"https://t.co/RvHas03BJh","expanded_url":"https://twitter.com/aesgp/status/1219957604736172033/photo/1","display_url":"pic.twitter.com/RvHas03BJh"}],"annotations":[{"start":107,"end":136,"probability":0.6459,"type":"Organization","normalized_text":"Stakeholder Consortium PREMIER"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":222,"end":228,"username":"EFPIA","id":"52084584"},{"start":229,"end":239,"username":"EU_Health","id":"606325697"},{"start":240,"end":247,"username":"EU_ENV","id":"366037745"},{"start":248,"end":263,"username":"medicinesforEU","id":"2315763655"},{"start":264,"end":275,"username":"HCWHeurope","id":"282063958"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"293991390","id":"1219957604736172033","in_reply_to_user_id":"116716199","text":"@EMA_News clarified that only 10% of medicines were in further studies after the Extended Risk Assessment. Stakeholder Consortium PREMIER is an open avenue for greater transparency to provide concrete data on the problem. @EFPIA @EU_Health @EU_ENV @medicinesforEU @HCWHeurope https://t.co/RvHas03BJh","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1219957604736172033","created_at":"2020-01-22T12:18:53.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1219957598268600320"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":197,"end":220,"url":"https://t.co/lAuS8hwJ5Z","expanded_url":"https://bit.ly/35J1btC","display_url":"bit.ly/35J1btC"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":137,"end":148,"tag":"regulatory"}]},"possibly_sensitive":false,"lang":"en","author_id":"248808171","id":"1219715061482127361","in_reply_to_user_id":"116716199","text":"@EMA_News drafted a strategy to advance the agency’s engagement with regulatory science to 2025. The strategy aims to create an adaptive #regulatory system for both human and veterinary medicines: https://t.co/lAuS8hwJ5Z","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1219715061482127361","created_at":"2020-01-21T20:15:06.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"1161561387950321664","id":"1219220175934971906","in_reply_to_user_id":"116716199","text":"@EMA_News Espero que  también sea así los implantes médicos defectuosos.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"1219206182210019328","created_at":"2020-01-20T11:28:36.000Z","referenced_tweets":[{"type":"replied_to","id":"1219206182210019328"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"556859372","id":"1218093323799408640","in_reply_to_user_id":"116716199","text":"@EMA_News I'm wishing you lots of success and happiness in your new job. Best of luck to you!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1217767200381194243","created_at":"2020-01-17T08:50:54.000Z","referenced_tweets":[{"type":"replied_to","id":"1217767200381194243"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":150,"end":173,"url":"https://t.co/3SHUm6ZGSu","expanded_url":"https://buff.ly/35WAYba","display_url":"buff.ly/35WAYba"},{"start":271,"end":294,"url":"https://t.co/jtVWQYAssj","expanded_url":"https://twitter.com/ScTBxConsulting/status/1218080573966757889/photo/1","display_url":"pic.twitter.com/jtVWQYAssj"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":189,"end":216,"tag":"ClinicalResearchinPortugal"},{"start":217,"end":221,"tag":"CRO"},{"start":222,"end":240,"tag":"ScientificToolBox"},{"start":241,"end":245,"tag":"EMA"},{"start":246,"end":255,"tag":"Guidance"},{"start":256,"end":261,"tag":"Side"},{"start":262,"end":270,"tag":"Effects"}]},"possibly_sensitive":false,"lang":"en","author_id":"3439194047","id":"1218080573966757889","in_reply_to_user_id":"116716199","text":"@EMA_News Management Board agreed to the mandatory use of a consistent international format for reporting individual cases of suspected side effects\n\nhttps://t.co/3SHUm6ZGSu\n(Source: EMA)\n\n#ClinicalResearchinPortugal #CRO #ScientificToolBox #EMA #Guidance #Side #Effects https://t.co/jtVWQYAssj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1218080573966757889","created_at":"2020-01-17T08:00:14.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1218080572708356097"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":135,"end":158,"url":"https://t.co/rne9OY6U3Y","expanded_url":"https://bit.ly/2PZ6QFT","display_url":"bit.ly/2PZ6QFT"},{"start":275,"end":298,"url":"https://t.co/fkZ7yUXfnO","expanded_url":"https://twitter.com/rkessler05/status/1217847385453481986/photo/1","display_url":"pic.twitter.com/fkZ7yUXfnO"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":159,"end":174,"username":"RevuePrescrire","id":"1143080729972289536"},{"start":175,"end":189,"username":"Drug_Evidence","id":"63255324"},{"start":190,"end":201,"username":"BUKOPharma","id":"499889187"},{"start":202,"end":213,"username":"BITNavarra","id":"434891334"},{"start":214,"end":220,"username":"RxISK","id":"267634622"},{"start":221,"end":229,"username":"DTB_BMJ","id":"142258326"},{"start":230,"end":243,"username":"HAImedicines","id":"429122255"},{"start":244,"end":257,"username":"nogracias_eu","id":"365352418"},{"start":258,"end":274,"username":"arzneitelegramm","id":"1193590496"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"965926911212998656","id":"1217847385453481986","in_reply_to_user_id":"116716199","text":"@EMA_News transparency policy should not be watered down argue 43 organisations including independent drug bulletins in an open letter https://t.co/rne9OY6U3Y @RevuePrescrire @Drug_Evidence @BUKOPharma @BITNavarra @RxISK @DTB_BMJ @HAImedicines @nogracias_eu @arzneitelegramm https://t.co/fkZ7yUXfnO","public_metrics":{"retweet_count":10,"reply_count":0,"like_count":7,"quote_count":2},"conversation_id":"1217847385453481986","created_at":"2020-01-16T16:33:37.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1217847380147654657"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"14327238","id":"1215644407908704257","in_reply_to_user_id":"116716199","text":"@EMA_News EMA Service Desk not working today?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1215644407908704257","created_at":"2020-01-10T14:39:47.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2734601055","id":"1215608056719073280","in_reply_to_user_id":"116716199","text":"@EMA_News it is either a more expensive pet or a abused receipt for ketamine.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1215562674232266752","created_at":"2020-01-10T12:15:20.000Z","referenced_tweets":[{"type":"replied_to","id":"1215562674232266752"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":208,"end":231,"url":"https://t.co/RC2ZhQEcIT","expanded_url":"https://www.ema.europa.eu/en/news/ema-management-board-highlights-december-2019-meeting","display_url":"ema.europa.eu/en/news/ema-ma…"}],"annotations":[{"start":27,"end":28,"probability":0.7091,"type":"Organization","normalized_text":"EU"},{"start":115,"end":134,"probability":0.526,"type":"Organization","normalized_text":"EMA Management Board"},{"start":173,"end":197,"probability":0.5108,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":45,"end":55,"tag":"medicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1214899985898180613","in_reply_to_user_id":"116716199","text":"@EMA_News budget for 2020, EU cooperation on #medicines’ availability and EU IT systems were discussed at the last EMA Management Board meeting. Read the full report on the European Medicines Agency website: https://t.co/RC2ZhQEcIT","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1214899985898180613","created_at":"2020-01-08T13:21:43.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":13,"end":38,"probability":0.7174,"type":"Organization","normalized_text":"Agencia Regulatory Europea"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":76,"end":94,"tag":"regulatoryaffairs"}]},"possibly_sensitive":false,"lang":"es","author_id":"1499848322","id":"1212641779306156033","in_reply_to_user_id":"116716199","text":"@EMA_News la Agencia Regulatory Europea aprobó en 2019, 66 nuevas moléculas #regulatoryaffairs","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1212641779306156033","created_at":"2020-01-02T07:48:24.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":213,"end":236,"url":"https://t.co/2JmKU6qxsM","expanded_url":"https://buff.ly/2LXuL8z","display_url":"buff.ly/2LXuL8z"},{"start":280,"end":303,"url":"https://t.co/WN21iUHmV3","expanded_url":"https://twitter.com/CytonBio/status/1210084835659792384/photo/1","display_url":"pic.twitter.com/WN21iUHmV3"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":87,"end":106,"tag":"VeterinaryMedicine"},{"start":237,"end":248,"tag":"Regulation"},{"start":249,"end":260,"tag":"veterinary"},{"start":261,"end":279,"tag":"RegulatoryAffairs"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1210084835659792384","in_reply_to_user_id":"116716199","text":"@EMA_News has published a series of updated life-cycle management Q&amp;A webpages for #VeterinaryMedicine and there have been developments on the new veterinary regulation. Read the details on Cyton's news feed. https://t.co/2JmKU6qxsM #Regulation #veterinary #RegulatoryAffairs https://t.co/WN21iUHmV3","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1210084835659792384","created_at":"2019-12-26T06:28:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1210084834409897984"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":264,"end":287,"url":"https://t.co/r8TKM0IkDD","expanded_url":"https://onlinelibrary.wiley.com/doi/full/10.1002/rth2.12287","display_url":"onlinelibrary.wiley.com/doi/full/10.10…"},{"start":288,"end":311,"url":"https://t.co/tNR5GwJefu","expanded_url":"https://twitter.com/RPTHjournal/status/1205599657260400640/photo/1","display_url":"pic.twitter.com/tNR5GwJefu"}],"annotations":[{"start":169,"end":174,"probability":0.498,"type":"Organization","normalized_text":"Fazili"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":154,"end":169,"tag":"RPTHCommentary"}]},"possibly_sensitive":false,"lang":"en","author_id":"798920671770382336","id":"1205599657260400640","in_reply_to_user_id":"116716199","text":"@EMA_News recommends against DOAC among antiphospholipid syndrome w/ hx of thrombosis &amp; cautions ↑ risk of recurrence w/ DOAC in triple-positive pts. #RPTHCommentary by Fazili et al discusses current evidence &amp; potential impact of EMA guidance. Read here: https://t.co/r8TKM0IkDD https://t.co/tNR5GwJefu","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":5,"quote_count":1},"conversation_id":"1205599657260400640","created_at":"2019-12-13T21:25:31.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1205599644958547968"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"essure"}]},"possibly_sensitive":false,"lang":"en","author_id":"1161561387950321664","id":"1205493443952332800","in_reply_to_user_id":"116716199","text":"@EMA_News #essure problems 😭","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1205446012858318848","created_at":"2019-12-13T14:23:28.000Z","referenced_tweets":[{"type":"replied_to","id":"1205446012858318848"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":139,"end":162,"url":"https://t.co/zXVsThsOve","expanded_url":"https://twitter.com/SilviaEFPIA/status/1205082647900368896","display_url":"twitter.com/SilviaEFPIA/st…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":125,"end":131,"username":"EFPIA","id":"52084584"},{"start":132,"end":138,"username":"EFGCP","id":"817602889"}],"hashtags":[{"start":10,"end":40,"tag":"RegulatoryScienceStrategy2025"}]},"possibly_sensitive":false,"lang":"en","author_id":"2876403948","id":"1205134562352943105","in_reply_to_user_id":"116716199","text":"@EMA_News #RegulatoryScienceStrategy2025 received input points to the need to have more platforms for stakeholder discussion @EFPIA @EFGCP https://t.co/zXVsThsOve","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1205134562352943105","created_at":"2019-12-12T14:37:24.000Z","referenced_tweets":[{"type":"quoted","id":"1205082647900368896"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":117,"end":140,"url":"https://t.co/sbSsVfwcoE","expanded_url":"https://www.ruminantia.it/ema-e-farmaci-veterinari-i-dettagli-della-riunione-cvmp-del-3-5-dicembre/","display_url":"ruminantia.it/ema-e-farmaci-…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":111,"end":116,"tag":"CVMP"}]},"possibly_sensitive":false,"lang":"it","author_id":"1235372959","id":"1204796205508780033","in_reply_to_user_id":"116716199","text":"@EMA_News: i risultati della riunione del 3-5 dicembre del Committee for Medicinal Products for Veterinary Use #CVMP https://t.co/sbSsVfwcoE","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1204796205508780033","created_at":"2019-12-11T16:12:54.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":92,"end":115,"url":"https://t.co/lFIg1m6jRx","expanded_url":"https://twitter.com/DrDomPimenta/status/1204512281897394177","display_url":"twitter.com/DrDomPimenta/s…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":84,"end":91,"username":"BMA_GP","id":"3964961067"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"800075637725622272","id":"1204713529430990849","in_reply_to_user_id":"116716199","text":"@EMA_News - protecting patients, regulating new drugs, engaging GPs @UEMOPresidency @BMA_GP https://t.co/lFIg1m6jRx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1204713529430990849","created_at":"2019-12-11T10:44:22.000Z","referenced_tweets":[{"type":"quoted","id":"1204512281897394177"}],"source":"Twitter for iPad","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":159,"end":182,"url":"https://t.co/znjuChjNi6","expanded_url":"https://buff.ly/2LnQo0v","display_url":"buff.ly/2LnQo0v"},{"start":222,"end":245,"url":"https://t.co/rj3RQO2lvN","expanded_url":"https://twitter.com/CytonBio/status/1204312301286895616/photo/1","display_url":"pic.twitter.com/rj3RQO2lvN"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":80,"end":93,"tag":"AnimalHealth"},{"start":183,"end":201,"tag":"RegulatoryAffairs"},{"start":202,"end":221,"tag":"VeterinaryMedicine"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1204312301286895616","in_reply_to_user_id":"116716199","text":"@EMA_News to hold international awareness session on science and regulation for #AnimalHealth and welfare, public health and the environment, 2-3 April 2020. \nhttps://t.co/znjuChjNi6 #RegulatoryAffairs #VeterinaryMedicine https://t.co/rj3RQO2lvN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1204312301286895616","created_at":"2019-12-10T08:10:02.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1204312299890192384"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1000072370395189249","id":"1204271036612653058","in_reply_to_user_id":"116716199","text":"@EMA_News You had me at \"promoted\". I believe you now","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1204049791153520642","created_at":"2019-12-10T05:26:04.000Z","referenced_tweets":[{"type":"replied_to","id":"1204049791153520642"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":221,"end":244,"url":"https://t.co/GjE4oFFi9t","expanded_url":"https://www.facebook.com/notes/women-essure-victims-regroupement-de-victimes/essure-une-%C3%A9quipe-europ%C3%A9enne-de-chercheurs-m%C3%A9decins-se-mobilisent/578455236059748/","display_url":"facebook.com/notes/women-es…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"1161561387950321664","id":"1204158690405888000","in_reply_to_user_id":"116716199","text":"@EMA_News ESSURE: Un equipo europeo de investigadores y médicos se está movilizando.\nVÍCTIMAS DE SEGURIDAD PARA MUJERES / REUNIFICACIÓN DE VÍCTIMAS · LUNES 9 DE DICIEMBRE DE 2019 · 4 MINUTOS\nGinebra 2 de diciembre. 2019\n\nhttps://t.co/GjE4oFFi9t","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1204036726878068737","created_at":"2019-12-09T21:59:38.000Z","referenced_tweets":[{"type":"replied_to","id":"1204036726878068737"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":94,"end":99,"tag":"lcsm"},{"start":100,"end":105,"tag":"ntrk"}]},"possibly_sensitive":false,"lang":"fr","author_id":"514578898","id":"1204097455626817538","in_reply_to_user_id":"116716199","text":"@EMA_News Entrectinib au programme : \"plus que\" 100j avant une AMM européenne pour les NTRK ? #lcsm #ntrk","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1204036726878068737","created_at":"2019-12-09T17:56:19.000Z","referenced_tweets":[{"type":"replied_to","id":"1204036726878068737"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3016147721","id":"1203800688318435329","in_reply_to_user_id":"116716199","text":"@EMA_News You guys cool commercials\n..what about ethics?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1202513412581986304","created_at":"2019-12-08T22:17:04.000Z","referenced_tweets":[{"type":"replied_to","id":"1202513412581986304"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"17621534","id":"1203663109619093505","in_reply_to_user_id":"116716199","text":"@EMA_News Save your regulations for yourself. In any Western country you have to way months to see your dentist or GP. How is this normal. Nowyou want to bring this policy in other countries which had way better healthcare than yours, but you cannot step aside and leave it be as it is.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1202558848202084353","created_at":"2019-12-08T13:10:22.000Z","referenced_tweets":[{"type":"replied_to","id":"1202558848202084353"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":36,"end":41,"probability":0.9987,"type":"Place","normalized_text":"EUROPE"},{"start":117,"end":119,"probability":0.9467,"type":"Place","normalized_text":"USA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":199,"end":212,"username":"FEFQ_CFspain","id":"266162824"},{"start":213,"end":228,"username":"ECFSConference","id":"394232968"},{"start":229,"end":245,"username":"FiliereMucoCFTR","id":"979247126352941056"}],"hashtags":[{"start":180,"end":198,"tag":"aprovetrikafkanow"}]},"possibly_sensitive":false,"lang":"en","author_id":"915466799159894016","id":"1203205618766622720","in_reply_to_user_id":"116716199","text":"@EMA_News Why takes so much time in EUROPE to approve a medication that not only it has ALREADY been approved on the USA but also is giving very good results? APROVE TRIKAFKA  NOW #aprovetrikafkanow @FEFQ_CFspain @ECFSConference @FiliereMucoCFTR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1203205618766622720","created_at":"2019-12-07T06:52:28.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":14,"end":38,"probability":0.4689,"type":"Organization","normalized_text":"European Medicines Agency"},{"start":133,"end":135,"probability":0.885,"type":"Place","normalized_text":"USA"},{"start":147,"end":161,"probability":0.3925,"type":"Person","normalized_text":"CIstic Fibrosis"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":203,"end":216,"username":"Figaro_Inter","id":"3087003729"},{"start":217,"end":227,"username":"lemondefr","id":"24744541"},{"start":228,"end":239,"username":"celinedion","id":"106854950"},{"start":240,"end":255,"username":"EmmanuelMacron","id":"1976143068"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"915466799159894016","id":"1203197233686032384","in_reply_to_user_id":"116716199","text":"@EMA_News The European Medicines Agency does not have a reason to be SO SLOW when drugs have already been APPROVED by a country like USA. TRIKAFKA CIstic Fibrosis is working :What is EMA waiting for??  .@Figaro_Inter @lemondefr @celinedion @EmmanuelMacron","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1202513412581986304","created_at":"2019-12-07T06:19:09.000Z","referenced_tweets":[{"type":"replied_to","id":"1202513412581986304"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"898450975601684480","id":"1203006831477579777","in_reply_to_user_id":"116716199","text":"@EMA_News I literally dont care","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"1202513412581986304","created_at":"2019-12-06T17:42:34.000Z","referenced_tweets":[{"type":"replied_to","id":"1202513412581986304"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":27,"end":50,"url":"https://t.co/zFgUz0Rr4T","expanded_url":"https://www.ema.europa.eu/en/news/ema-update-metformin-diabetes-medicines","display_url":"ema.europa.eu/en/news/ema-up…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"pl","author_id":"1141308150924173312","id":"1202975847529041920","in_reply_to_user_id":"116716199","text":"@EMA_News o metforminie ‼\n https://t.co/zFgUz0Rr4T","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1202975847529041920","created_at":"2019-12-06T15:39:26.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":64,"end":87,"url":"https://t.co/M79qUbojkt","expanded_url":"https://twitter.com/LMC_PACIENTES/status/1202624434055602178/photo/1","display_url":"pic.twitter.com/M79qUbojkt"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":35,"end":46,"username":"eupatients","id":"465674067"},{"start":47,"end":63,"username":"eupatientsforum","id":"545343465"}],"hashtags":[{"start":14,"end":31,"tag":"PatientsInvolved"}]},"possibly_sensitive":false,"lang":"und","author_id":"776034821323755521","id":"1202624434055602178","in_reply_to_user_id":"116716199","text":"@EMA_News And #PatientsInvolved¡¡¡\n@eupatients @eupatientsforum https://t.co/M79qUbojkt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1202558848202084353","created_at":"2019-12-05T16:23:03.000Z","referenced_tweets":[{"type":"replied_to","id":"1202558848202084353"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1202624426354921472"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":26,"username":"ConefreyPharmac","id":"273912739"},{"start":27,"end":39,"username":"oacsireland","id":"3305935205"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"2712962446","id":"1200163923489697797","in_reply_to_user_id":"116716199","text":"@EMA_News @ConefreyPharmac @oacsireland","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1200083753776959488","created_at":"2019-11-28T21:25:51.000Z","referenced_tweets":[{"type":"replied_to","id":"1200083753776959488"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/N9XcRKWgi5","expanded_url":"https://twitter.com/JuanPed80322027/status/1199270822487187457/photo/1","display_url":"pic.twitter.com/N9XcRKWgi5"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"882502658715766784","id":"1199270822487187457","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/N9XcRKWgi5","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1199270822487187457","created_at":"2019-11-26T10:17:00.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1199270813305847810"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"EUnetHTA","id":"56493220"}],"hashtags":[{"start":20,"end":27,"tag":"essure"}]},"possibly_sensitive":false,"lang":"en","author_id":"1161561387950321664","id":"1197885827763888129","in_reply_to_user_id":"116716199","text":"@EMA_News @EUnetHTA #essure problems","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1197878482937757696","created_at":"2019-11-22T14:33:31.000Z","referenced_tweets":[{"type":"replied_to","id":"1197878482937757696"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"8677602","id":"1197152619216723969","in_reply_to_user_id":"116716199","text":"@EMA_News @WHO Plazmiacin! (Zemdri). Hope you approve it for BSI usage!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1197088948696354816","created_at":"2019-11-20T14:00:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1197088948696354816"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":133,"end":140,"username":"BMA_GP","id":"3964961067"},{"start":141,"end":149,"username":"MidRCGP","id":"3293199335"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"800075637725622272","id":"1197101890347110401","in_reply_to_user_id":"116716199","text":"@EMA_News new regulations for veterinary medicines and medical devices. Essential for health care and patient safety @UEMOPresidency @BMA_GP @MidRCGP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1197101890347110401","created_at":"2019-11-20T10:38:26.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":75,"end":82,"username":"BMA_GP","id":"3964961067"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"800075637725622272","id":"1197101208139378689","in_reply_to_user_id":"116716199","text":"@EMA_News stimulating meeting learning about future plans. @UEMOPresidency @BMA_GP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1197101208139378689","created_at":"2019-11-20T10:35:43.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":102,"end":125,"url":"https://t.co/JQAsYl5Pu4","expanded_url":"https://twitter.com/JoseDrabwell/status/1197067826231758850/photo/1","display_url":"pic.twitter.com/JQAsYl5Pu4"}],"annotations":[{"start":40,"end":49,"probability":0.7016,"type":"Person","normalized_text":"Guido Rasi"},{"start":77,"end":100,"probability":0.8588,"type":"Organization","normalized_text":"Europran Medicine Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"788682338297405440","id":"1197067826231758850","in_reply_to_user_id":"116716199","text":"@EMA_News tasks and vision delivered by Guido Rasi Executive Director at the Europran Medicine Agency https://t.co/JQAsYl5Pu4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1197067826231758850","created_at":"2019-11-20T08:23:04.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1197067811606212608"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/Y7Ru1XZ1wp","expanded_url":"https://www.europeanpharmaceuticalreview.com/news/105657/ema-announces-medicine-approval-recommendations-from-november-meeting/","display_url":"europeanpharmaceuticalreview.com/news/105657/em…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":101,"end":111,"tag":"medicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1196888616053686273","in_reply_to_user_id":"116716199","text":"@EMA_News announces medicine approval recommendations from November meeting: https://t.co/Y7Ru1XZ1wp #medicines","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1196888616053686273","created_at":"2019-11-19T20:30:57.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/aeXhL7LNIy","expanded_url":"https://www.clinicaltrialsregister.eu/ctr-search/search?query=","display_url":"clinicaltrialsregister.eu/ctr-search/sea…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"21731707","id":"1196859379112394752","in_reply_to_user_id":"116716199","text":"@EMA_News Hello, the EUCTR currently is missing the vast majority of trials. https://t.co/aeXhL7LNIy","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1196859379112394752","created_at":"2019-11-19T18:34:47.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":180,"end":203,"url":"https://t.co/taTai0tMIz","expanded_url":"https://globalgenes.org/2019/11/18/ema-grants-orchard-accelerated-assessment-of-therapy-for-patients-with-mld/","display_url":"globalgenes.org/2019/11/18/ema…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":49,"end":60,"username":"orchard_tx","id":"821345809576972288"}],"hashtags":[{"start":151,"end":163,"tag":"raredisease"},{"start":164,"end":178,"tag":"CareAboutRare"}]},"possibly_sensitive":false,"lang":"en","author_id":"90424954","id":"1196782799346380801","in_reply_to_user_id":"116716199","text":"@EMA_News has granted accelerated assessment for @orchard_tx OTL-200, a gene therapy in development for the treatment of metachromatic leukodystrophy. #raredisease #CareAboutRare\n\nhttps://t.co/taTai0tMIz","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1196782799346380801","created_at":"2019-11-19T13:30:29.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"ECDC_EU","id":"204752573"},{"start":19,"end":29,"username":"EU_Health","id":"606325697"},{"start":30,"end":38,"username":"EAAD_EU","id":"1725283578"},{"start":60,"end":69,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":83,"end":99,"tag":"Fluoroquinolone"},{"start":206,"end":236,"tag":"stop_fluoroquinolones_madness"}]},"possibly_sensitive":false,"lang":"en","author_id":"41140781","id":"1196723464767447041","in_reply_to_user_id":"116716199","text":"@EMA_News @ECDC_EU @EU_Health @EAAD_EU A start would be for @EMA_News to takle the #Fluoroquinolone disaster: Recognise victims, stop the gaslighting and prescribe FQ only when there is no alternative....\n\n#stop_fluoroquinolones_madness","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1196719173893869569","created_at":"2019-11-19T09:34:42.000Z","referenced_tweets":[{"type":"replied_to","id":"1196719173893869569"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":254,"end":267,"username":"VertexPharma","id":"17542775"},{"start":268,"end":281,"username":"ChrisMRiches","id":"20773070"},{"start":282,"end":290,"username":"cftrust","id":"21299778"}],"hashtags":[{"start":34,"end":49,"tag":"cysticfibrosis"},{"start":112,"end":125,"tag":"TrikaftaNext"},{"start":161,"end":165,"tag":"AMR"}]},"possibly_sensitive":false,"lang":"en","author_id":"197236444","id":"1196549364983967751","in_reply_to_user_id":"116716199","text":"@EMA_News / Due to the nature  of #cysticfibrosis, we need lots of antibiotics Please ensure speedy approval of #TrikaftaNext so Europeans with CF don’t acquire #AMR infections so much as they’re unavoidable\nTrikafta will really help reduce infections🙏🏻 @VertexPharma @ChrisMRiches @cftrust","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"1196374368185704448","created_at":"2019-11-18T22:02:54.000Z","referenced_tweets":[{"type":"replied_to","id":"1196374368185704448"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/6eJJjc5HuV","expanded_url":"https://twitter.com/sara8smiles/status/1196505338742226944","display_url":"twitter.com/sara8smiles/st…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"134804229","id":"1196518510450622464","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/6eJJjc5HuV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196369828577239041","created_at":"2019-11-18T20:00:17.000Z","referenced_tweets":[{"type":"quoted","id":"1196505338742226944"},{"type":"replied_to","id":"1196369828577239041"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1113774353492189184","id":"1196466326056972289","in_reply_to_user_id":"116716199","text":"@EMA_News dr's dont prescribe ABX for Virals. This tweet is pointless.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196369828577239041","created_at":"2019-11-18T16:32:56.000Z","referenced_tweets":[{"type":"replied_to","id":"1196369828577239041"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1000880096771760128","id":"1196465439230087171","in_reply_to_user_id":"116716199","text":"@EMA_News Why does every physician I know use them for themselves for colds and viruses and swear it works?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1196369828577239041","created_at":"2019-11-18T16:29:24.000Z","referenced_tweets":[{"type":"replied_to","id":"1196369828577239041"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2600918936","id":"1196463818202763264","in_reply_to_user_id":"116716199","text":"@EMA_News Wait, does that mean we shouldn't be taking things like decongestants and over-the-counter cold medications???","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1196369828577239041","created_at":"2019-11-18T16:22:58.000Z","referenced_tweets":[{"type":"replied_to","id":"1196369828577239041"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"817934269","id":"1196463053182820354","in_reply_to_user_id":"116716199","text":"@EMA_News Thankfully, I have a Medical background and Knew this when My Children were growing up bcuz 'Antibiotics Resistance' is a REAL Deal.✔ Unfortunately, back in the day, A Lot of Doctors DIDN'T tell This To their Patients......Many just Doled out RX's.😕🙄","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1196369828577239041","created_at":"2019-11-18T16:19:55.000Z","referenced_tweets":[{"type":"replied_to","id":"1196369828577239041"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"429834351","id":"1196447183404441602","in_reply_to_user_id":"116716199","text":"@EMA_News What about the breakdown session A streaming? Thanks","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196397644597407744","created_at":"2019-11-18T15:16:52.000Z","referenced_tweets":[{"type":"replied_to","id":"1196397644597407744"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":44,"end":67,"url":"https://t.co/OOZDbHq2pg","expanded_url":"https://investinholland.com/news/the-netherlands-delivers-new-headquarters-to-ema/","display_url":"investinholland.com/news/the-nethe…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"838735422318645248","id":"1196446857662218245","in_reply_to_user_id":"116716199","text":"@EMA_News  -Welcome to the neighborhood ;)\n\nhttps://t.co/OOZDbHq2pg","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196446857662218245","created_at":"2019-11-18T15:15:34.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1725861590","id":"1196440174571524097","in_reply_to_user_id":"116716199","text":"@EMA_News Tell this to the Chinese they demand antibiotics from their doctors for everything","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1196369828577239041","created_at":"2019-11-18T14:49:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1196369828577239041"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":64,"tag":"HTA"},{"start":224,"end":239,"tag":"RegScience2025"}]},"possibly_sensitive":false,"lang":"en","author_id":"36387470","id":"1196431286417666049","in_reply_to_user_id":"116716199","text":"@EMA_News post-marketing registry requirements and national #HTA registry requirements should be aligned, better coupled, better the SAME. Patients want to participate in meaningful research and reduce double or triple work #RegScience2025","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1196431286417666049","created_at":"2019-11-18T14:13:41.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/MsFssp0YaR","expanded_url":"http://www.sdpnoticias.com/amp/columnas/cancer-existe-cura.html","display_url":"sdpnoticias.com/amp/columnas/c…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"796477465782693889","id":"1196429139647107074","in_reply_to_user_id":"116716199","text":"@EMA_News Good morning, I share with you this information about the treatment of cancer with citric acid:\nhttps://t.co/MsFssp0YaR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196429139647107074","created_at":"2019-11-18T14:05:10.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":48,"end":50,"probability":0.9141,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":104,"end":119,"username":"EspanaFibrosis","id":"1076772227226456064"},{"start":120,"end":136,"username":"FibrosisQuistic","id":"205156437"},{"start":137,"end":150,"username":"FEFQ_CFspain","id":"266162824"},{"start":151,"end":162,"username":"fqcatalana","id":"3003041476"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"915466799159894016","id":"1196415153392279554","in_reply_to_user_id":"116716199","text":"@EMA_News How long is going to take the already FDA approved  Trikafta from Vertex? Is URGENTLY needed. @EspanaFibrosis @FibrosisQuistic @FEFQ_CFspain @fqcatalana","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1195302928522731520","created_at":"2019-11-18T13:09:35.000Z","referenced_tweets":[{"type":"replied_to","id":"1195302928522731520"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":254,"end":277,"url":"https://t.co/hETfLI825A","expanded_url":"https://www.ema.europa.eu/en/events/multi-stakeholder-workshop-draft-regulatory-science-2025-strategy-stakeholders-human-medicines","display_url":"ema.europa.eu/en/events/mult…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":74,"end":93,"tag":"publicconsultation"},{"start":102,"end":120,"tag":"RegulatoryScience"},{"start":174,"end":188,"tag":"realworlddata"},{"start":189,"end":193,"tag":"RWD"},{"start":194,"end":198,"tag":"RWE"},{"start":202,"end":206,"tag":"HTA"},{"start":207,"end":234,"tag":"healthtechnologyassessment"}]},"possibly_sensitive":false,"lang":"en","author_id":"887610222319153153","id":"1196383292410486784","in_reply_to_user_id":"116716199","text":"@EMA_News's multi-stakeholder workshop Nov 18-19 to share outcomes of its #publicconsultation on its '#RegulatoryScience to 2025' strategy. See today's session on the use of #realworlddata #RWD #RWE in #HTA #healthtechnologyassessment. LIVE PODCAST=&gt; https://t.co/hETfLI825A.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196383292410486784","created_at":"2019-11-18T11:02:59.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":200,"end":223,"url":"https://t.co/NIuZVFFdzj","expanded_url":"https://twitter.com/AimingRightAtU/status/1194783676778844162","display_url":"twitter.com/AimingRightAtU…"},{"start":224,"end":247,"url":"https://t.co/RWcNXKA9PB","expanded_url":"https://twitter.com/ProfJillCook/status/1177238832791486465?s=20","display_url":"twitter.com/ProfJillCook/s…"},{"start":248,"end":271,"url":"https://t.co/f6mdnZIHvu","expanded_url":"https://twitter.com/phellinckx/status/1193896960186552320?s=20","display_url":"twitter.com/phellinckx/sta…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":16,"end":32,"tag":"Fluoroquinolone"},{"start":149,"end":179,"tag":"stop_fluoroquinolones_madness"},{"start":180,"end":187,"tag":"Floxed"},{"start":188,"end":198,"tag":"IDtwitter"}]},"possibly_sensitive":false,"lang":"en","author_id":"41140781","id":"1196375340756733953","in_reply_to_user_id":"116716199","text":"@EMA_News Avoid #Fluoroquinolone except when there is no alternative.\n\nStop the gaslighting  and recognise victims of the Fluoroquinolones disaster\n\n#stop_fluoroquinolones_madness\n#Floxed\n#IDtwitter\n\nhttps://t.co/NIuZVFFdzj\nhttps://t.co/RWcNXKA9PB\nhttps://t.co/f6mdnZIHvu","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1196374368185704448","created_at":"2019-11-18T10:31:23.000Z","referenced_tweets":[{"type":"quoted","id":"1193896960186552320"},{"type":"replied_to","id":"1196374368185704448"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":143,"end":166,"url":"https://t.co/NnwDpbsIoh","expanded_url":"https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-11-14-november-2019","display_url":"ema.europa.eu/en/news/meetin…"},{"start":167,"end":190,"url":"https://t.co/jfmGiMyW6h","expanded_url":"https://twitter.com/seQureLS/status/1196097863408857088/photo/1","display_url":"pic.twitter.com/jfmGiMyW6h"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":67,"end":77,"tag":"medicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1196097863408857088","in_reply_to_user_id":"116716199","text":"@EMA_News’s human medicines committee (CHMP) has recommended seven #medicines for approval. Check out the highlights of its last meeting here: https://t.co/NnwDpbsIoh https://t.co/jfmGiMyW6h","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1196097863408857088","created_at":"2019-11-17T16:08:47.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1196097857046155266"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":106,"end":107,"probability":0.9123,"type":"Place","normalized_text":"UK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"Dominic_Tyer","id":"17988404"},{"start":24,"end":31,"username":"MinVWS","id":"15581273"},{"start":32,"end":45,"username":"relocatemaEN","id":"1005070894602039296"},{"start":46,"end":62,"username":"RijksvastgoedNL","id":"109229083"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"34019585","id":"1195713575828033536","in_reply_to_user_id":"116716199","text":"@EMA_News @Dominic_Tyer @MinVWS @relocatemaEN @RijksvastgoedNL Great news for our Dutch friends. Bad  for UK life sciences :-(","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1195350479154434048","created_at":"2019-11-16T14:41:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1195350479154434048"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"MinVWS","id":"15581273"},{"start":18,"end":31,"username":"relocatemaEN","id":"1005070894602039296"},{"start":32,"end":48,"username":"RijksvastgoedNL","id":"109229083"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1466579064","id":"1195662949169451009","in_reply_to_user_id":"116716199","text":"@EMA_News @MinVWS @relocatemaEN @RijksvastgoedNL Excellent- and lots of great women will make that move too- just saying ...","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1195350479154434048","created_at":"2019-11-16T11:20:36.000Z","referenced_tweets":[{"type":"replied_to","id":"1195350479154434048"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":81,"end":86,"probability":0.9956,"type":"Place","normalized_text":"London"},{"start":112,"end":117,"probability":0.4157,"type":"Other","normalized_text":"Brexit"},{"start":152,"end":157,"probability":0.5141,"type":"Other","normalized_text":"Brexit"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"},{"start":21,"end":28,"username":"MinVWS","id":"15581273"},{"start":29,"end":42,"username":"relocatemaEN","id":"1005070894602039296"},{"start":43,"end":59,"username":"RijksvastgoedNL","id":"109229083"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"87259041","id":"1195368269760385024","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health @MinVWS @relocatemaEN @RijksvastgoedNL We lost the EMA from London to the Dutch because of Brexit. \n\nUnbelievably stupid. But then Brexit is.","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":5,"quote_count":0},"conversation_id":"1195350479154434048","created_at":"2019-11-15T15:49:39.000Z","referenced_tweets":[{"type":"replied_to","id":"1195350479154434048"}],"source":"Twitter for iPad","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"MinVWS","id":"15581273"},{"start":18,"end":31,"username":"relocatemaEN","id":"1005070894602039296"},{"start":32,"end":48,"username":"RijksvastgoedNL","id":"109229083"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1145643197185609728","id":"1195350827256438789","in_reply_to_user_id":"116716199","text":"@EMA_News @MinVWS @relocatemaEN @RijksvastgoedNL Many congratulations and good luck!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1195350479154434048","created_at":"2019-11-15T14:40:20.000Z","referenced_tweets":[{"type":"replied_to","id":"1195350479154434048"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":106,"end":129,"url":"https://t.co/NN7GM2ntSN","expanded_url":"http://miguelangelblanes.com/2016/10/25/mea","display_url":"miguelangelblanes.com/2016/10/25/mea"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"516897567","id":"1195068936217346048","in_reply_to_user_id":"116716199","text":"@EMA_News In case it is useful: measures to increase transparency, accountability and integrity in the EU https://t.co/NN7GM2ntSN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1195068936217346048","created_at":"2019-11-14T20:00:12.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":71,"end":94,"url":"https://t.co/6hazxAC4Mf","expanded_url":"https://www.ruminantia.it/ema-e-farmaci-veterinari-meeting-del-5-7-novembre-2019-del-cvmp/","display_url":"ruminantia.it/ema-e-farmaci-…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":12,"end":30,"tag":"farmaciveterinari"}]},"possibly_sensitive":false,"lang":"es","author_id":"1235372959","id":"1194621278855909377","in_reply_to_user_id":"116716199","text":"@EMA_News e #farmaciveterinari, meeting del 5-7 novembre 2019 del CVMP https://t.co/6hazxAC4Mf","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1194621278855909377","created_at":"2019-11-13T14:21:22.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":269,"end":292,"url":"https://t.co/XZIorRzybt","expanded_url":"https://twitter.com/Asphalion/status/1194260687381520384/photo/1","display_url":"pic.twitter.com/XZIorRzybt"}],"annotations":[{"start":35,"end":37,"probability":0.5035,"type":"Organization","normalized_text":"Q&A"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":128,"end":132,"tag":"MDR"},{"start":137,"end":142,"tag":"IVDR"}]},"possibly_sensitive":false,"lang":"en","author_id":"717962540","id":"1194260687381520384","in_reply_to_user_id":"116716199","text":"@EMA_News has recently revised the Q&amp;A document that provides practical considerations concerning the implementation of the #MDR and #IVDR. If you're interested to obtain advisory about how to accomplish EC requirements about fair market access for MD, contact us! https://t.co/XZIorRzybt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1194260687381520384","created_at":"2019-11-12T14:28:30.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1194260676535042049"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"essure"}]},"possibly_sensitive":false,"lang":"pt","author_id":"1161561387950321664","id":"1193948419573846016","in_reply_to_user_id":"116716199","text":"@EMA_News #essure problem mundial","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1193920568812285952","created_at":"2019-11-11T17:47:40.000Z","referenced_tweets":[{"type":"replied_to","id":"1193920568812285952"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/dqexEEiQfn","expanded_url":"https://www.elle.com/es/belleza/cara-cuerpo/a29736443/eccemas-soluciones/","display_url":"elle.com/es/belleza/car…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"luisacarcedo","id":"925676922838929408"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"1161561387950321664","id":"1193918758345232385","in_reply_to_user_id":"116716199","text":"@EMA_News\n@luisacarcedo\n, ojalá estas explicaciones que da este dermatólogo,  nos la hubieran dado antes!!\nhttps://t.co/dqexEEiQfn","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1193918758345232385","created_at":"2019-11-11T15:49:48.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":129,"end":152,"url":"https://t.co/Jze1Jandml","expanded_url":"https://tinyurl.com/yx8lyoal","display_url":"tinyurl.com/yx8lyoal"},{"start":153,"end":176,"url":"https://t.co/o23QvkSCmZ","expanded_url":"https://twitter.com/onmedicanews/status/1193551425944670209/photo/1","display_url":"pic.twitter.com/o23QvkSCmZ"}],"annotations":[{"start":85,"end":92,"probability":0.433,"type":"Person","normalized_text":"Lemtrada"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"42178750","id":"1193551425944670209","in_reply_to_user_id":"116716199","text":"@EMA_News has recommended new measures to minimise risk of serious side effects with Lemtrada for MS. Find out the details here: https://t.co/Jze1Jandml https://t.co/o23QvkSCmZ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1193551425944670209","created_at":"2019-11-10T15:30:09.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1193551424023617538"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":75,"end":98,"url":"https://t.co/WAp809dATo","expanded_url":"https://buff.ly/2pZ7fPr","display_url":"buff.ly/2pZ7fPr"},{"start":99,"end":122,"url":"https://t.co/zy6wb7mMYu","expanded_url":"https://twitter.com/WMidsMedsInfo/status/1189464105960333312/photo/1","display_url":"pic.twitter.com/zy6wb7mMYu"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":29,"end":48,"tag":"PatientInformation"},{"start":52,"end":63,"tag":"Biosimilar"}]},"possibly_sensitive":false,"lang":"en","author_id":"1176081054505013249","id":"1189464105960333312","in_reply_to_user_id":"116716199","text":"@EMA_News have updated their #PatientInformation on #Biosimilar medicines: https://t.co/WAp809dATo https://t.co/zy6wb7mMYu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1189464105960333312","created_at":"2019-10-30T08:48:36.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1189464104613883904"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":14,"end":15,"probability":0.9254,"type":"Place","normalized_text":"US"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":266,"end":278,"username":"parsisotope","id":"1060256743668805632"}],"hashtags":[{"start":240,"end":250,"tag":"I_ASK_YOU"}]},"possibly_sensitive":false,"lang":"en","author_id":"1136794594203590656","id":"1189153303504019459","in_reply_to_user_id":"116716199","text":"@EMA_News The US says that the Iranian government is the main target of sanctions – and food and medicine are exempt. But with banks and financial institutions refusing to handle transactions, the shortages of medicine is raising a concern\n#I_ASK_YOU to search fact\n@parsisotope","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1189098419937337344","created_at":"2019-10-29T12:13:35.000Z","referenced_tweets":[{"type":"replied_to","id":"1189098419937337344"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":112,"end":135,"url":"https://t.co/lAfGGiuv5X","expanded_url":"https://tinyurl.com/y65zlf5f","display_url":"tinyurl.com/y65zlf5f"},{"start":136,"end":159,"url":"https://t.co/EolhHWyJEv","expanded_url":"https://twitter.com/onmedicanews/status/1188432696667787264/photo/1","display_url":"pic.twitter.com/EolhHWyJEv"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"42178750","id":"1188432696667787264","in_reply_to_user_id":"116716199","text":"@EMA_News announces the recommendation of the first non-injectable treatment for severe low blood sugar levels: https://t.co/lAfGGiuv5X https://t.co/EolhHWyJEv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1188432696667787264","created_at":"2019-10-27T12:30:09.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1188432695057178630"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":136,"end":159,"url":"https://t.co/JHmtFk3aoY","expanded_url":"https://europa.eu/!By46HW","display_url":"europa.eu/!By46HW"}],"annotations":[{"start":83,"end":97,"probability":0.5573,"type":"Place","normalized_text":"Churchill Place"},{"start":100,"end":105,"probability":0.7273,"type":"Place","normalized_text":"London"},{"start":114,"end":115,"probability":0.6429,"type":"Place","normalized_text":"UK"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":18,"tag":"tenders"}]},"possibly_sensitive":false,"lang":"en","author_id":"294046348","id":"1187356818554515457","in_reply_to_user_id":"116716199","text":"@EMA_News #tenders Provision of Legal Advice in Real Estate for EMA Building at 30 Churchill Place, London, under UK Law - 22/11/2019 - https://t.co/JHmtFk3aoY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1187356818554515457","created_at":"2019-10-24T13:15:00.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":143,"end":166,"url":"https://t.co/0z23kG0L45","expanded_url":"https://www.raps.org/news-and-articles/news-articles/2019/10/ema-updates-qa-on-mdr-ivdr","display_url":"raps.org/news-and-artic…"},{"start":182,"end":205,"url":"https://t.co/PHvFgoqQle","expanded_url":"https://twitter.com/seQureLS/status/1186746626733412352/photo/1","display_url":"pic.twitter.com/PHvFgoqQle"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":97,"end":101,"tag":"MDR"},{"start":106,"end":111,"tag":"IVDR"},{"start":167,"end":181,"tag":"medicaldevice"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1186746626733412352","in_reply_to_user_id":"116716199","text":"@EMA_News has just released an updated and revised Q&amp;A document on the implementation of the #MDR and #IVDR. \nMore details available here: https://t.co/0z23kG0L45\n#medicaldevice https://t.co/PHvFgoqQle","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1186746626733412352","created_at":"2019-10-22T20:50:19.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1186746616251912194"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":122,"end":145,"url":"https://t.co/iXauhlhiZO","expanded_url":"https://www.gmp-compliance.org/gmp-news/nitrosamine-contamination-ema-requests-risk-evaluation-for-drug-products-containing-chemically-synthesised-apis","display_url":"gmp-compliance.org/gmp-news/nitro…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":146,"end":156,"tag":"medicines"},{"start":157,"end":168,"tag":"healthcare"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1186356366648184833","in_reply_to_user_id":"116716199","text":"@EMA_News requests risk evaluation for drug products containing chemically synthesised APIs. More details available here: https://t.co/iXauhlhiZO #medicines #healthcare","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1186356366648184833","created_at":"2019-10-21T18:59:33.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":29,"end":52,"url":"https://t.co/XSuxMKdnqr","expanded_url":"https://twitter.com/gurudutch/status/1185496708236619776?s=21","display_url":"twitter.com/gurudutch/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":14,"username":"WHO","id":"14499829"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2504804636","id":"1185852264944197632","in_reply_to_user_id":"116716199","text":"@EMA_News @WHO Please help 🙏 https://t.co/XSuxMKdnqr","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1185163618012352512","created_at":"2019-10-20T09:36:26.000Z","referenced_tweets":[{"type":"quoted","id":"1185496708236619776"},{"type":"replied_to","id":"1185163618012352512"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/v37NNpo6Wc","expanded_url":"https://www.raps.org/news-and-articles/news-articles/2019/10/emas-chmp-recommends-first-ebola-vaccine-6-other","display_url":"raps.org/news-and-artic…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":102,"end":113,"tag":"healthcare"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1185529606041997314","in_reply_to_user_id":"116716199","text":"@EMA_News's CHMP recommends first Ebola vaccine. More details available here: https://t.co/v37NNpo6Wc #healthcare","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1185529606041997314","created_at":"2019-10-19T12:14:18.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"BertrandBio","id":"3142088601"},{"start":23,"end":27,"username":"WHO","id":"14499829"},{"start":28,"end":36,"username":"ECDC_EU","id":"204752573"},{"start":37,"end":47,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"292902687","id":"1185499150802214913","in_reply_to_user_id":"116716199","text":"@EMA_News @BertrandBio @WHO @ECDC_EU @EU_Health Great! New hope","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1185150302460231681","created_at":"2019-10-19T10:13:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1185150302460231681"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/CwG1udZeOt","expanded_url":"http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=77914","display_url":"quotidianosanita.it/scienza-e-farm…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":46,"end":52,"tag":"Ebola"},{"start":99,"end":106,"tag":"Sanità"}]},"possibly_sensitive":false,"lang":"it","author_id":"321385733","id":"1185185343152283648","in_reply_to_user_id":"116716199","text":"@Ema_news. Via libera al primo vaccino contro #Ebola. Aggiornate anche le Faq su caso nitrosammine #Sanità https://t.co/CwG1udZeOt","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1185185343152283648","created_at":"2019-10-18T13:26:20.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"781246698278514689","id":"1185183809475620864","in_reply_to_user_id":"116716199","text":"@EMA_News i have one","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1185179343984701442","created_at":"2019-10-18T13:20:14.000Z","referenced_tweets":[{"type":"replied_to","id":"1185179343984701442"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":51,"end":56,"probability":0.994,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"18349503","id":"1185153108722233344","in_reply_to_user_id":"116716199","text":"@EMA_News Finally Baqsimi for Diabetes patients in Europe!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1185152292523261953","created_at":"2019-10-18T11:18:14.000Z","referenced_tweets":[{"type":"replied_to","id":"1185152292523261953"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/4HU2HuNBIy","expanded_url":"https://twitter.com/FiverrGigs10/status/1185139910417829888/video/1","display_url":"twitter.com/FiverrGigs10/s…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1185152592692830209","id":"1185152716437442560","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/4HU2HuNBIy","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1185152292523261953","created_at":"2019-10-18T11:16:41.000Z","referenced_tweets":[{"type":"replied_to","id":"1185152292523261953"}],"source":"Mobile Web (M2)","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":217,"end":240,"url":"https://t.co/vaEAG6b4Uf","expanded_url":"https://bit.ly/31dxnmJ","display_url":"bit.ly/31dxnmJ"},{"start":267,"end":290,"url":"https://t.co/0wr3moz60O","expanded_url":"https://twitter.com/Boehringer_AH/status/1184801420173828096/photo/1","display_url":"pic.twitter.com/0wr3moz60O"}],"annotations":[{"start":149,"end":154,"probability":0.9901,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":72,"end":84,"tag":"antibiotics"},{"start":118,"end":129,"tag":"veterinary"},{"start":241,"end":254,"tag":"AnimalHealth"},{"start":255,"end":266,"tag":"prevention"}]},"possibly_sensitive":false,"lang":"en","author_id":"17066119","id":"1184801420173828096","in_reply_to_user_id":"116716199","text":"@EMA_News reports that European countries continue to reduce the use of #antibiotics in animals. The overall sales of #veterinary antibiotics across Europe dropped by more than 32% between 2011 and 2017. Read more: ➡ https://t.co/vaEAG6b4Uf #AnimalHealth #prevention https://t.co/0wr3moz60O","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1184801420173828096","created_at":"2019-10-17T12:00:45.000Z","referenced_tweets":{},"source":"Gain Platform","attachments":{"media_keys":["3_1184801416923230213"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":120,"end":124,"probability":0.4892,"type":"Person","normalized_text":"Glaxo"},{"start":240,"end":244,"probability":0.3888,"type":"Person","normalized_text":"Glaxo"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1006282168161751040","id":"1184255038803402755","in_reply_to_user_id":"116716199","text":"@EMA_News My GP has said it is ok for me to still take my 300mg of Ranitidine twice a day, as long as it is not made by Glaxo. I have been on this medication for years.\nIs it safe to take them if they are made by another company other than Glaxo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1184255038803402755","created_at":"2019-10-15T23:49:38.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":213,"end":236,"url":"https://t.co/mZJvHT0AVs","expanded_url":"https://www.ruminantia.it/ema-le-vendite-complessive-di-antibiotici-veterinari-in-europa-sono-diminuite-di-oltre-il-32-tra-il-2011-e-il-2017/","display_url":"ruminantia.it/ema-le-vendite…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":17,"end":29,"tag":"reportESVAC"},{"start":47,"end":71,"tag":"EuropeanMedicinesAgency"},{"start":163,"end":175,"tag":"antibiotici"},{"start":190,"end":212,"tag":"antibioticoresistenza"}]},"possibly_sensitive":false,"lang":"it","author_id":"1235372959","id":"1184129965262016513","in_reply_to_user_id":"116716199","text":"@EMA_News: nuovo #reportESVAC pubblicato dalla #EuropeanMedicinesAgency mostra che i paesi europei stanno aumentando il loro impegno per un uso responsabile degli #antibiotici negli animali\n#antibioticoresistenza\nhttps://t.co/mZJvHT0AVs","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1184129965262016513","created_at":"2019-10-15T15:32:38.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":0,"end":23,"url":"https://t.co/bYj6VbBEVs","expanded_url":"https://twitter.com/EMA_News/status/1184087174528094209/photo/1","display_url":"pic.twitter.com/bYj6VbBEVs"}],"annotations":{},"mentions":{},"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"116716199","id":"1184087174528094209","in_reply_to_user_id":"116716199","text":"https://t.co/bYj6VbBEVs","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":8,"quote_count":1},"conversation_id":"1184086624621223942","created_at":"2019-10-15T12:42:36.000Z","referenced_tweets":[{"type":"replied_to","id":"1184086747707256832"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1184087168232427521"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":0,"end":23,"url":"https://t.co/kwCMAeBGQ8","expanded_url":"https://twitter.com/EMA_News/status/1184086747707256832/photo/1","display_url":"pic.twitter.com/kwCMAeBGQ8"}],"annotations":{},"mentions":{},"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"116716199","id":"1184086747707256832","in_reply_to_user_id":"116716199","text":"https://t.co/kwCMAeBGQ8","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":3,"quote_count":0},"conversation_id":"1184086624621223942","created_at":"2019-10-15T12:40:54.000Z","referenced_tweets":[{"type":"replied_to","id":"1184086624621223942"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1184086741269073920"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":146,"end":169,"url":"https://t.co/gWNo9PfHYF","expanded_url":"http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71029a-eng.php","display_url":"healthycanadians.gc.ca/recall-alert-r…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"GovCanHealth","id":"36375825"}],"hashtags":[{"start":101,"end":114,"tag":"nitrosamines"}]},"possibly_sensitive":false,"lang":"en","author_id":"795374891814031361","id":"1184084275026636801","in_reply_to_user_id":"116716199","text":"@EMA_News @GovCanHealth using a similar approach has provided MAH with acceptable interim limits for #nitrosamines in drug products, API sources. https://t.co/gWNo9PfHYF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1177162912693182465","created_at":"2019-10-15T12:31:05.000Z","referenced_tweets":[{"type":"replied_to","id":"1177162912693182465"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":216,"end":239,"url":"https://t.co/rjl266TFwy","expanded_url":"https://diievents.dii.eu/annual-health-care-summit/inscription/","display_url":"diievents.dii.eu/annual-health-…"},{"start":240,"end":263,"url":"https://t.co/bEVt2cQBHX","expanded_url":"https://twitter.com/EventsPOLITICO/status/1181909038998720512/video/1","display_url":"pic.twitter.com/bEVt2cQBHX"}],"annotations":[{"start":45,"end":52,"probability":0.8266,"type":"Organization","normalized_text":"POLITICO"},{"start":56,"end":73,"probability":0.5078,"type":"Other","normalized_text":"Health Care Summit"},{"start":86,"end":94,"probability":0.9448,"type":"Place","normalized_text":"Amsterdam"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3151845088","id":"1181909038998720512","in_reply_to_user_id":"116716199","text":"@EMA_News - We are trying to reach you about POLITICO's Health Care Summit, coming to Amsterdam in late November. We'd love your team to join us for free. Can you forward them this info? Thanks! They can register on https://t.co/rjl266TFwy https://t.co/bEVt2cQBHX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1181909038998720512","created_at":"2019-10-09T12:27:28.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["7_1181908945688027142"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/GhzzQBEUn0","expanded_url":"https://uk.reuters.com/video/2019/10/07/digital-platform-brings-health-awareness?videoId=609672069","display_url":"uk.reuters.com/video/2019/10/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"3316933737","id":"1181812021182042114","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/GhzzQBEUn0","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1180101361670742019","created_at":"2019-10-09T06:01:57.000Z","referenced_tweets":[{"type":"replied_to","id":"1180101361670742019"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/CVKWmtX616","expanded_url":"https://animalpharm.agribusinessintelligence.informa.com/articles/2019/10/08/ema-to-review-organizational-structure-due-to-brexit-constraints","display_url":"….agribusinessintelligence.informa.com/articles/2019/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":52,"end":59,"tag":"Brexit"}]},"possibly_sensitive":false,"lang":"en","author_id":"939253770889912321","id":"1181541159308578818","in_reply_to_user_id":"116716199","text":"@EMA_News to review organizational structure due to #Brexit constraints https://t.co/CVKWmtX616","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1181541159308578818","created_at":"2019-10-08T12:05:39.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":211,"end":234,"url":"https://t.co/SmYWtI9vKm","expanded_url":"https://www.ema.europa.eu/en/news/ema-review-ranitidine-medicines-following-detection-ndma","display_url":"ema.europa.eu/en/news/ema-re…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"104266110","id":"1181191009214111749","in_reply_to_user_id":"116716199","text":"@EMA_News Does no-one check these documents before they are issued? Ranitidine is also available as an oral solution and the following spelling error - a class of medicines known as H2 (histsamine-2) blockers - https://t.co/SmYWtI9vKm","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1177162912693182465","created_at":"2019-10-07T12:54:16.000Z","referenced_tweets":[{"type":"replied_to","id":"1177162912693182465"}],"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":80,"end":103,"url":"https://t.co/I55iVgozoA","expanded_url":"https://www.statnews.com/pharmalot/2019/10/04/ema-clinical-trials-transparency/","display_url":"statnews.com/pharmalot/2019…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":108,"end":118,"username":"pharmalot","id":"13171622"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"28824136","id":"1180219169121419267","in_reply_to_user_id":"116716199","text":"@EMA_News warns that its clinical trial transparency efforts may be jeopardized https://t.co/I55iVgozoA via @pharmalot","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1180219169121419267","created_at":"2019-10-04T20:32:31.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":45,"end":64,"probability":0.4275,"type":"Product","normalized_text":"Baqsimi glucagon kit"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"18349503","id":"1180100802272215040","in_reply_to_user_id":"116716199","text":"@EMA_News When will you discuss allowance of Baqsimi glucagon kit?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1180100559422066688","created_at":"2019-10-04T12:42:11.000Z","referenced_tweets":[{"type":"replied_to","id":"1180100559422066688"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":137,"end":160,"url":"https://t.co/sEKKDwKzzR","expanded_url":"http://bit.ly/2oOotyw","display_url":"bit.ly/2oOotyw"},{"start":161,"end":184,"url":"https://t.co/4huuk6rNYZ","expanded_url":"https://twitter.com/EURACTIVjobsite/status/1180040935905906688/photo/1","display_url":"pic.twitter.com/4huuk6rNYZ"}],"annotations":[{"start":91,"end":99,"probability":0.9875,"type":"Place","normalized_text":"Amsterdam"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"26476638","id":"1180040935905906688","in_reply_to_user_id":"116716199","text":"@EMA_News (European Medicines Agency) is looking for a Talent Development Officer based in Amsterdam. Apply before 13th October (23:59). https://t.co/sEKKDwKzzR https://t.co/4huuk6rNYZ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1180040935905906688","created_at":"2019-10-04T08:44:17.000Z","referenced_tweets":{},"source":"Echobox","attachments":{"media_keys":["3_1180040933666103297"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":120,"end":143,"url":"https://t.co/YTcHLHUVlM","expanded_url":"http://ow.ly/EXZr30pEJZo","display_url":"ow.ly/EXZr30pEJZo"},{"start":144,"end":167,"url":"https://t.co/Actd0oLFzb","expanded_url":"http://ow.ly/29u630pEJYh","display_url":"ow.ly/29u630pEJYh"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1179720609967857666","in_reply_to_user_id":"116716199","text":"@EMA_News \nExpertos proponen ideas para superar las reticencias al uso de datos de vida real en evaluación de fármacos\n\nhttps://t.co/YTcHLHUVlM\nhttps://t.co/Actd0oLFzb","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1179720609967857666","created_at":"2019-10-03T11:31:26.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":190,"end":213,"url":"https://t.co/IRncDQR1Nr","expanded_url":"https://buff.ly/2kQDNsR","display_url":"buff.ly/2kQDNsR"},{"start":241,"end":264,"url":"https://t.co/lbWb3eyNTe","expanded_url":"https://twitter.com/CREATION/status/1178571436673384448/photo/1","display_url":"pic.twitter.com/lbWb3eyNTe"}],"annotations":[{"start":43,"end":53,"probability":0.5212,"type":"Person","normalized_text":"Stelara EMA"},{"start":174,"end":186,"probability":0.8997,"type":"Place","normalized_text":"United States"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":40,"username":"JanssenGlobal","id":"2474345197"}],"hashtags":[{"start":11,"end":16,"tag":"HCPs"},{"start":214,"end":228,"tag":"WhatHCPsThink"},{"start":229,"end":240,"tag":"EMAtracker"}]},"possibly_sensitive":false,"lang":"en","author_id":"208972233","id":"1178571436673384448","in_reply_to_user_id":"116716199","text":"@EMA_News: #HCPs consider @JanssenGlobal's Stelara EMA approval as “great news to the patients and their doctors” and express expectations to see this label expansion in the United States. \nhttps://t.co/IRncDQR1Nr #WhatHCPsThink #EMAtracker https://t.co/lbWb3eyNTe","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1178571436673384448","created_at":"2019-09-30T07:25:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1178571435192795138"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":16,"tag":"BfArM"}]},"possibly_sensitive":false,"lang":"nl","author_id":"4127230337","id":"1177982146683768833","in_reply_to_user_id":"116716199","text":"@EMA_News #BfArM koordiniert als Rapporteur","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1177162912693182465","created_at":"2019-09-28T16:23:24.000Z","referenced_tweets":[{"type":"replied_to","id":"1177162912693182465"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":81,"end":104,"url":"https://t.co/8g3PjaGsyF","expanded_url":"https://twitter.com/iamalsorg/status/1177261174485897221","display_url":"twitter.com/iamalsorg/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"saude_pt","id":"729607264605241344"},{"start":20,"end":32,"username":"INFARMED_IP","id":"1392501529"},{"start":33,"end":45,"username":"IMMolecular","id":"174253444"},{"start":46,"end":58,"username":"RTPNoticias","id":"16451028"},{"start":68,"end":80,"username":"SICNoticias","id":"17163446"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1177276628210245633","in_reply_to_user_id":"116716199","text":"@EMA_News @saude_pt @INFARMED_IP @IMMolecular @RTPNoticias @tvi24pt @SICNoticias https://t.co/8g3PjaGsyF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1177276628210245633","created_at":"2019-09-26T17:39:55.000Z","referenced_tweets":[{"type":"quoted","id":"1177261174485897221"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":231,"end":254,"url":"https://t.co/opWg517SIf","expanded_url":"http://bit.ly/2ljzl5X","display_url":"bit.ly/2ljzl5X"},{"start":255,"end":278,"url":"https://t.co/6qxOvUtl3s","expanded_url":"https://twitter.com/EMA_News/status/1177162912693182465","display_url":"twitter.com/EMA_News/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":66,"end":79,"tag":"nitrosaminas"}]},"possibly_sensitive":false,"lang":"es","author_id":"826777706914279424","id":"1177202298772176896","in_reply_to_user_id":"116716199","text":"@EMA_News  informa:\n\n🔴 Pasos a seguir para evitar la presencia de #nitrosaminas  \n en medicamentos de uso humano \n\n☞  Documento de preguntas y respuestas para titulares de autorizaciones de comercialización. Toda la información en https://t.co/opWg517SIf https://t.co/6qxOvUtl3s","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1177202298772176896","created_at":"2019-09-26T12:44:34.000Z","referenced_tweets":[{"type":"quoted","id":"1177162912693182465"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"PatientJournal","id":"81127451"},{"start":26,"end":42,"username":"eupatientsforum","id":"545343465"},{"start":43,"end":52,"username":"KaisaBxl","id":"188726957"},{"start":62,"end":71,"username":"KaisaBxl","id":"188726957"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"20804061","id":"1177104508612227072","in_reply_to_user_id":"116716199","text":"@EMA_News @PatientJournal @eupatientsforum @KaisaBxl Congrats @KaisaBxl","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1176891109005508615","created_at":"2019-09-26T06:15:59.000Z","referenced_tweets":[{"type":"replied_to","id":"1176891109005508615"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"EHA_Hematology","id":"279001852"}],"hashtags":{}},"possibly_sensitive":false,"lang":"de","author_id":"188726957","id":"1176913510577713152","in_reply_to_user_id":"116716199","text":"@EMA_News @EHA_Hematology Congratulations Ulrich!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1176891931424677888","created_at":"2019-09-25T17:37:01.000Z","referenced_tweets":[{"type":"replied_to","id":"1176891931424677888"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":152,"end":175,"url":"https://t.co/ZNLN0tsWjQ","expanded_url":"https://www.ruminantia.it/il-lavoro-della-european-medicines-agency-sui-nuovi-progressi-nella-regolamentazione-veterinaria/","display_url":"ruminantia.it/il-lavoro-dell…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":130,"end":151,"tag":"medicinaliveterinari"}]},"possibly_sensitive":false,"lang":"it","author_id":"1235372959","id":"1176885008423895041","in_reply_to_user_id":"116716199","text":"@EMA_News ha lanciato una nuova pagina web che mostra i progressi compiuti dall’Agenzia nell’attuazione del nuovo regolamento sui #medicinaliveterinari https://t.co/ZNLN0tsWjQ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1176885008423895041","created_at":"2019-09-25T15:43:46.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":77,"end":100,"url":"https://t.co/Bk3vPMYioV","expanded_url":"https://tinyurl.com/yxtzqxdf","display_url":"tinyurl.com/yxtzqxdf"},{"start":101,"end":124,"url":"https://t.co/Cgz5ywok0R","expanded_url":"https://twitter.com/onmedicanews/status/1175749129177370625/photo/1","display_url":"pic.twitter.com/Cgz5ywok0R"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"42178750","id":"1175749129177370625","in_reply_to_user_id":"116716199","text":"@EMA_News begins review on ranitidine medicines following detection of NDMA: https://t.co/Bk3vPMYioV https://t.co/Cgz5ywok0R","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1175749129177370625","created_at":"2019-09-22T12:30:11.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1175749127956848645"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":202,"end":225,"url":"https://t.co/dJOHupAvyR","expanded_url":"https://ec.europa.eu/health/documents/public_call/call_index_en#fragment0","display_url":"ec.europa.eu/health/documen…"}],"annotations":[{"start":84,"end":96,"probability":0.6504,"type":"Organization","normalized_text":"Civil Society"},{"start":121,"end":139,"probability":0.8231,"type":"Organization","normalized_text":"Pediatric Committee"},{"start":191,"end":199,"probability":0.9718,"type":"Place","normalized_text":"Amsterdam"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"EMCDDA","id":"50638521"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3697434814","id":"1175004348440559616","in_reply_to_user_id":"116716199","text":"@EMA_News @EMCDDA \nThe Commission is launching a selection procedure to appoint the Civil Society representatives to the Pediatric Committee (PDCO) of the European Medicines Agency (EMA), in Amsterdam.\nhttps://t.co/dJOHupAvyR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1175004348440559616","created_at":"2019-09-20T11:10:41.000Z","referenced_tweets":{},"source":"Twitter for iPad","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":159,"end":182,"url":"https://t.co/y3OezTWLfQ","expanded_url":"http://ow.ly/Z7zK30pzApw","display_url":"ow.ly/Z7zK30pzApw"}],"annotations":[{"start":11,"end":41,"probability":0.3991,"type":"Organization","normalized_text":"Agencia Europea de Medicamentos"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":114,"end":127,"tag":"nitrosaminas"}]},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1174999493743435776","in_reply_to_user_id":"116716199","text":"@EMA_News  Agencia Europea de Medicamentos informa que se encuentra trabajando ⇒ en orientaciones para evitar las #nitrosaminas en medicamentos para humanos.\n\nhttps://t.co/y3OezTWLfQ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1174999493743435776","created_at":"2019-09-20T10:51:24.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"496387193","id":"1174923633795297280","in_reply_to_user_id":"116716199","text":"@EMA_News Which brands are interested?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1172482656350670851","created_at":"2019-09-20T05:49:57.000Z","referenced_tweets":[{"type":"replied_to","id":"1172482656350670851"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":68,"end":93,"probability":0.3069,"type":"Product","normalized_text":"Baqsimi nasal glucagon kit"},{"start":98,"end":103,"probability":0.8601,"type":"Place","normalized_text":"europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"18349503","id":"1174825711124844544","in_reply_to_user_id":"116716199","text":"@EMA_News are there any news / status updates about the approval of Baqsimi nasal glucagon kit in europe?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1174825711124844544","created_at":"2019-09-19T23:20:51.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":243,"end":266,"url":"https://t.co/8if6lwhzTU","expanded_url":"https://buff.ly/30pvSkG","display_url":"buff.ly/30pvSkG"},{"start":267,"end":290,"url":"https://t.co/NWWCBJpv77","expanded_url":"https://twitter.com/CytonBio/status/1174555724439085056/photo/1","display_url":"pic.twitter.com/NWWCBJpv77"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":84,"end":104,"tag":"VeterinaryMedicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1174555724439085056","in_reply_to_user_id":"116716199","text":"@EMA_News has issued the first advice to the EC regarding implementation of the new #VeterinaryMedicines regulation: collection of data regarding antimicrobials; amendments to Annex II; the union database; variations not requiring assessment. https://t.co/8if6lwhzTU https://t.co/NWWCBJpv77","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1174555724439085056","created_at":"2019-09-19T05:28:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1174555722853621761"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":133,"end":156,"url":"https://t.co/NpXwmPCfIS","expanded_url":"http://ow.ly/Gf2v30py4cr","display_url":"ow.ly/Gf2v30py4cr"},{"start":157,"end":180,"url":"https://t.co/XPT6txVQ9D","expanded_url":"http://ow.ly/uPf430py4pV","display_url":"ow.ly/uPf430py4pV"}],"annotations":[{"start":53,"end":73,"probability":0.4037,"type":"Place","normalized_text":"N-Nitrosodimetilamina"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1173916177799745536","in_reply_to_user_id":"116716199","text":"@EMA_News @AEMPSGOB  han alertado de la detección de N-Nitrosodimetilamina (NDMA) en algunos medicamentos que contienen ranitidina.\n\nhttps://t.co/NpXwmPCfIS\nhttps://t.co/XPT6txVQ9D","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1173916177799745536","created_at":"2019-09-17T11:06:41.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":31,"end":41,"username":"Patologie","id":"110757507"},{"start":162,"end":178,"username":"MinisteroSalute","id":"1904010924"},{"start":179,"end":194,"username":"Aifa_ufficiale","id":"441940097"},{"start":195,"end":206,"username":"WRicciardi","id":"305236970"},{"start":207,"end":218,"username":"americo691","id":"2785966062"},{"start":219,"end":233,"username":"chiaragnocchi","id":"361880566"},{"start":234,"end":249,"username":"silvia_starita","id":"1171681975"}],"hashtags":[{"start":89,"end":97,"tag":"ricerca"},{"start":102,"end":110,"tag":"farmaci"},{"start":147,"end":161,"tag":"eupati_italia"}]},"possibly_sensitive":false,"lang":"it","author_id":"3193996847","id":"1173879300879265792","in_reply_to_user_id":"116716199","text":"@EMA_News Per i registri sulle @patologie è importante coinvolgere i Pazienti Esperti in #ricerca dei #farmaci   formati da Accademia dei Pazienti #eupati_italia @MinisteroSalute @Aifa_ufficiale @WRicciardi @americo691 @chiaragnocchi @silvia_starita","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1165950657653891072","created_at":"2019-09-17T08:40:09.000Z","referenced_tweets":[{"type":"replied_to","id":"1165950657653891072"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":211,"end":234,"url":"https://t.co/lex9JhQgnN","expanded_url":"http://ow.ly/Iq6050wcGdl","display_url":"ow.ly/Iq6050wcGdl"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"899540204","id":"1173870162509991938","in_reply_to_user_id":"116716199","text":"@EMA_News Workshop on the use of registries for the monitoring of tumour histology-independent therapies 29th November 2019 with overview of the authorised products larotrectinib and entrectinib\n\nDraft agenda - https://t.co/lex9JhQgnN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1173870162509991938","created_at":"2019-09-17T08:03:50.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":16,"end":21,"probability":0.9688,"type":"Place","normalized_text":"EUROPE"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3696204433","id":"1172260010186936344","in_reply_to_user_id":"116716199","text":"@EMA_News \nDOES EUROPE HAVE WARNING LABELS THAT MORNING AFTER PILL NOT EFFECTIVE FOR WOMAN OVER 175LBS??","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1172260010186936344","created_at":"2019-09-12T21:25:40.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":238,"end":261,"url":"https://t.co/OWPZ8IAGTX","expanded_url":"https://twitter.com/WBJonline/status/1171878857261101056","display_url":"twitter.com/WBJonline/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":36,"end":43,"username":"US_FDA","id":"208120290"},{"start":177,"end":188,"username":"novavaxinc","id":"1259924131665055744"}],"hashtags":[{"start":68,"end":72,"tag":"RSV"},{"start":73,"end":81,"tag":"vaccine"},{"start":189,"end":215,"tag":"RespiratorySyncytialVirus"},{"start":216,"end":229,"tag":"RSVAwareness"},{"start":230,"end":237,"tag":"EndRSV"}]},"possibly_sensitive":false,"lang":"en","author_id":"814881013373530116","id":"1172248513117396992","in_reply_to_user_id":"116716199","text":"@EMA_News seemingly going to follow @US_FDA on the ResVax (maternal #RSV #vaccine) trial...\n“EMA is likely to recommend another phase 3 trial to confirm the vaccine’s efficacy”\n@NovavaxInc #RespiratorySyncytialVirus #RSVAwareness #EndRSV https://t.co/OWPZ8IAGTX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1172248513117396992","created_at":"2019-09-12T20:39:59.000Z","referenced_tweets":[{"type":"quoted","id":"1171878857261101056"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"797329184196620288","id":"1172164909926367232","in_reply_to_user_id":"116716199","text":"@EMA_News @sanofipasteur Exactly!! This is the responsibility of any regulatory agency to ensure safety, quality and effectiveness of vaccine before giving green signal for marketing authorisation.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1172122559367827456","created_at":"2019-09-12T15:07:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1172122559367827456"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":208,"end":231,"url":"https://t.co/PrXIqHs4hY","expanded_url":"https://twitter.com/EMA_News/status/1172154249330995200/photo/1","display_url":"pic.twitter.com/PrXIqHs4hY"}],"annotations":{},"mentions":{},"hashtags":[{"start":173,"end":186,"tag":"VaccinesWork"},{"start":187,"end":207,"tag":"VaccinationSummit19"}]},"possibly_sensitive":false,"lang":"en","author_id":"116716199","id":"1172154249330995200","in_reply_to_user_id":"116716199","text":"Remember, as long as a vaccine remains on the EU market, EMA will permanently monitor, collect and analyse new information on the efficacy, quality and safety of a vaccine. #VaccinesWork #VaccinationSummit19 https://t.co/PrXIqHs4hY","public_metrics":{"retweet_count":11,"reply_count":0,"like_count":21,"quote_count":1},"conversation_id":"1172122559367827456","created_at":"2019-09-12T14:25:25.000Z","referenced_tweets":[{"type":"replied_to","id":"1172154017687973888"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1172154244931211265"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":193,"end":216,"url":"https://t.co/ZnW9eQVgw3","expanded_url":"https://twitter.com/EMA_News/status/1172154017687973888/photo/1","display_url":"pic.twitter.com/ZnW9eQVgw3"}],"annotations":{},"mentions":{},"hashtags":[{"start":158,"end":171,"tag":"VaccinesWork"},{"start":172,"end":192,"tag":"VaccinationSummit19"}]},"possibly_sensitive":false,"lang":"en","author_id":"116716199","id":"1172154017687973888","in_reply_to_user_id":"116716199","text":"Even after a vaccine starts being used, EMA's experts continuously look into evidence and research results to make sure benefits are still higher than risks. #VaccinesWork #VaccinationSummit19 https://t.co/ZnW9eQVgw3","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":16,"quote_count":0},"conversation_id":"1172122559367827456","created_at":"2019-09-12T14:24:30.000Z","referenced_tweets":[{"type":"replied_to","id":"1172122559367827456"}],"source":"Twitter Web App","attachments":{"media_keys":["3_1172154012789026817"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":12,"end":35,"url":"https://t.co/MuS6DgSEfJ","expanded_url":"https://twitter.com/FarmaTrust/status/1169898288050343938?s=19","display_url":"twitter.com/FarmaTrust/sta…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"846372037585072128","id":"1170350206522540033","in_reply_to_user_id":"116716199","text":"@EMA_News \n\nhttps://t.co/MuS6DgSEfJ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1170350206522540033","created_at":"2019-09-07T14:56:47.000Z","referenced_tweets":[{"type":"quoted","id":"1169898288050343938"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/z11XbVOZPQ","expanded_url":"https://www.gmp-compliance.org/gmp-news/ema-publishes-first-two-guidances-on-drug-shortages","display_url":"gmp-compliance.org/gmp-news/ema-p…"},{"start":125,"end":148,"url":"https://t.co/vVjUFArNSi","expanded_url":"https://twitter.com/seQureLS/status/1169634465037131776/photo/1","display_url":"pic.twitter.com/vVjUFArNSi"}],"annotations":[{"start":30,"end":38,"probability":0.3744,"type":"Organization","normalized_text":"Guidances"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":102,"end":113,"tag":"healthcare"},{"start":114,"end":124,"tag":"medicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1169634465037131776","in_reply_to_user_id":"116716199","text":"@EMA_News publishes first two Guidances on Drug Shortages. More details here: https://t.co/z11XbVOZPQ #healthcare #medicines https://t.co/vVjUFArNSi","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1169634465037131776","created_at":"2019-09-05T15:32:41.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1169634459391537154"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":103,"end":126,"url":"https://t.co/5d1O2tSBwE","expanded_url":"https://europa.eu/!Cm97Bh","display_url":"europa.eu/!Cm97Bh"}],"annotations":[{"start":77,"end":101,"probability":0.6133,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":131,"end":140,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":74,"tag":"clinicaltrials"}]},"possibly_sensitive":false,"lang":"en","author_id":"265036344","id":"1167647552814104576","in_reply_to_user_id":"116716199","text":"@EMA_News  Global public meeting on draft ICH guideline on #clinicaltrials | European Medicines Agency https://t.co/5d1O2tSBwE via @EMA_News","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1167647552814104576","created_at":"2019-08-31T03:57:25.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":172,"end":195,"url":"https://t.co/iwmX6oGBYi","expanded_url":"https://www.change.org/p/fda-approval-for-life-saving-nurown-for-als-patients","display_url":"change.org/p/fda-approval…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"ICH_news","id":"305434870"},{"start":20,"end":27,"username":"US_FDA","id":"208120290"},{"start":126,"end":141,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":99,"end":106,"tag":"Nurown"},{"start":111,"end":115,"tag":"ALS"},{"start":116,"end":120,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1167409499273158656","in_reply_to_user_id":"116716199","text":"@EMA_News @ICH_news @US_FDA More than 100.500 people already signed. \nPlease, continue to share!!\n\n#Nurown for #ALS #ELA from @BrainstormCell\nSign the Petition and share!!\nhttps://t.co/iwmX6oGBYi","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1167407843311529988","created_at":"2019-08-30T12:11:28.000Z","referenced_tweets":[{"type":"replied_to","id":"1167407843311529988"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"laruedupass","id":"3012693377"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"48113280","id":"1167340574913044481","in_reply_to_user_id":"116716199","text":"@EMA_News @laruedupass 😢","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1106495322128334849","created_at":"2019-08-30T07:37:35.000Z","referenced_tweets":[{"type":"replied_to","id":"1106495322128334849"}],"source":"Twitter for iPad","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":82,"end":92,"probability":0.9806,"type":"Place","normalized_text":"Netherlands"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":100,"end":113,"username":"BorisJohnson","id":"3131144855"},{"start":114,"end":130,"username":"Jacob_Rees_Mogg","id":"885838630928994304"},{"start":131,"end":143,"username":"michaelgove","id":"748453510048518145"}],"hashtags":[{"start":246,"end":259,"tag":"stopthecoupe"}]},"possibly_sensitive":false,"lang":"en","author_id":"943079637621538816","id":"1167135140973178880","in_reply_to_user_id":"116716199","text":"@EMA_News Good luck to you and I am sure you will be welcomed and flourish in the Netherlands. Well @BorisJohnson @Jacob_Rees_Mogg @michaelgove thanks a bunch you selfish liars. You know there will more that follows and more companies have gone. #stopthecoupe","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1106495322128334849","created_at":"2019-08-29T18:01:16.000Z","referenced_tweets":[{"type":"replied_to","id":"1106495322128334849"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":21,"end":30,"username":"EMA_News","id":"116716199"},{"start":77,"end":92,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":54,"end":61,"tag":"nurown"},{"start":98,"end":102,"tag":"ALS"},{"start":103,"end":107,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1166444341902155776","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA So @EMA_News , are you aware of the #nurown treatment from @BrainstormCell  for #ALS #ELA?","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1162343030021664769","created_at":"2019-08-27T20:16:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1162343030021664769"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":213,"end":236,"url":"https://t.co/2JmKU6qxsM","expanded_url":"https://buff.ly/2LXuL8z","display_url":"buff.ly/2LXuL8z"},{"start":280,"end":303,"url":"https://t.co/SCTftb7KO2","expanded_url":"https://twitter.com/CytonBio/status/1165982984857628672/photo/1","display_url":"pic.twitter.com/SCTftb7KO2"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":87,"end":106,"tag":"VeterinaryMedicine"},{"start":237,"end":248,"tag":"Regulation"},{"start":249,"end":260,"tag":"veterinary"},{"start":261,"end":279,"tag":"RegulatoryAffairs"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1165982984857628672","in_reply_to_user_id":"116716199","text":"@EMA_News has published a series of updated life-cycle management Q&amp;A webpages for #VeterinaryMedicine and there have been developments on the new veterinary regulation. Read the details on Cyton's news feed. https://t.co/2JmKU6qxsM #Regulation #veterinary #RegulatoryAffairs https://t.co/SCTftb7KO2","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1165982984857628672","created_at":"2019-08-26T13:43:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1165982983393808384"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":228,"end":251,"url":"https://t.co/tSauTiDMWj","expanded_url":"http://ow.ly/Nisl30ppPsa","display_url":"ow.ly/Nisl30ppPsa"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1165892260715741184","in_reply_to_user_id":"116716199","text":"@EMA_News Nueva indicación para las inmunoglobulinas en pacientes inmunosuprimidos: se extiende no sólo a trasplantados de órgano sólido sino a pacientes inmunosuprimidos con linfoma o pacientes con enfermedades inflamatorias.\n\nhttps://t.co/tSauTiDMWj","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1165892260715741184","created_at":"2019-08-26T07:42:30.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":100,"end":123,"url":"https://t.co/A1DVlBY9KZ","expanded_url":"https://www.transparimed.org/single-post/2019/08/20/Patient-groups-demand-sanctions-on-those-who-fail-to-report-clinical-trial-results","display_url":"transparimed.org/single-post/20…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"837335683215798272","id":"1164088028803022849","in_reply_to_user_id":"116716199","text":"@EMA_News Can you please pass this on to your policy team, and the team managing EUCTR? Thank you.\n\nhttps://t.co/A1DVlBY9KZ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1164088028803022849","created_at":"2019-08-21T08:13:08.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":179,"end":202,"url":"https://t.co/Co2mDDFvBX","expanded_url":"https://scq.io/gesAFQo","display_url":"scq.io/gesAFQo"},{"start":222,"end":245,"url":"https://t.co/PwKfdlpzOg","expanded_url":"https://twitter.com/AnTanghe/status/1163882838602735618/photo/1","display_url":"pic.twitter.com/PwKfdlpzOg"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":14,"end":21,"username":"US_FDA","id":"208120290"},{"start":207,"end":221,"username":"BioPharmaDive","id":"1564125781"}],"hashtags":[{"start":65,"end":70,"tag":"Drug"},{"start":71,"end":80,"tag":"Approval"},{"start":156,"end":160,"tag":"DTx"},{"start":165,"end":175,"tag":"medicalAI"}]},"possibly_sensitive":false,"lang":"en","author_id":"2174725821","id":"1163882838602735618","in_reply_to_user_id":"116716199","text":"@EMA_News and @US_FDA Historically Agree on Just About Every New #Drug #Approval (should get interesting to see comparison with CFDA, and more recently for #DTx and #medicalAI) - https://t.co/Co2mDDFvBX via @BioPharmaDive https://t.co/PwKfdlpzOg","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1163882838602735618","created_at":"2019-08-20T18:37:47.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1163882834160947202"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/5dIV4Q53aK","expanded_url":"https://buff.ly/2XbWV1j","display_url":"buff.ly/2XbWV1j"},{"start":243,"end":266,"url":"https://t.co/JzP4y8thIY","expanded_url":"https://twitter.com/CytonBio/status/1163725863189450752/photo/1","display_url":"pic.twitter.com/JzP4y8thIY"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":188,"end":205,"tag":"Tierarzneimittel"},{"start":206,"end":224,"tag":"RegulatoryAffairs"},{"start":225,"end":242,"tag":"Veterinarmedizin"}]},"possibly_sensitive":false,"lang":"de","author_id":"988381683341766656","id":"1163725863189450752","in_reply_to_user_id":"116716199","text":"@EMA_News zu den CESSP, Innovation Task Force (ITF), Zulassungseinreichungen und Empfehlenswerte Vorgehensweisen nach der Zulassung finden Sie auf Cyton news page https://t.co/5dIV4Q53aK  #Tierarzneimittel #RegulatoryAffairs #Veterinarmedizin https://t.co/JzP4y8thIY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1163725863189450752","created_at":"2019-08-20T08:14:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1163725861746565121"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"117318947","id":"1162676794799075328","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA Fascinating. Real question - why is there the 10% difference?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1162343030021664769","created_at":"2019-08-17T10:45:24.000Z","referenced_tweets":[{"type":"replied_to","id":"1162343030021664769"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":154,"end":177,"url":"https://t.co/DLqf832FLm","expanded_url":"https://www.ema.europa.eu/en/news/emafda-analysis-shows-high-degree-alignment-marketing-application-decisions-between-eu-us","display_url":"ema.europa.eu/en/news/emafda…"}],"annotations":[{"start":104,"end":105,"probability":0.4611,"type":"Organization","normalized_text":"EU"},{"start":111,"end":112,"probability":0.6703,"type":"Place","normalized_text":"US"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":13,"end":20,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1162453923225096192","in_reply_to_user_id":"116716199","text":"@EMA_News  / @US_FDA analysis shows high degree of alignment in marketing application decisions between EU and US. Learn more about their alignment here: https://t.co/DLqf832FLm","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1162453923225096192","created_at":"2019-08-16T19:59:47.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"120455989","id":"1162439130606972929","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA No news here. It was always like this","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1162343030021664769","created_at":"2019-08-16T19:01:00.000Z","referenced_tweets":[{"type":"replied_to","id":"1162343030021664769"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":205,"end":207,"probability":0.8,"type":"Organization","normalized_text":"FDA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":89,"end":93,"tag":"FDA"},{"start":102,"end":106,"tag":"EMA"}]},"possibly_sensitive":false,"lang":"en","author_id":"1143153214809923586","id":"1162407353737781249","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA Robust technical engagement may be contributing to an alignment in how #FDA and the #EMA view regulatory science. See EMA news today on a joint analysis finding &gt; 90% concordance between FDA &amp; EMA's marketing decisions for new medicines from 2014 to 2016.","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"1162343030021664769","created_at":"2019-08-16T16:54:44.000Z","referenced_tweets":[{"type":"replied_to","id":"1162343030021664769"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":97,"end":120,"url":"https://t.co/TpaHV2AT9n","expanded_url":"https://link.springer.com/article/10.2165%2F00148365-200605030-00004","display_url":"link.springer.com/article/10.216…"}],"annotations":[{"start":49,"end":50,"probability":0.9519,"type":"Place","normalized_text":"UK"},{"start":56,"end":58,"probability":0.9574,"type":"Place","normalized_text":"USA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"4179179176","id":"1162388180643041282","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA There's also alignment between UK and USA wrt post-approval insurance cover. 👉 https://t.co/TpaHV2AT9n","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1162343030021664769","created_at":"2019-08-16T15:38:33.000Z","referenced_tweets":[{"type":"replied_to","id":"1162343030021664769"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":69,"end":76,"tag":"NurOwn"},{"start":83,"end":91,"tag":"ALSplea"}]},"possibly_sensitive":false,"lang":"en","author_id":"1882365956","id":"1162094093994012673","in_reply_to_user_id":"116716199","text":"@EMA_News Hey!!! Screams from the graves, do you hear us??!! Approve #NurOwn now!! #ALSplea","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"1162094093994012673","created_at":"2019-08-15T20:09:57.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":115,"end":138,"url":"https://t.co/nLgJJorzTa","expanded_url":"https://twitter.com/CuraparaEla/status/1162059883530903552","display_url":"twitter.com/CuraparaEla/st…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":18,"end":34,"username":"FDACommissioner","id":"1113782559194984448"},{"start":35,"end":50,"username":"BrainstormCell","id":"802020620"},{"start":52,"end":64,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":[{"start":88,"end":95,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1162071533269016578","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA @FDACommissioner @BrainstormCell \n@INFARMED_IP\nAll of you can approve #NurOwn at the same time?? https://t.co/nLgJJorzTa","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1162071533269016578","created_at":"2019-08-15T18:40:18.000Z","referenced_tweets":[{"type":"quoted","id":"1162059883530903552"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":114,"end":137,"url":"https://t.co/qFMI5rUVDN","expanded_url":"https://twitter.com/sbaron26/status/1161614354560819202","display_url":"twitter.com/sbaron26/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":18,"end":34,"username":"FDACommissioner","id":"1113782559194984448"},{"start":35,"end":50,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":74,"end":81,"tag":"NurOwn"},{"start":95,"end":99,"tag":"ALS"},{"start":100,"end":108,"tag":"ALSplea"},{"start":109,"end":113,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1161923450073755649","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA @FDACommissioner @BrainstormCell do something!! Approve #NurOwn now, please!\n#ALS #ALSplea #ELA https://t.co/qFMI5rUVDN","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1161923450073755649","created_at":"2019-08-15T08:51:52.000Z","referenced_tweets":[{"type":"quoted","id":"1161614354560819202"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":129,"end":152,"url":"https://t.co/IIssHE17k4","expanded_url":"https://twitter.com/FinishALS/status/1161624680480092160","display_url":"twitter.com/FinishALS/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":18,"end":34,"username":"FDACommissioner","id":"1113782559194984448"},{"start":35,"end":48,"username":"FDAenEspanol","id":"570148387"},{"start":81,"end":96,"username":"BrainstormCell","id":"802020620"},{"start":97,"end":109,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":[{"start":58,"end":65,"tag":"NurOwn"},{"start":110,"end":114,"tag":"ELA"},{"start":115,"end":123,"tag":"ALSplea"},{"start":124,"end":128,"tag":"ALS"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1161922887865053186","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA @FDACommissioner @FDAenEspanol \nApprove #NurOwn now, please?? \n@BrainstormCell @INFARMED_IP #ELA #ALSplea #ALS https://t.co/IIssHE17k4","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1161922887865053186","created_at":"2019-08-15T08:49:38.000Z","referenced_tweets":[{"type":"quoted","id":"1161624680480092160"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":123,"end":146,"url":"https://t.co/dltQeoUr5Y","expanded_url":"https://twitter.com/jimiLdorado/status/1161893746662957059","display_url":"twitter.com/jimiLdorado/st…"}],"annotations":[{"start":95,"end":119,"probability":0.3877,"type":"Organization","normalized_text":"European Medicines Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"INFARMED_IP","id":"1392501529"},{"start":23,"end":28,"username":"ansm","id":"2443530930"},{"start":58,"end":73,"username":"BrainstormCell","id":"802020620"},{"start":85,"end":94,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":29,"end":36,"tag":"NurOwn"},{"start":37,"end":41,"tag":"ALS"},{"start":42,"end":50,"tag":"ALSplea"},{"start":51,"end":55,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"en","author_id":"1156472560391020544","id":"1161920797860081664","in_reply_to_user_id":"116716199","text":"@EMA_News @INFARMED_IP @ansm #NurOwn #ALS #ALSplea #ELA \n\n@BrainstormCell what about @EMA_News European Medicines Agency?? https://t.co/dltQeoUr5Y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1161920797860081664","created_at":"2019-08-15T08:41:20.000Z","referenced_tweets":[{"type":"quoted","id":"1161893746662957059"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":69,"end":76,"tag":"NurOwn"},{"start":83,"end":91,"tag":"ALSplea"}]},"possibly_sensitive":false,"lang":"en","author_id":"1882365956","id":"1161893746662957059","in_reply_to_user_id":"116716199","text":"@EMA_News Hey!!! Screams from the graves, do you hear us??!! Approve #NurOwn now!! #ALSplea","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":4,"quote_count":1},"conversation_id":"1161893746662957059","created_at":"2019-08-15T06:53:50.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":163,"end":186,"url":"https://t.co/5dIV4Q53aK","expanded_url":"https://buff.ly/2XbWV1j","display_url":"buff.ly/2XbWV1j"},{"start":243,"end":266,"url":"https://t.co/INk91VkimL","expanded_url":"https://twitter.com/CytonBio/status/1161872149466030080/photo/1","display_url":"pic.twitter.com/INk91VkimL"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":188,"end":205,"tag":"Tierarzneimittel"},{"start":206,"end":224,"tag":"RegulatoryAffairs"},{"start":225,"end":242,"tag":"Veterinarmedizin"}]},"possibly_sensitive":false,"lang":"de","author_id":"988381683341766656","id":"1161872149466030080","in_reply_to_user_id":"116716199","text":"@EMA_News zu den CESSP, Innovation Task Force (ITF), Zulassungseinreichungen und Empfehlenswerte Vorgehensweisen nach der Zulassung finden Sie auf Cyton news page https://t.co/5dIV4Q53aK  #Tierarzneimittel #RegulatoryAffairs #Veterinarmedizin https://t.co/INk91VkimL","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1161872149466030080","created_at":"2019-08-15T05:28:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1161872148098691072"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":72,"end":95,"url":"https://t.co/NnTX7AV5fv","expanded_url":"https://twitter.com/alsnewstoday/status/1160945552852508672","display_url":"twitter.com/alsnewstoday/s…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"IMMolecular","id":"174253444"},{"start":23,"end":35,"username":"INFARMED_IP","id":"1392501529"},{"start":62,"end":71,"username":"saude_pt","id":"729607264605241344"}],"hashtags":[{"start":36,"end":46,"tag":"masitinib"},{"start":47,"end":51,"tag":"ELA"},{"start":52,"end":56,"tag":"ALS"},{"start":57,"end":61,"tag":"MND"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1161060007447801862","in_reply_to_user_id":"116716199","text":"@EMA_News @IMMolecular @INFARMED_IP #masitinib #ELA #ALS #MND @saude_pt https://t.co/NnTX7AV5fv","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1161060007447801862","created_at":"2019-08-12T23:40:51.000Z","referenced_tweets":[{"type":"quoted","id":"1160945552852508672"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":44,"end":67,"url":"https://t.co/ck8I7pKitZ","expanded_url":"https://twitter.com/VBeukers/status/1160585488882970625","display_url":"twitter.com/VBeukers/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":26,"end":33,"tag":"NurOwn"},{"start":34,"end":38,"tag":"ALS"},{"start":39,"end":43,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1160585827312967680","in_reply_to_user_id":"116716199","text":"@EMA_News @BrainstormCell #NurOwn #ALS #ELA https://t.co/ck8I7pKitZ","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1160585827312967680","created_at":"2019-08-11T16:16:38.000Z","referenced_tweets":[{"type":"quoted","id":"1160585488882970625"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":129,"end":152,"url":"https://t.co/LtBQiLjCxC","expanded_url":"https://twitter.com/gregkochak/status/1160529907534979072","display_url":"twitter.com/gregkochak/sta…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"IMMolecular","id":"174253444"},{"start":23,"end":32,"username":"saude_pt","id":"729607264605241344"},{"start":33,"end":38,"username":"ansm","id":"2443530930"},{"start":39,"end":50,"username":"FDArecalls","id":"18058609"},{"start":51,"end":67,"username":"FDACommissioner","id":"1113782559194984448"},{"start":68,"end":80,"username":"INFARMED_IP","id":"1392501529"},{"start":81,"end":96,"username":"BrainstormCell","id":"802020620"}],"hashtags":[{"start":97,"end":104,"tag":"NurOwn"},{"start":105,"end":113,"tag":"ALSplea"},{"start":114,"end":118,"tag":"ALS"},{"start":119,"end":123,"tag":"ELA"},{"start":124,"end":128,"tag":"MND"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1160577273898160128","in_reply_to_user_id":"116716199","text":"@EMA_News @IMMolecular @saude_pt @ansm @FDArecalls @FDACommissioner @INFARMED_IP @BrainstormCell #NurOwn #ALSplea #ALS #ELA #MND https://t.co/LtBQiLjCxC","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1160577273898160128","created_at":"2019-08-11T15:42:39.000Z","referenced_tweets":[{"type":"quoted","id":"1160529907534979072"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":46,"end":58,"tag":"SouthAfrica"},{"start":266,"end":277,"tag":"ginnette35"},{"start":284,"end":292,"tag":"diane35"}]},"possibly_sensitive":false,"lang":"en","author_id":"3155270643","id":"1159929272796160007","in_reply_to_user_id":"116716199","text":"@EMA_News These pills are freely available in #SouthAfrica, yet many countries barred them due to the HIGH risk of blood clotting. I personally used these and lost most of my vision in 6 Months, in Roodeport-SA a girl became blind after using these pills as well... #ginnette35 &amp; #diane35","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"299865156375158784","created_at":"2019-08-09T20:47:43.000Z","referenced_tweets":[{"type":"replied_to","id":"299865156375158784"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/3YPpCQLKjA","expanded_url":"https://twitter.com/VBeukers/status/1159767868290080773","display_url":"twitter.com/VBeukers/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":36,"end":51,"username":"BrainstormCell","id":"802020620"},{"start":52,"end":64,"username":"IMMolecular","id":"174253444"},{"start":65,"end":77,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":[{"start":10,"end":14,"tag":"ALS"},{"start":15,"end":19,"tag":"ELA"},{"start":20,"end":27,"tag":"Europe"},{"start":28,"end":35,"tag":"NurOwn"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159778420701696001","in_reply_to_user_id":"116716199","text":"@EMA_News #ALS #ELA #Europe #NurOwn @BrainstormCell @IMMolecular @INFARMED_IP https://t.co/3YPpCQLKjA","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1159778420701696001","created_at":"2019-08-09T10:48:17.000Z","referenced_tweets":[{"type":"quoted","id":"1159767868290080773"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":139,"end":162,"url":"https://t.co/wr2FTLDMo6","expanded_url":"https://twitter.com/Nightline/status/1159675015840829441","display_url":"twitter.com/Nightline/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"US_FDA","id":"208120290"},{"start":18,"end":33,"username":"BrainstormCell","id":"802020620"},{"start":34,"end":46,"username":"IMMolecular","id":"174253444"},{"start":47,"end":56,"username":"saude_pt","id":"729607264605241344"},{"start":57,"end":62,"username":"ansm","id":"2443530930"},{"start":63,"end":75,"username":"RTPNoticias","id":"16451028"},{"start":76,"end":88,"username":"SICNoticias","id":"17163446"},{"start":89,"end":93,"username":"tvi","id":"498086098"},{"start":94,"end":106,"username":"INFARMED_IP","id":"1392501529"},{"start":107,"end":118,"username":"euronewspt","id":"266677514"},{"start":119,"end":128,"username":"euronews","id":"25067168"}],"hashtags":[{"start":129,"end":133,"tag":"ALS"},{"start":134,"end":138,"tag":"ELA"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159776811930259456","in_reply_to_user_id":"116716199","text":"@EMA_News @US_FDA @BrainstormCell @IMMolecular @saude_pt @ansm @RTPNoticias @SICNoticias @tvi @INFARMED_IP @euronewspt @euronews #ALS #ELA https://t.co/wr2FTLDMo6","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1159776811930259456","created_at":"2019-08-09T10:41:54.000Z","referenced_tweets":[{"type":"quoted","id":"1159675015840829441"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":141,"end":164,"url":"https://t.co/APDu5Mvg0A","expanded_url":"https://twitter.com/up_als/status/1159322387797512192","display_url":"twitter.com/up_als/status/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"IMMolecular","id":"174253444"},{"start":23,"end":37,"username":"ChampalimaudF","id":"202211958"},{"start":38,"end":51,"username":"SNS_Portugal","id":"911233786066735105"},{"start":52,"end":61,"username":"saude_pt","id":"729607264605241344"},{"start":62,"end":67,"username":"ansm","id":"2443530930"},{"start":68,"end":80,"username":"INFARMED_IP","id":"1392501529"},{"start":81,"end":92,"username":"euronewspt","id":"266677514"},{"start":93,"end":104,"username":"euronewses","id":"266669687"},{"start":105,"end":116,"username":"euronewsfr","id":"266653632"},{"start":117,"end":132,"username":"BrainstormCell","id":"802020620"},{"start":133,"end":140,"username":"US_FDA","id":"208120290"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159776438418993153","in_reply_to_user_id":"116716199","text":"@EMA_News @IMMolecular @ChampalimaudF @SNS_Portugal @saude_pt @ansm @INFARMED_IP @euronewspt @euronewses @euronewsfr @BrainstormCell @US_FDA https://t.co/APDu5Mvg0A","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1159776438418993153","created_at":"2019-08-09T10:40:25.000Z","referenced_tweets":[{"type":"quoted","id":"1159322387797512192"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":60,"end":83,"url":"https://t.co/jJL5or3ADR","expanded_url":"https://twitter.com/MinoSean/status/1159579785200226304","display_url":"twitter.com/MinoSean/statu…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"saude_pt","id":"729607264605241344"},{"start":20,"end":33,"username":"SNS_Portugal","id":"911233786066735105"},{"start":34,"end":46,"username":"INFARMED_IP","id":"1392501529"},{"start":47,"end":59,"username":"IMMolecular","id":"174253444"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159773791192567809","in_reply_to_user_id":"116716199","text":"@EMA_News @saude_pt @SNS_Portugal @INFARMED_IP @IMMolecular https://t.co/jJL5or3ADR","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1159773791192567809","created_at":"2019-08-09T10:29:54.000Z","referenced_tweets":[{"type":"quoted","id":"1159579785200226304"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":88,"end":111,"url":"https://t.co/VkC6k0cs3R","expanded_url":"https://twitter.com/tekaywalk/status/1159516971756638208","display_url":"twitter.com/tekaywalk/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":25,"username":"BrainstormCell","id":"802020620"},{"start":26,"end":33,"username":"US_FDA","id":"208120290"},{"start":42,"end":51,"username":"saude_pt","id":"729607264605241344"},{"start":52,"end":63,"username":"euronewspt","id":"266677514"},{"start":64,"end":75,"username":"euronewses","id":"266669687"},{"start":76,"end":87,"username":"euronewsfr","id":"266653632"}],"hashtags":[{"start":34,"end":41,"tag":"europe"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159600573831962624","in_reply_to_user_id":"116716199","text":"@EMA_News @BrainstormCell @US_FDA #europe @saude_pt @euronewspt @euronewses @euronewsfr https://t.co/VkC6k0cs3R","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1159600573831962624","created_at":"2019-08-08T23:01:35.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":148,"end":171,"url":"https://t.co/LKlyDgUJS9","expanded_url":"https://twitter.com/bsw5020/status/1159509696128192515","display_url":"twitter.com/bsw5020/status…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"IMMolecular","id":"174253444"},{"start":23,"end":35,"username":"INFARMED_IP","id":"1392501529"},{"start":36,"end":48,"username":"SICNoticias","id":"17163446"},{"start":49,"end":61,"username":"RTPNoticias","id":"16451028"},{"start":71,"end":82,"username":"euronewspt","id":"266677514"},{"start":83,"end":94,"username":"euronewses","id":"266669687"},{"start":95,"end":106,"username":"euronewsfr","id":"266653632"},{"start":107,"end":122,"username":"BrainstormCell","id":"802020620"},{"start":123,"end":130,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":131,"end":139,"tag":"alsplea"},{"start":140,"end":147,"tag":"nurown"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159599689680990211","in_reply_to_user_id":"116716199","text":"@EMA_News @IMMolecular @INFARMED_IP @SICNoticias @RTPNoticias @tvi24pt @euronewspt @euronewses @euronewsfr @BrainstormCell @US_FDA #alsplea #nurown https://t.co/LKlyDgUJS9","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1159599689680990211","created_at":"2019-08-08T22:58:04.000Z","referenced_tweets":[{"type":"quoted","id":"1159509696128192515"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":187,"end":210,"url":"https://t.co/jfNSCOYcJP","expanded_url":"https://twitter.com/FinishALS/status/1159597018341355522","display_url":"twitter.com/FinishALS/stat…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"saude_pt","id":"729607264605241344"},{"start":20,"end":33,"username":"SNS_Portugal","id":"911233786066735105"},{"start":34,"end":46,"username":"INFARMED_IP","id":"1392501529"},{"start":47,"end":59,"username":"SICNoticias","id":"17163446"},{"start":69,"end":81,"username":"RTPNoticias","id":"16451028"},{"start":82,"end":97,"username":"BrainstormCell","id":"802020620"},{"start":98,"end":105,"username":"US_FDA","id":"208120290"},{"start":106,"end":118,"username":"IMMolecular","id":"174253444"},{"start":119,"end":131,"username":"Europarl_PT","id":"40872043"},{"start":132,"end":143,"username":"euronewspt","id":"266677514"},{"start":144,"end":155,"username":"euronewses","id":"266669687"},{"start":156,"end":167,"username":"euronewsfr","id":"266653632"}],"hashtags":[{"start":168,"end":177,"tag":"Portugal"},{"start":178,"end":186,"tag":"alsplea"}]},"possibly_sensitive":false,"lang":"und","author_id":"1156472560391020544","id":"1159599019120824327","in_reply_to_user_id":"116716199","text":"@EMA_News @saude_pt @SNS_Portugal @INFARMED_IP @SICNoticias @tvi24pt @RTPNoticias @BrainstormCell @US_FDA @IMMolecular @Europarl_PT @euronewspt @euronewses @euronewsfr #Portugal #alsplea https://t.co/jfNSCOYcJP","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1159599019120824327","created_at":"2019-08-08T22:55:25.000Z","referenced_tweets":[{"type":"quoted","id":"1159597018341355522"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":17,"end":19,"probability":0.9745,"type":"Place","normalized_text":"USA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"20174215","id":"1159455410031681537","in_reply_to_user_id":"116716199","text":"@EMA_News Should USA residents complete the survey?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1159443792094814208","created_at":"2019-08-08T13:24:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1159443792094814208"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":89,"end":112,"url":"https://t.co/eW0XxnwdtD","expanded_url":"https://seekingalpha.com/news/3487457-ema-accepts-allergan-application-abicipar-neovascular-amd","display_url":"seekingalpha.com/news/3487457-e…"}],"annotations":[{"start":10,"end":33,"probability":0.4546,"type":"Organization","normalized_text":"EuropeanMedicines Agency"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3059013257","id":"1159206169073934336","in_reply_to_user_id":"116716199","text":"@EMA_News EuropeanMedicines Agency accepts @Allergan  application for abicipar for nAMD. https://t.co/eW0XxnwdtD","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1159206169073934336","created_at":"2019-08-07T20:54:22.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":249,"end":272,"url":"https://t.co/He27PYtMTn","expanded_url":"http://cort.as/-MSrp","display_url":"cort.as/-MSrp"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2184775389","id":"1158445062801559567","in_reply_to_user_id":"116716199","text":"@EMA_News EMA Recommends Extension of Indications for:\n\n\"Elotuzumab, plus pomalidomide and dexamethasone, for patients with relapsed and refractory MM who have received at least two prior therapies including lenalidomide and a proteasome inhibitor\" https://t.co/He27PYtMTn","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1158445062801559567","created_at":"2019-08-05T18:30:00.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":171,"end":194,"url":"https://t.co/He27PYtMTn","expanded_url":"http://cort.as/-MSrp","display_url":"cort.as/-MSrp"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2184775389","id":"1158434400889200641","in_reply_to_user_id":"116716199","text":"@EMA_News EMA Recommends Extension of Indications for:\n\n\"Pembrolizumab, in combination with axitinib, is indicated for the first-line treatment of advanced RCC in adults\" https://t.co/He27PYtMTn","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1158434400889200641","created_at":"2019-08-05T17:47:38.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"866025998768328705","id":"1158339557676519426","in_reply_to_user_id":"116716199","text":"@EMA_News Excellent! Glad to see this is moving :)","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1158338821320249344","created_at":"2019-08-05T11:30:46.000Z","referenced_tweets":[{"type":"replied_to","id":"1158338821320249344"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/c2GQ75wsYy","expanded_url":"https://tinyurl.com/yxs5job2","display_url":"tinyurl.com/yxs5job2"},{"start":125,"end":148,"url":"https://t.co/W3SNVX0uKU","expanded_url":"https://twitter.com/onmedicanews/status/1157992120990470144/photo/1","display_url":"pic.twitter.com/W3SNVX0uKU"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"42178750","id":"1157992120990470144","in_reply_to_user_id":"116716199","text":"@EMA_News updates restrictions for Gilenya, a multiple sclerosis medicine, for use during pregnancy: https://t.co/c2GQ75wsYy https://t.co/W3SNVX0uKU","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1157992120990470144","created_at":"2019-08-04T12:30:10.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1157992118914359297"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":199,"end":222,"url":"https://t.co/jYe8amvtih","expanded_url":"https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-quality-requirements-drug-device-combinations_en.pdf","display_url":"ema.europa.eu/en/documents/s…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1157399762062192640","in_reply_to_user_id":"116716199","text":"@EMA_News has published a draft guideline on quality requirements for combinations of medicinal products and medical devices (so-called Drug Device Combinations - DDCs). What does the draft contain? https://t.co/jYe8amvtih","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1157399762062192640","created_at":"2019-08-02T21:16:21.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"188726957","id":"1157273964441247749","in_reply_to_user_id":"116716199","text":"@EMA_News @EPFyouth spread this to your networks!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1157253963336617984","created_at":"2019-08-02T12:56:28.000Z","referenced_tweets":[{"type":"replied_to","id":"1157253963336617984"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":205,"end":228,"url":"https://t.co/qyUmEPjQaS","expanded_url":"https://lnkd.in/dc5iwEp","display_url":"lnkd.in/dc5iwEp"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":230,"end":239,"username":"begisare","id":"2204586601"},{"start":240,"end":253,"username":"retinamadrid","id":"923097527167193088"},{"start":254,"end":264,"username":"retinosis","id":"49289968"},{"start":265,"end":280,"username":"retinosisfarpe","id":"1073608856"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"136026441","id":"1157209845180882945","in_reply_to_user_id":"116716199","text":"@EMA_News paediatric committee (PDCO) wants to hear the views of young patients with X-linked retinitis pigmentosa, a rare eye disease, on a potential new gene therapy. Fill in the survey until 16 August: https://t.co/qyUmEPjQaS  @begisare @retinamadrid @retinosis @retinosisfarpe","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1157209845180882945","created_at":"2019-08-02T08:41:41.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":58,"end":81,"url":"https://t.co/nEXjQc3ST0","expanded_url":"https://www.deutsche-apotheker-zeitung.de/news/artikel/2019/07/30/umzug-innerhalb-amsterdams-verzoegert-sich","display_url":"deutsche-apotheker-zeitung.de/news/artikel/2…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"de","author_id":"2789645880","id":"1156519803844255744","in_reply_to_user_id":"116716199","text":"@EMA_News: Der Umzug innerhalb Amsterdams verzögert sich. https://t.co/nEXjQc3ST0","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1156519803844255744","created_at":"2019-07-31T10:59:42.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":191,"end":214,"url":"https://t.co/JsYEO4TgDo","expanded_url":"http://ow.ly/pK2E30pfR9c","display_url":"ow.ly/pK2E30pfR9c"}],"annotations":[{"start":49,"end":57,"probability":0.2449,"type":"Other","normalized_text":"Tecentriq"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":79,"end":91,"username":"Roche_spain","id":"1216714503863373824"},{"start":94,"end":100,"username":"Roche","id":"20815041"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1156470914952957952","in_reply_to_user_id":"116716199","text":"@EMA_News  ha emitido una opinión positiva para 'Tecentriq' (atezolizumab), de @Roche_spain   @Roche   combinado con quimioterapia como primera línea en cáncer de pulmón de células pequeñas.\nhttps://t.co/JsYEO4TgDo","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1156470914952957952","created_at":"2019-07-31T07:45:26.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":107,"end":130,"url":"https://t.co/bLQy0C7Tfx","expanded_url":"http://ow.ly/l0xe30pfgC6","display_url":"ow.ly/l0xe30pfgC6"}],"annotations":[{"start":75,"end":80,"probability":0.9907,"type":"Place","normalized_text":"Europa"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}]},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1156114534865821696","in_reply_to_user_id":"116716199","text":"@EMA_News Opinión positiva de #CHMP  para larotrectinib, primer fármaco en Europa con indicación agnóstica\nhttps://t.co/bLQy0C7Tfx","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1156114534865821696","created_at":"2019-07-30T08:09:19.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":19,"end":42,"url":"https://t.co/WdzLQMCrDr","expanded_url":"https://www.amazon.co.uk/dp/1912639610/","display_url":"amazon.co.uk/dp/1912639610/"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"TheHPRA","id":"780795318778470400"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"145703465","id":"1155913989739753472","in_reply_to_user_id":"116716199","text":"@EMA_News @TheHPRA https://t.co/WdzLQMCrDr TBI=Groundhog day memory probs. Twitter augments my memory for engagement daily. 25+ yrs on 2017 breast cancer so I wrote book. Don't lose hope as u lose memory; life can be easier because u can't recall. email td said book shd be read by medical students","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1151493684145328129","created_at":"2019-07-29T18:52:25.000Z","referenced_tweets":[{"type":"replied_to","id":"1151493684145328129"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":70,"end":93,"url":"https://t.co/nMT5BdiFqX","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155727647508320257/photo/1","display_url":"pic.twitter.com/nMT5BdiFqX"}],"annotations":[{"start":28,"end":41,"probability":0.6281,"type":"Place","normalized_text":"United Kingdom"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":59,"end":69,"username":"MHRAgovuk","id":"330993102"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1155727647508320257","in_reply_to_user_id":"116716199","text":"@EMA_News CHMP members from United Kingdom regulatory body @MHRAgovuk https://t.co/nMT5BdiFqX","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155727647508320257","created_at":"2019-07-29T06:31:58.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155727631607746561"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4849]}}},{"entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/HFSTvo6G89","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155727217449566208/photo/1","display_url":"pic.twitter.com/HFSTvo6G89"}],"annotations":[{"start":28,"end":34,"probability":0.9736,"type":"Place","normalized_text":"Germany"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":52,"end":58,"tag":"bfArM"}]},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1155727217449566208","in_reply_to_user_id":"116716199","text":"@EMA_News CHMP members from Germany regulatory body #bfArM https://t.co/HFSTvo6G89","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155727217449566208","created_at":"2019-07-29T06:30:15.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155727202836602880"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4849]}}},{"entities":{"urls":[{"start":41,"end":64,"url":"https://t.co/740hvq4776","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155726925987377152/photo/1","display_url":"pic.twitter.com/740hvq4776"}],"annotations":[{"start":28,"end":33,"probability":0.9812,"type":"Place","normalized_text":"France"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":35,"end":40,"username":"ansm","id":"2443530930"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1155726925987377152","in_reply_to_user_id":"116716199","text":"@EMA_News CHMP members from France @ansm https://t.co/740hvq4776","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155726925987377152","created_at":"2019-07-29T06:29:06.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155726914100662273"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4849]}}},{"entities":{"urls":[{"start":59,"end":82,"url":"https://t.co/wTAUpiTOMf","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155726467252146177/photo/1","display_url":"pic.twitter.com/wTAUpiTOMf"}],"annotations":[{"start":28,"end":34,"probability":0.9167,"type":"Place","normalized_text":"Austria"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1155726467252146177","in_reply_to_user_id":"116716199","text":"@EMA_News CHMP members from Austria regulatory body (AGES) https://t.co/wTAUpiTOMf","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155726467252146177","created_at":"2019-07-29T06:27:16.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155726455239614466"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4849]}}},{"entities":{"urls":[{"start":36,"end":59,"url":"https://t.co/0cLnoRmmdw","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155725806519275523/photo/1","display_url":"pic.twitter.com/0cLnoRmmdw"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1155725806519275523","in_reply_to_user_id":"116716199","text":"@EMA_News CHMP Chair and Vice chair https://t.co/0cLnoRmmdw","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155725806519275523","created_at":"2019-07-29T06:24:39.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155725795362369537"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4848]}}},{"entities":{"urls":[{"start":37,"end":60,"url":"https://t.co/lYnPRxyC49","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155721485975052288/photo/1","display_url":"pic.twitter.com/lYnPRxyC49"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"ro","author_id":"839985545287720965","id":"1155721485975052288","in_reply_to_user_id":"116716199","text":"@EMA_News Executive Director profile https://t.co/lYnPRxyC49","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155721485975052288","created_at":"2019-07-29T06:07:29.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155721471257300993"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4849]}}},{"entities":{"urls":[{"start":40,"end":63,"url":"https://t.co/vP2ISjILGu","expanded_url":"https://twitter.com/KNReddy_Trump/status/1155720702520991751/photo/1","display_url":"pic.twitter.com/vP2ISjILGu"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1155720702520991751","in_reply_to_user_id":"116716199","text":"@EMA_News Cahir and Vice-Chair contacts https://t.co/vP2ISjILGu","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1155720702520991751","created_at":"2019-07-29T06:04:22.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1155720692148498432"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4849]}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"943184736003993601","id":"1154987348666605568","in_reply_to_user_id":"116716199","text":"@EMA_News Very good news for our Young patients.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1154704162447384576","created_at":"2019-07-27T05:30:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1154704162447384576"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/uf7ts5OB6Y","expanded_url":"https://bit.ly/32SXcuj","display_url":"bit.ly/32SXcuj"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"277963374","id":"1154764747436449793","in_reply_to_user_id":"116716199","text":"@EMA_News recomienda aprobar cinco nuevos medicamentos, uno de ellos genérico https://t.co/uf7ts5OB6Y","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1154764747436449793","created_at":"2019-07-26T14:45:44.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":213,"end":236,"url":"https://t.co/2JmKU6qxsM","expanded_url":"https://buff.ly/2LXuL8z","display_url":"buff.ly/2LXuL8z"},{"start":280,"end":303,"url":"https://t.co/LBSCKLuDyY","expanded_url":"https://twitter.com/CytonBio/status/1154711748349501442/photo/1","display_url":"pic.twitter.com/LBSCKLuDyY"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":87,"end":106,"tag":"VeterinaryMedicine"},{"start":237,"end":248,"tag":"Regulation"},{"start":249,"end":260,"tag":"veterinary"},{"start":261,"end":279,"tag":"RegulatoryAffairs"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1154711748349501442","in_reply_to_user_id":"116716199","text":"@EMA_News has published a series of updated life-cycle management Q&amp;A webpages for #VeterinaryMedicine and there have been developments on the new veterinary regulation. Read the details on Cyton's news feed. https://t.co/2JmKU6qxsM #Regulation #veterinary #RegulatoryAffairs https://t.co/LBSCKLuDyY","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1154711748349501442","created_at":"2019-07-26T11:15:08.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1154711747154108416"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":178,"end":201,"url":"https://t.co/P7b2HVrzgP","expanded_url":"https://twitter.com/cancereu/status/1154661821166604289/photo/1","display_url":"pic.twitter.com/P7b2HVrzgP"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"140344419","id":"1154661821166604289","in_reply_to_user_id":"116716199","text":"@EMA_News set up their public engagement department to involve patients, consumers, academics and health care professionals in their work. Check out what they have been up to! 👇 https://t.co/P7b2HVrzgP","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1154661821166604289","created_at":"2019-07-26T07:56:45.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":["3_1154661814690615296"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":101,"end":124,"url":"https://t.co/3bvbMe9s8n","expanded_url":"https://www.ema.europa.eu/en/documents/referral/cyproterone-article-31-referral-review-started_en.pdf","display_url":"ema.europa.eu/en/documents/r…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"fr","author_id":"1108738606435323904","id":"1153766970594136064","in_reply_to_user_id":"116716199","text":"@EMA_News l'EMA (agence européenne du médicament) fait ENFIN une alerte sur l'acétate de cyprotérone\nhttps://t.co/3bvbMe9s8n","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1153766970594136064","created_at":"2019-07-23T20:40:56.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":159,"end":182,"url":"https://t.co/1gbL2RGBvH","expanded_url":"https://www.ema.europa.eu/en/documents/leaflet/public-engagement-highlights-2018_en.pdf","display_url":"ema.europa.eu/en/documents/l…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":28,"tag":"patients"},{"start":30,"end":40,"tag":"consumers"},{"start":42,"end":53,"tag":"healthcare"},{"start":73,"end":83,"tag":"academics"}]},"possibly_sensitive":false,"lang":"en","author_id":"850008375710674944","id":"1153384425306120198","in_reply_to_user_id":"116716199","text":"@EMA_News involves #patients, #consumers, #healthcare professionals, and #academics in its daily work. What were the highlights of this collaboration in 2018? https://t.co/1gbL2RGBvH","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1153384425306120198","created_at":"2019-07-22T19:20:50.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":188,"end":211,"url":"https://t.co/5rZ9iv4RFP","expanded_url":"https://www.businesswire.com/news/home/20190719005133/en/Janssen-Seeks-EMA-Approval-Subcutaneous-Formulation-DARZALEX%C2%AE%E2%96%BC#.XTLUJrHkPW0.twitter","display_url":"businesswire.com/news/home/2019…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"HematonNL","id":"1011249745"},{"start":21,"end":35,"username":"MyelomaEurope","id":"1277121884"},{"start":55,"end":67,"username":"Janssen_Ned","id":"3147810000"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"161378850","id":"1152501141755875332","in_reply_to_user_id":"116716199","text":"@EMA_News @HematonNL @MyelomaEurope How can we support @Janssen_Ned to make the the subcutaneous admission as soon as possible available for patients: Safer, More Qualiy of Life, Cheaper: https://t.co/5rZ9iv4RFP","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"1152501141755875332","created_at":"2019-07-20T08:50:59.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":12,"end":35,"url":"https://t.co/2mmlYh7H9a","expanded_url":"https://twitter.com/GavinGiovannoni/status/1151854483753840640","display_url":"twitter.com/GavinGiovannon…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1618555326","id":"1152004235044646912","in_reply_to_user_id":"116716199","text":"@EMA_News ? https://t.co/2mmlYh7H9a","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1152004235044646912","created_at":"2019-07-18T23:56:27.000Z","referenced_tweets":[{"type":"quoted","id":"1151854483753840640"}],"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":162,"end":185,"url":"https://t.co/pWyyk6Q0Y8","expanded_url":"https://buff.ly/2lvUGZA","display_url":"buff.ly/2lvUGZA"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":255,"end":267,"username":"zebra_trans","id":"879356361720680448"}],"hashtags":[{"start":186,"end":190,"tag":"SPC"},{"start":191,"end":195,"tag":"LSP"},{"start":196,"end":200,"tag":"xl8"},{"start":201,"end":208,"tag":"medxl8"},{"start":209,"end":213,"tag":"t9n"},{"start":214,"end":219,"tag":"l10n"},{"start":220,"end":227,"tag":"pharma"},{"start":228,"end":241,"tag":"multilingual"},{"start":242,"end":254,"tag":"zebra_trans"},{"start":268,"end":280,"tag":"newprojects"}]},"possibly_sensitive":false,"lang":"en","author_id":"879356361720680448","id":"1151461703785336834","in_reply_to_user_id":"116716199","text":"@EMA_News has released a new QRD template version. Please make sure to download the appropriate version for your language combination\nNew version available here: https://t.co/pWyyk6Q0Y8\n#SPC #LSP #xl8 #medxl8 #t9n #l10n #pharma #multilingual #zebra_trans @zebra_trans #newprojects","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1151461703785336834","created_at":"2019-07-17T12:00:37.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":176,"end":199,"url":"https://t.co/TMCm3f5eQY","expanded_url":"https://buff.ly/2L1fG5r","display_url":"buff.ly/2L1fG5r"},{"start":219,"end":242,"url":"https://t.co/j9rbUd56j8","expanded_url":"https://twitter.com/CytonBio/status/1150762697421656064/photo/1","display_url":"pic.twitter.com/j9rbUd56j8"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":154,"end":174,"tag":"VeterinaryMedicines"},{"start":200,"end":218,"tag":"RegulatoryAffairs"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1150762697421656064","in_reply_to_user_id":"116716199","text":"@EMA_News has issued an extensively updated Q &amp; A document on post-authorisation measures (recommendations, conditions and  specific obligations) for #VeterinaryMedicines. https://t.co/TMCm3f5eQY #RegulatoryAffairs https://t.co/j9rbUd56j8","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1150762697421656064","created_at":"2019-07-15T13:43:01.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1150762695173521408"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":302,"end":325,"url":"https://t.co/9th2f60XlL","expanded_url":"https://twitter.com/KNReddy_Trump/status/1149960256660750343/photo/1","display_url":"pic.twitter.com/9th2f60XlL"}],"annotations":[{"start":45,"end":55,"probability":0.986,"type":"Person","normalized_text":"Guido Rassi"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":26,"end":42,"username":"FDACommissioner","id":"1113782559194984448"},{"start":265,"end":272,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":279,"end":283,"tag":"EMA"}]},"possibly_sensitive":false,"lang":"en","author_id":"839985545287720965","id":"1149960256660750343","in_reply_to_user_id":"116716199","text":"@EMA_News Congratulations @FDACommissioner &amp; Guido Rassi for MRA. I hope this will decrease the over burden of inspections on both the organisations. And also it will reduce the duplication of work.\n\nFocus on Mutual Regultory guidelines of GMP &amp; GCP by the @US_FDA &amp; #EMA\n\nAll the best🇺🇸🇪🇺 https://t.co/9th2f60XlL","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1149669852975489027","created_at":"2019-07-13T08:34:25.000Z","referenced_tweets":[{"type":"replied_to","id":"1149669852975489027"}],"source":"Twitter for Android","attachments":{"media_keys":["3_1149960250235092992"]},"geo":{"place_id":"07d9d12cb1888001","coordinates":{"type":"Point","coordinates":[78.5606,17.4848]}}},{"entities":{"urls":[{"start":125,"end":148,"url":"https://t.co/qDHdo03Lmw","expanded_url":"https://buff.ly/2FegXCo","display_url":"buff.ly/2FegXCo"},{"start":168,"end":191,"url":"https://t.co/MUvlNNX7sw","expanded_url":"https://twitter.com/CytonBio/status/1149188577038884870/photo/1","display_url":"pic.twitter.com/MUvlNNX7sw"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":103,"end":123,"tag":"VeterinaryMedicines"},{"start":149,"end":167,"tag":"RegulatoryAffairs"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1149188577038884870","in_reply_to_user_id":"116716199","text":"@EMA_News has issued an extensively updated Q &amp; A document on marketing authorisation renewals for #VeterinaryMedicines. https://t.co/qDHdo03Lmw #RegulatoryAffairs https://t.co/MUvlNNX7sw","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1149188577038884870","created_at":"2019-07-11T05:28:02.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1149188575482826752"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":123,"end":146,"url":"https://t.co/s4xley4PHR","expanded_url":"https://www.cochrane.org/news/cochrane-supports-european-regulators-they-urge-clinical-trial-sponsors-share-their-results","display_url":"cochrane.org/news/cochrane-…"},{"start":147,"end":170,"url":"https://t.co/0dbEBd82QS","expanded_url":"https://twitter.com/CochraneLibrary/status/1148973756838268928/photo/1","display_url":"pic.twitter.com/0dbEBd82QS"}],"annotations":[{"start":25,"end":32,"probability":0.5845,"type":"Organization","normalized_text":"Cochrane"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"20520810","id":"1148973756838268928","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission Cochrane supports European regulators as they urge clinical trial sponsors to share their results https://t.co/s4xley4PHR https://t.co/0dbEBd82QS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1146391046877851648","created_at":"2019-07-10T15:14:25.000Z","referenced_tweets":[{"type":"replied_to","id":"1146391046877851648"}],"source":"Twitter Web Client","attachments":{"media_keys":["3_1148973563157917696"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":149,"end":172,"url":"https://t.co/AJFjd2LjjG","expanded_url":"https://twitter.com/IAPOvoice/status/1148911312384249856/photo/1","display_url":"pic.twitter.com/AJFjd2LjjG"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":34,"end":55,"tag":"InternationalAffiars"},{"start":56,"end":60,"tag":"EMA"},{"start":62,"end":89,"tag":"MutualRegulatoryAgreements"},{"start":98,"end":112,"tag":"patientsafety"},{"start":117,"end":124,"tag":"access"},{"start":137,"end":147,"tag":"suffering"}]},"possibly_sensitive":false,"lang":"en","author_id":"180728609","id":"1148911312384249856","in_reply_to_user_id":"116716199","text":"@EMA_News @AgnesSaintRaymond head #InternationalAffiars #EMA. #MutualRegulatoryAgreements improve #patientsafety and #access and prevent #suffering. https://t.co/AJFjd2LjjG","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1148911312384249856","created_at":"2019-07-10T11:06:17.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1148911296005509120"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":[{"start":26,"end":40,"probability":0.7573,"type":"Person","normalized_text":"jitendra Dsouza"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"2151280290","id":"1147189801776402432","in_reply_to_user_id":"116716199","text":"@EMA_News  hii my name is jitendra Dsouza ..\nI am 26 now . i am suffering from keretoconus from last 17 to 18 Years..\nI am searching for LENS SOLUTION ...the name is CONSOL GP .i am not getting it any where .i want it   And i will pay for it.\nPls contact me on +91 7666660600","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1147189801776402432","created_at":"2019-07-05T17:05:37.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"place_id":"7929cea6bd5b32bd","coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"inspire2live","id":"83431239"},{"start":24,"end":34,"username":"HematonNL","id":"1011249745"},{"start":228,"end":237,"username":"mvmateos","id":"2239926566"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"161378850","id":"1146678707366563841","in_reply_to_user_id":"116716199","text":"@EMA_News @inspire2live @HematonNL My hemato-incologist cannot give my my Daratumumab subcutaneous because it is not yet allowed due to regulations. Please do something about that. It is effective and safe: @EHA presentation by @mvmateos⁩ with details from the COLUMBO trial","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1146678707366563841","created_at":"2019-07-04T07:14:42.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":126,"end":149,"url":"https://t.co/FW8I9OmE3K","expanded_url":"https://buff.ly/2KWgZ5C","display_url":"buff.ly/2KWgZ5C"},{"start":169,"end":192,"url":"https://t.co/t47UGmChjO","expanded_url":"https://twitter.com/CytonBio/status/1146651861925208064/photo/1","display_url":"pic.twitter.com/t47UGmChjO"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":104,"end":124,"tag":"VeterinaryMedicines"},{"start":150,"end":168,"tag":"RegulatoryAffairs"}]},"possibly_sensitive":false,"lang":"en","author_id":"988381683341766656","id":"1146651861925208064","in_reply_to_user_id":"116716199","text":"@EMA_News has issued an extensively updated Q &amp; A document on marketing authorisation transfers for #VeterinaryMedicines. https://t.co/FW8I9OmE3K #RegulatoryAffairs https://t.co/t47UGmChjO","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1146651861925208064","created_at":"2019-07-04T05:28:02.000Z","referenced_tweets":{},"source":"Buffer","attachments":{"media_keys":["3_1146651859970600961"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"johncoxnuig","id":"825691208479563776"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1603548319","id":"1146514030321983490","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @johncoxnuig more extrinsic motivators!","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1146391046877851648","created_at":"2019-07-03T20:20:20.000Z","referenced_tweets":[{"type":"replied_to","id":"1146391046877851648"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1144598523184406528","id":"1146481183334764544","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission That’s wonderful. But why does European Medicines Agencies not consistently grant access to clinical study reports? Currently, some do. EMA does. Others don’t. All should. Because drug appeoval from one European Medicines Agency affect all EU.","public_metrics":{"retweet_count":4,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"1146391046877851648","created_at":"2019-07-03T18:09:49.000Z","referenced_tweets":[{"type":"replied_to","id":"1146391046877851648"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":164,"end":187,"url":"https://t.co/vpWxRPMcqA","expanded_url":"https://www.clinicaltrialsregister.eu/ctr-search/search?query=melanoma&status=completed","display_url":"clinicaltrialsregister.eu/ctr-search/sea…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"810969654","id":"1146470600254414849","in_reply_to_user_id":"116716199","text":"@EMA_News pity that the text download of trial search results doesn't include the field 'published results'- would make it WAY easier to track the non-publishers!! https://t.co/vpWxRPMcqA","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1146470600254414849","created_at":"2019-07-03T17:27:46.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1106307201273073667","id":"1146468890693832704","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission All clinical trials should be registered before they take place! Now industry can make bad trials just disappear! WHEN WILL THIS UPGRADE TAKE PLACE?","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"1146391046877851648","created_at":"2019-07-03T17:20:58.000Z","referenced_tweets":[{"type":"replied_to","id":"1146391046877851648"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1714991388","id":"1146166819004264454","in_reply_to_user_id":"116716199","text":"@EMA_News Do you have a document of the estimated saving EU countries make by having a common agency rather the doing your work each themselves?","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1146166819004264454","created_at":"2019-07-02T21:20:39.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":200,"end":223,"url":"https://t.co/Anxl7rwy3v","expanded_url":"http://ow.ly/qYss30p2tPS","display_url":"ow.ly/qYss30p2tPS"}],"annotations":[{"start":146,"end":175,"probability":0.4049,"type":"Other","normalized_text":"EMA Regulatory Science to 2025"},{"start":178,"end":197,"probability":0.4751,"type":"Organization","normalized_text":"Strategic Reflection"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"22400139","id":"1145600220308398081","in_reply_to_user_id":"116716199","text":"@EMA_News : último llamamiento a las partes interesadas para que contribuyan a la reflexión, tras la presentación a finales de 2018 el documento 'EMA Regulatory Science to 2025. Strategic Reflection\"\nhttps://t.co/Anxl7rwy3v","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1145600220308398081","created_at":"2019-07-01T07:49:11.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":146,"end":169,"url":"https://t.co/8sebppOEzH","expanded_url":"https://twitter.com/PrimaryCare4um/status/1144612229804896256/photo/1","display_url":"pic.twitter.com/8sebppOEzH"}],"annotations":[{"start":10,"end":20,"probability":0.9373,"type":"Person","normalized_text":"Ivana Silva"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":95,"end":110,"username":"PrimaryCare4um","id":"164835748"},{"start":111,"end":123,"username":"WoncaEurope","id":"708589971079307266"}],"hashtags":[{"start":25,"end":41,"tag":"WONCAEurope2019"},{"start":82,"end":94,"tag":"primarycare"}]},"possibly_sensitive":false,"lang":"en","author_id":"164835748","id":"1144612229804896256","in_reply_to_user_id":"116716199","text":"@EMA_News Ivana Silva at #WONCAEurope2019 to present the collaboration with GP/FM #primarycare @PrimaryCare4um @WoncaEurope &amp; @UEMOPresidency https://t.co/8sebppOEzH","public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1144612229804896256","created_at":"2019-06-28T14:23:16.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1144612213854003201"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":171,"end":194,"url":"https://t.co/e1b0uWGg2m","expanded_url":"https://twitter.com/NathalieMoll/status/1144261309241942016/photo/1","display_url":"pic.twitter.com/e1b0uWGg2m"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":164,"end":170,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":142,"end":163,"tag":"ConnectingHealthcare"}]},"possibly_sensitive":false,"lang":"en","author_id":"3293090771","id":"1144261309241942016","in_reply_to_user_id":"116716199","text":"@EMA_News 4 actions 2 drive excellence in regulation: listening 2 stakeholders; learning from science; enabling innovation;  embracing change #ConnectingHealthcare @EFPIA https://t.co/e1b0uWGg2m","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1144261309241942016","created_at":"2019-06-27T15:08:50.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1144261302682038273"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":118,"end":141,"url":"https://t.co/JM1IKeBdAO","expanded_url":"https://twitter.com/NathalieMoll/status/1144260150888456194/photo/1","display_url":"pic.twitter.com/JM1IKeBdAO"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":88,"end":94,"username":"EFPIA","id":"52084584"}],"hashtags":[{"start":66,"end":87,"tag":"ConnectingHealthcare"}]},"possibly_sensitive":false,"lang":"en","author_id":"3293090771","id":"1144260150888456194","in_reply_to_user_id":"116716199","text":"@EMA_News as enabler of patient access by connecting stakeholders #ConnectingHealthcare @EFPIA annual conference 2019 https://t.co/JM1IKeBdAO","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1144260150888456194","created_at":"2019-06-27T15:04:13.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1144260146538983425"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":244,"end":267,"url":"https://t.co/sgnuOza039","expanded_url":"https://www.ema.europa.eu/en/about-us/careers","display_url":"ema.europa.eu/en/about-us/ca…"}],"annotations":[{"start":106,"end":128,"probability":0.3665,"type":"Organization","normalized_text":"Management Board of EMA"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"741404372","id":"1144163454862929920","in_reply_to_user_id":"116716199","text":"@EMA_News is looking for a new boss-Deadline extended to July 4! \"The Exec. Dir. will be appointed by the Management Board of EMA on the basis of a list drawn up by the EC, after having made a statement to and answering questions from the EP.\"\nhttps://t.co/sgnuOza039","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1144163454862929920","created_at":"2019-06-27T08:39:59.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":10,"end":33,"url":"https://t.co/L7EAAah13U","expanded_url":"https://twitter.com/claraalonso30/status/1143780106642571264?s=21","display_url":"twitter.com/claraalonso30/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":true,"lang":"und","author_id":"1083400308104011777","id":"1143780314906603521","in_reply_to_user_id":"116716199","text":"@EMA_News https://t.co/L7EAAah13U","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1143174440391467011","created_at":"2019-06-26T07:17:32.000Z","referenced_tweets":[{"type":"quoted","id":"1143780106642571264"},{"type":"replied_to","id":"1143174440391467011"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":240,"end":263,"url":"https://t.co/OtbLMPZn7o","expanded_url":"https://www.funda.nl/koop/amstelveen/huis-86657517-specht-24/","display_url":"funda.nl/koop/amstelvee…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":29,"end":39,"username":"expathelp","id":"133943422"},{"start":40,"end":51,"username":"expatsblog","id":"834055856"},{"start":59,"end":71,"username":"IntlSchAmst","id":"3158808324"},{"start":109,"end":120,"username":"amstelveen","id":"17657095"},{"start":126,"end":137,"username":"HelloExpat","id":"3438045963"},{"start":138,"end":147,"username":"iamexpat","id":"1232040100491595781"}],"hashtags":[{"start":10,"end":17,"tag":"zuidas"},{"start":18,"end":28,"tag":"amsterdam"},{"start":52,"end":58,"tag":"expat"},{"start":72,"end":81,"tag":"schiphol"},{"start":82,"end":87,"tag":"home"},{"start":88,"end":108,"tag":"internationalschool"},{"start":121,"end":125,"tag":"WTC"},{"start":148,"end":152,"tag":"EMA"},{"start":153,"end":161,"tag":"forsale"},{"start":162,"end":169,"tag":"nature"},{"start":170,"end":176,"tag":"woods"},{"start":177,"end":191,"tag":"HomeSweetHome"},{"start":192,"end":198,"tag":"funda"},{"start":233,"end":239,"tag":"funda"}]},"possibly_sensitive":false,"lang":"nl","author_id":"48254736","id":"1143523243476865025","in_reply_to_user_id":"116716199","text":"@EMA_News #zuidas #amsterdam @expathelp @expatsblog #expat @IntlSchAmst #schiphol #home #internationalschool @amstelveen #WTC @HelloExpat @IamExpat #EMA #forsale #nature #woods #HomeSweetHome #funda Woning gevonden in Amstelveen via #funda https://t.co/OtbLMPZn7o","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1143523243476865025","created_at":"2019-06-25T14:16:01.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":211,"end":234,"url":"https://t.co/hN2PkJuDEe","expanded_url":"https://www.transparimed.org/single-post/2019/06/20/Fantastic-news-UK-universities-get-serious-about-clinical-trial-transparency","display_url":"transparimed.org/single-post/20…"},{"start":235,"end":258,"url":"https://t.co/1rVLkozyBo","expanded_url":"https://twitter.com/TranspariMED/status/1141987263875883008/photo/1","display_url":"pic.twitter.com/1rVLkozyBo"}],"annotations":[{"start":41,"end":42,"probability":0.8267,"type":"Place","normalized_text":"UK"},{"start":193,"end":198,"probability":0.97,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"YNatsis","id":"741404372"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"837335683215798272","id":"1141987263875883008","in_reply_to_user_id":"116716199","text":"@EMA_News @YNatsis \nExcellent news: Most UK univerities now working hard to improve their clinical trial reporting\n\n-&gt; prospectively &amp; retrospectively\n\n-&gt; good models for other universities in Europe\n\nhttps://t.co/hN2PkJuDEe https://t.co/1rVLkozyBo","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"1141987263875883008","created_at":"2019-06-21T08:32:35.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":["3_1141986331809189888"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":63,"end":86,"url":"https://t.co/R37jSdv2z9","expanded_url":"https://www.theguardian.com/politics/2019/jun/19/vital-medicine-supplies-risk-no-deal-brexit-mps-warned-pharmaceutical-industry?CMP=Share_AndroidApp_Tweet","display_url":"theguardian.com/politics/2019/…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"18800238","id":"1141345766616784896","in_reply_to_user_id":"116716199","text":"@EMA_News surely this headline should be \"..MPs warned again\"\n\nhttps://t.co/R37jSdv2z9","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1141345766616784896","created_at":"2019-06-19T14:03:30.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":36,"end":59,"url":"https://t.co/izY3g1CQ2o","expanded_url":"https://twitter.com/keplerniko/status/1141317689920643075/photo/1","display_url":"pic.twitter.com/izY3g1CQ2o"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":23,"username":"relocatemaEN","id":"1005070894602039296"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"42232124","id":"1141317689920643075","in_reply_to_user_id":"116716199","text":"@EMA_News @relocatemaEN We miss you https://t.co/izY3g1CQ2o","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1141317689920643075","created_at":"2019-06-19T12:11:56.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1141317675257344000"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":227,"end":250,"url":"https://t.co/67doiqadb9","expanded_url":"https://www.ema.europa.eu/en/news/consultation-draft-guideline-quality-requirements-medical-devices-combination-products","display_url":"ema.europa.eu/en/news/consul…"},{"start":251,"end":274,"url":"https://t.co/RNqlTl7NHk","expanded_url":"https://twitter.com/ECCRT/status/1140983032922431490/photo/1","display_url":"pic.twitter.com/RNqlTl7NHk"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":88,"tag":"medicaldevices"}]},"possibly_sensitive":false,"lang":"en","author_id":"373932811","id":"1140983032922431490","in_reply_to_user_id":"116716199","text":"@EMA_News has released a draft guideline on the quality requirements for #medicaldevices in human medicines that include a medical device, known as drug-device combinations, for a 3-month public consultation. Find out more in:\nhttps://t.co/67doiqadb9 https://t.co/RNqlTl7NHk","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1140983032922431490","created_at":"2019-06-18T14:02:08.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":["3_1140983017000906752"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":253,"end":276,"url":"https://t.co/7d2OdqOaPj","expanded_url":"https://bit.ly/2N2ith0","display_url":"bit.ly/2N2ith0"},{"start":277,"end":300,"url":"https://t.co/8ylzQCtwNV","expanded_url":"https://twitter.com/PrimeVigilance/status/1140574456156434432/photo/1","display_url":"pic.twitter.com/8ylzQCtwNV"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":11,"end":15,"tag":"EMA"},{"start":44,"end":49,"tag":"PRAC"}]},"possibly_sensitive":false,"lang":"en","author_id":"2615562036","id":"1140574456156434432","in_reply_to_user_id":"116716199","text":"@EMA_News  #EMA Meeting highlights from the #PRAC 11-14 June 2019 NOW available. PRA has started a review of leuprorelin medicines ...to read more and about all their latest signals and reports click on the following link to their latest meeting agenda https://t.co/7d2OdqOaPj https://t.co/8ylzQCtwNV","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1140574456156434432","created_at":"2019-06-17T10:58:35.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":["3_1140574447637794816"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":121,"end":144,"url":"https://t.co/tt6gv7FqFM","expanded_url":"https://twitter.com/DrvanBemden/status/1139497558525583360/photo/1","display_url":"pic.twitter.com/tt6gv7FqFM"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":85,"end":95,"username":"eular_org","id":"273422795"},{"start":107,"end":120,"username":"ArthritisFdn","id":"17076146"}],"hashtags":[{"start":35,"end":54,"tag":"patientpartnership"},{"start":58,"end":84,"tag":"medicalproductdevelopment"},{"start":96,"end":106,"tag":"EULAR2019"}]},"possibly_sensitive":false,"lang":"en","author_id":"342232437","id":"1139497558525583360","in_reply_to_user_id":"116716199","text":"@EMA_News sharing great example of #patientpartnership in #medicalproductdevelopment @eular_org #EULAR2019 @ArthritisFdn https://t.co/tt6gv7FqFM","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1139497558525583360","created_at":"2019-06-14T11:39:23.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1139497552787755011"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":119,"end":142,"url":"https://t.co/FyOKFhH2kB","expanded_url":"https://twitter.com/oligogirl/status/1138704713417994240/photo/1","display_url":"pic.twitter.com/FyOKFhH2kB"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":49,"end":59,"username":"kardamyla","id":"59722141"}],"hashtags":[{"start":27,"end":48,"tag":"eurordissummerschool"}]},"possibly_sensitive":false,"lang":"en","author_id":"705814975198183425","id":"1138704713417994240","in_reply_to_user_id":"116716199","text":"@EMA_News day today at the #eurordissummerschool @kardamyla kicks off with an overview of what EMA is and what they do https://t.co/FyOKFhH2kB","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":6,"quote_count":0},"conversation_id":"1138704713417994240","created_at":"2019-06-12T07:08:54.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":["3_1138704706832871424"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1587585210","id":"1138460188921536513","in_reply_to_user_id":"116716199","text":"@EMA_News Great... waiting for discussion","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1138457106313465856","created_at":"2019-06-11T14:57:15.000Z","referenced_tweets":[{"type":"replied_to","id":"1138457106313465856"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":51,"end":70,"tag":"enfermedaddeWilson"},{"start":178,"end":188,"tag":"genéricos"},{"start":197,"end":209,"tag":"tratamiento"},{"start":213,"end":234,"tag":"infeccionesmicóticas"}]},"possibly_sensitive":false,"lang":"es","author_id":"1006500622982578176","id":"1137662872882991104","in_reply_to_user_id":"116716199","text":"@EMA_News ha aprobado: \n📌 \"Cufence\" para tratar la #enfermedaddeWilson\n\n📌\"LysaKare\" para proteger los riñones de la radiación durante la terapia con oxutotreotida lutecio \n\n📌Dos #genéricos para el #tratamiento de #infeccionesmicóticas : Posaconazol Accord  y Posaconazol AHCL.","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1137662872882991104","created_at":"2019-06-09T10:09:00.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":21,"end":44,"url":"https://t.co/WdzLQMCrDr","expanded_url":"https://www.amazon.co.uk/dp/1912639610/","display_url":"amazon.co.uk/dp/1912639610/"}],"annotations":[{"start":118,"end":124,"probability":0.7736,"type":"Product","normalized_text":"Twitter"},{"start":178,"end":184,"probability":0.7025,"type":"Product","normalized_text":"Twitter"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"EU_Health","id":"606325697"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"145703465","id":"1136657319650103298","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Health https://t.co/WdzLQMCrDr Wrote book while going thru breast cancer. Because of brain injury I use Twitter daily to augment memory so my marketing plan is via Twitter (No Plan). Hope u find time to read this unique story","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1136636358896836608","created_at":"2019-06-06T15:33:17.000Z","referenced_tweets":[{"type":"replied_to","id":"1136636358896836608"}],"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":128,"end":151,"url":"https://t.co/cF8TZ2TxGm","expanded_url":"https://bit.ly/2Z2YqQS","display_url":"bit.ly/2Z2YqQS"},{"start":152,"end":175,"url":"https://t.co/bGyMCjUNPc","expanded_url":"https://twitter.com/PracticalPain/status/1136362052350611456/photo/1","display_url":"pic.twitter.com/bGyMCjUNPc"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":21,"end":35,"tag":"Buprenorphine"},{"start":91,"end":97,"tag":"Sixmo"}]},"possibly_sensitive":false,"lang":"en","author_id":"288268474","id":"1136362052350611456","in_reply_to_user_id":"116716199","text":"@EMA_News Recommends #Buprenorphine Implant Device: Trial shows better patient response to #Sixmo than sublingual buprenorphine https://t.co/cF8TZ2TxGm https://t.co/bGyMCjUNPc","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1136362052350611456","created_at":"2019-06-05T20:00:00.000Z","referenced_tweets":{},"source":"TweetDeck","attachments":{"media_keys":["3_1135558826495762434"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":38,"end":61,"url":"https://t.co/1e6Wl7FGKd","expanded_url":"https://twitter.com/hvanrootselaar/status/1136224685740441600","display_url":"twitter.com/hvanrootselaar…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":24,"username":"EU_Commission","id":"157981564"},{"start":25,"end":37,"username":"Europarl_EN","id":"36329597"}],"hashtags":{}},"possibly_sensitive":false,"lang":"und","author_id":"1286629496","id":"1136225619417677825","in_reply_to_user_id":"116716199","text":"@EMA_News @EU_Commission @Europarl_EN https://t.co/1e6Wl7FGKd","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1136225619417677825","created_at":"2019-06-05T10:57:52.000Z","referenced_tweets":[{"type":"quoted","id":"1136224685740441600"}],"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"886108661160042497","id":"1135938072774873088","in_reply_to_user_id":"116716199","text":"@EMA_News just issued a draft \"Guideline on the quality requirements for drug-device combinations\". \n\n\"The availability of commercialised devices with automated functions is increasing and this may benefit patients (...).","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"1135938072774873088","created_at":"2019-06-04T15:55:15.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"1054276143514304514","id":"1135547971729330177","in_reply_to_user_id":"116716199","text":"@EMA_News Something to bear in mind when planning clinical investigations with combination products.","public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"1135536707191881729","created_at":"2019-06-03T14:05:08.000Z","referenced_tweets":[{"type":"replied_to","id":"1135536707191881729"}],"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":253,"end":276,"url":"https://t.co/NAZiyBsA3M","expanded_url":"https://www.bmj.com/content/365/bmj.l2268.full?ijkey=zAzJqEcHVHgVTuL&keytype=ref","display_url":"bmj.com/content/365/bm…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":43,"end":54,"tag":"HPVVaccine"},{"start":235,"end":242,"tag":"Bought"},{"start":243,"end":251,"tag":"science"}]},"possibly_sensitive":false,"lang":"en","author_id":"1115357260539154432","id":"1134508654433054720","in_reply_to_user_id":"116716199","text":"@EMA_News review of assoc between POTS and #HPVVaccine used only half of manufacturer randomised trials and follow ups. 3 years on, independent investigators are no closer to having more than half of eligible reports for their review. #Bought #science. https://t.co/NAZiyBsA3M","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1134508654433054720","created_at":"2019-05-31T17:15:16.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":184,"end":207,"url":"https://t.co/ZyvQX1EWYy","expanded_url":"https://go.nature.com/2X8Qn4d","display_url":"go.nature.com/2X8Qn4d"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":209,"end":225,"tag":"DrugDevelopment"},{"start":226,"end":237,"tag":"Healthcare"}]},"possibly_sensitive":false,"lang":"en","author_id":"890860865985105920","id":"1134049838096683015","in_reply_to_user_id":"116716199","text":"@EMA_News article shows that eliminating scientifically justified flexibility in drug development and authorization, may not produce good results for patients and health-care systems. https://t.co/ZyvQX1EWYy\n\n#DrugDevelopment #Healthcare","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1134049838096683015","created_at":"2019-05-30T10:52:05.000Z","referenced_tweets":{},"source":"Twitter Web App","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":57,"end":80,"url":"https://t.co/2KjaN8ZOFS","expanded_url":"https://www.onclive.com/web-exclusives/ema-accepts-application-for-trastuzumab-biosimilar","display_url":"onclive.com/web-exclusives…","status":200,"unwound_url":"https://www.onclive.com/view/ema-accepts-application-for-trastuzumab-biosimilar"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"43051682","id":"1133810379266699264","in_reply_to_user_id":"116716199","text":"@EMA_News Accepts Application for Trastuzumab Biosimilar https://t.co/2KjaN8ZOFS","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1133810379266699264","created_at":"2019-05-29T19:00:34.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":{},"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"297306966","id":"1132923467781873664","in_reply_to_user_id":"116716199","text":"@EMA_News It would be a good idea to ensure that all regulatory websites were put in layman terms for reporting ADRS .\n\nYou will find some complicated even HCP can't find there way around...","public_metrics":{"retweet_count":2,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"1130779134479740930","created_at":"2019-05-27T08:16:18.000Z","referenced_tweets":[{"type":"replied_to","id":"1130779134479740930"}],"source":"Twitter for Android","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":85,"end":108,"url":"https://t.co/xi95XqEWeF","expanded_url":"https://tinyurl.com/yxbe6cvv","display_url":"tinyurl.com/yxbe6cvv"},{"start":109,"end":132,"url":"https://t.co/5kUsGAm2eb","expanded_url":"https://twitter.com/onmedicanews/status/1132602405219180544/photo/1","display_url":"pic.twitter.com/5kUsGAm2eb"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"42178750","id":"1132602405219180544","in_reply_to_user_id":"116716199","text":"@EMA_News announces withdrawal of marketing authorisations for fenspiride medicines: https://t.co/xi95XqEWeF https://t.co/5kUsGAm2eb","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1132602405219180544","created_at":"2019-05-26T11:00:30.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":["3_1132602403289747456"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":197,"end":220,"url":"https://t.co/hK2l4p26lI","expanded_url":"https://bit.ly/2HyUUHW","display_url":"bit.ly/2HyUUHW"},{"start":221,"end":244,"url":"https://t.co/tOf763MTg6","expanded_url":"https://twitter.com/LungCancerEu/status/1131955377011077120/photo/1","display_url":"pic.twitter.com/tOf763MTg6"}],"annotations":[{"start":131,"end":136,"probability":0.9949,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":158,"end":176,"tag":"ManyFacesOneVoice"},{"start":177,"end":195,"tag":"SafetyOfMedicines"}]},"possibly_sensitive":false,"lang":"en","author_id":"811532090655260672","id":"1131955377011077120","in_reply_to_user_id":"116716199","text":"@EMA_News launched a social media campaign to highlight how the European medicines regulatory network keeps medicines available in Europe safe and effective.\n#ManyFacesOneVoice #SafetyOfMedicines \nhttps://t.co/hK2l4p26lI https://t.co/tOf763MTg6","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1131955377011077120","created_at":"2019-05-24T16:09:27.000Z","referenced_tweets":{},"source":"Twitter for Android","attachments":{"media_keys":["3_1131955374897213440"]},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":133,"end":156,"url":"https://t.co/SBPgUILOTw","expanded_url":"http://miguelangelblanes.com/2019/05/21/la-","display_url":"miguelangelblanes.com/2019/05/21/la-","status":200,"unwound_url":"http://miguelangelblanes.com/2019/05/21/la-transparencia-del-precio-real-de-los-medicamentos-financiados-con-fondos-publicos/"}],"annotations":[{"start":126,"end":131,"probability":0.9925,"type":"Place","normalized_text":"España"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"es","author_id":"516897567","id":"1131584419192606722","in_reply_to_user_id":"116716199","text":"@EMA_News Por si resulta de utilidad: la transparencia del precio real de los medicamentos financiados con fondos públicos en España https://t.co/SBPgUILOTw","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1131584419192606722","created_at":"2019-05-23T15:35:24.000Z","referenced_tweets":{},"source":"Twitter for iPhone","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":162,"end":185,"url":"https://t.co/atYb7xnb5N","expanded_url":"http://ow.ly/Dq1550umG3y","display_url":"ow.ly/Dq1550umG3y"}],"annotations":[{"start":135,"end":140,"probability":0.9975,"type":"Place","normalized_text":"Europe"}],"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{}},"possibly_sensitive":false,"lang":"en","author_id":"3331528055","id":"1131571760070103040","in_reply_to_user_id":"116716199","text":"@EMA_News has launched a social media campaign highlighting how the European medicines regulatory network keeps medicines available in Europe safe and effective. https://t.co/atYb7xnb5N","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1131571760070103040","created_at":"2019-05-23T14:45:05.000Z","referenced_tweets":{},"source":"Hootsuite Inc.","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":202,"end":225,"url":"https://t.co/fHfzbeepCF","expanded_url":"https://hpr-rps.hres.ca/static/content/form-formule.php?lang=en","display_url":"hpr-rps.hres.ca/static/content…"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":35,"tag":"HealthCanada"}]},"possibly_sensitive":false,"lang":"en","author_id":"795374891814031361","id":"1130801118076968960","in_reply_to_user_id":"116716199","text":"@EMA_News Aligns with #HealthCanada Plain Language Label initiative to maximize patient engagement and safety. On-line side-effect form facilitates direct reporting of incidents by consumers, patients. https://t.co/fHfzbeepCF","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"1130779134479740930","created_at":"2019-05-21T11:42:50.000Z","referenced_tweets":[{"type":"replied_to","id":"1130779134479740930"}],"source":"Twitter Web Client","attachments":{"media_keys":{}},"geo":{"coordinates":{"coordinates":{}}}},{"entities":{"urls":[{"start":257,"end":280,"url":"https://t.co/BnBImxKL1Z","expanded_url":"https://bit.ly/2JTpoGq","display_url":"bit.ly/2JTpoGq"},{"start":281,"end":304,"url":"https://t.co/ktPFBNFtGZ","expanded_url":"https://twitter.com/PrimeVigilance/status/1130397841728442370/photo/1","display_url":"pic.twitter.com/ktPFBNFtGZ"}],"annotations":{},"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":44,"end":49,"tag":"PRAC"}]},"possibly_sensitive":false,"lang":"en","author_id":"2615562036","id":"1130397841728442370","in_reply_to_user_id":"116716199","text":"@EMA_News 13-16 May 2019 Meeting highlights #PRAC on all topics discussed and recommendations on risk management of medicines for human, recommends withdrawal of marketing authorisations for fenspiride medicines and restrictions in use of Xeljanz.. more at https://t.co/BnBImxKL1Z https://t.co/ktPFBNFtGZ","public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"1130397841728442370","created_at":"2019-05-20T09:00:21.000Z","referenced_tweets":{},"source":"Twitter Web Client","attachments":{"media_keys":["3_1130397650191306753"]},"geo":{"coordinates":{"coordinates":{}}}}]
